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Abstract
The Ryan White HIV/AIDS Program (RWHAP) provides HIV care to uninsured people
living with HIV/AIDS (PLWHA). Although the RWHAP has helped PLWHA achieve a
viral suppression rate of 84%, this does not meet the 90% target goals under the U.N. 9090-90 plan to end the AIDS epidemic. The Affordable Care Act (ACA) was enacted to
enhance access and health status, but outcomes have not been measured for PLWHA.
The purpose of this quantitative correlational cross-sectional study was to determine
whether PLWHA enrolled in an ACA qualified health plan (ACAQHP) achieved
improved health status compared to PLWHA enrolled in the RWHAP. Andersen’s
behavioral model of health services use provided the theoretical framework for this study.
Research questions addressed variables such as demographic factors, difficulty in paying
out-of-pocket medical expenses, health status, coverage status, treatment compliance, and
engagement in care. A purposeful convenience sample of weighted secondary data from
30,670 PLWHA residing in Florida who participated in the 2015-2017 Medical
Monitoring Project survey was used. Multiple linear regression only showed a
statistically significant relationship between engagement in care and health status. MannWhitney U tests indicated a statistically significant difference in treatment compliance
and engagement in care, but not in health status between RWHAP and ACAQHP
enrollees. Findings also showed that those enrolled in the ACAQHP had less difficulty in
paying their health care expenses than those in the RWHAP. Study results may be used to
encourage enrollment in an ACAQHP and improve health outcomes due to access to
more affordable comprehensive services.
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Chapter 1: Introduction to the Study
Introduction
HIV is a public health concern in the United States as approximately 1.1 million
people are currently diagnosed with HIV and an additional 50,000 new cases are detected
annually (McQuade, Raimondo, Phivilay-Bessette, Marak, & Loberti, 2015). The federal
government created the Ryan White HIV/AIDS program (RWHAP) in 1990 to help
people living with HIV/AIDS (PLWHA) receive necessary medical care (Health
Resources and Services Administration [HRSA], 2016a). The RWHAP is the payer of
last resort as it provides funding for the medical care for more than 500,000 enrollees and
covers expenses related to HIV medical services, case management, support services,
antiretroviral therapy (ART) medications, health insurance premiums, coinsurance,
copayments, and deductibles after all other sources of insurance coverage have been
exhausted (Morin, 2015).
The Affordable Care Act (ACA) was passed into law in 2010 to improve
insurance access and benefit quality of medical care for the underinsured and uninsured
(U.S. Department of Health & Human Services, 2016b). Prior to the passage of the ACA,
an estimated 30% (380,000) of PLWHA did not have health insurance and relied solely
on support from the RWHAP (Rozin et al., 2015). Improved access under the ACA was
achieved through the creation of state health care exchanges to sell insurance policies to
consumers, the expansion of Medicaid coverage, and the elimination of insurance
companies having the ability to deny coverage due to preexisting conditions (U.S.
Department of Health & Human Services, 2016b). Because the RWHAP covers only
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HIV-related care and support services on an outpatient basis, the ACA expanded the
benefits offered to PLWHA by including access to physicians for preventive and
subspecialty care and hospitalization, eliminated financial lifetime limits on covered
claims, and improved the coordination and delivery of care (Dawson & Kates, 2015; U.S.
Department of Health & Human Services, 2016b). To minimize monthly premium costs,
ACA health insurance plans include large patient out-of-pocket expenses due to
copayments, coinsurance, and deductibles. Researchers have shown that allocating
greater financial costs to people enrolled in high-deductible health plans reduces the
utilization of needed health care services resulting in a delayed diagnosis and increased
rate of suffering and mortality for many chronic diseases including HIV/AIDS, cancer,
and diabetes (Kannan & Veazie, 2014; Taber, Leyva, & Persoskie, 2015). To eliminate
the burden of these out-of-pocket expenses, the HRSA (2014) approved the use of
RWHAP funds to support the enrollment of their ACA-eligible consumers to an ACA
Silver level plan by paying for insurance premiums, deductibles, copayments, and other
out-of-pocket health care expenses.
Despite the creation of the RWHAP to provide PLWHA with HIV/AIDS-related
care, PLWHA have not achieved the necessary level of viral suppression. It is unclear
whether the transition to ACA health insurance coverage for PLWHA in Florida has
resulted in improved health outcomes as measured by an increase in the viral suppression
among PLWHA. This quantitative correlational cross-sectional study was conducted to
review de-identified patient data obtained from the Florida Department of Health to
determine whether PLWHA enrolled in an ACA qualified health plan (ACAQHP)
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achieved improved health status compared to PLWHA enrolled in the RWHAP. The
results may lead to individuals afflicted with HIV/AIDS benefiting from improved health
status by availing themselves of the subsidies offered to purchase ACA health insurance
coverage. Chapter 1 includes the study background, problem statement, purpose, research
questions and hypotheses, theoretical framework, nature of study, term definitions,
assumptions, limitations, scope, delimitations, and significance of the study.
Background
Prior to the passage of the ACA in 2010, millions of Americans did not have
health insurance coverage. The uninsured rate among the nonelderly population surged in
the years immediately preceding the passage of this important legislation (The Henry J.
Kaiser Family Foundation, 2016b). During calendar year 2010, more than 47 million
people representing over 18% of the population of the United States did not have health
insurance (Garfield, Majerol, Damico, & Foutz, 2016; The Henry J. Kaiser Family
Foundation, 2016b). The health insurance coverage status of an individual is an important
determinant in their overall health. Individuals with health insurance are generally
healthier and experience lower disease and overall mortality rates than those without
health insurance coverage (Wilper et al, 2009). Wilper et al. (2009) indicated that nearly
45,000 people die annually due to the lack of health insurance coverage. If the dearth of
health insurance were considered an illness or disease, it would be ranked as the 10th
leading cause of death in the United States (Centers for Disease Control and Prevention
[CDC], 2017c). Work-aged people without health insurance experience a risk of death
that is 40% higher than similarly aged people with health insurance coverage (Wilper et
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al., 2009). Health insurance coverage has been found to be associated with the improved
diagnosis, treatment, management, and mortality rate for people afflicted with numerous
chronic medical conditions (Hogan et al., 2015; Yehia et al., 2014). Individuals covered
with health insurance experienced a 14% increase in the frequency of being diagnosed
with diabetes and high cholesterol and a 9% increase in the rate of diagnosis for high
blood pressure (Hogan et al., 2015). People with health insurance were also more likely
to have a lower blood pressure, total cholesterol, and hemoglobin A1C (Hogan et al.,
2015). Health insurance coverage is also associated with prolonged viral suppression,
reduced likelihood of HIV progressing to AIDS, and reduced likelihood of premature
death (Bradley et al., 2016; Dawson and Kates, 2019; McManus et al., 2016; McManus et
al., 2018; Raifman et al., 2019; Yehia et al., 2014).
To reduce the number of people without health insurance coverage and improve
overall health, the ACA was passed into law in 2010. Numerous provisions were written
into the law to achieve health-related goals. First, the ACA includes an individual
mandate that requires all U.S. citizens and legal residents to obtain health insurance
coverage or pay a fine (Kates, Dawson, Undem, & Perry, 2014; Westmoreland, 2016).
The fine serves as an inducement to encourage people to sign up for health insurance
coverage. The penalty for not enrolling in a health insurance plan in 2018 was the greater
of 2.5% of annual household income, or a per person charge of $695 per adult with a
maximum of $2,085 per family per year (Internal Revenue Service, 2017b).
Consumer protections were included in the ACA to ensure that insurance
companies continued to provide coverage and pay for needed health care services should
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an enrollee become afflicted with a medical problem. For example, provisions of the
ACA preclude insurance companies from denying coverage or raising the premium rates
for people with preexisting medical conditions, establishing annual or lifetime financial
coverage limits, and retroactively cancelling coverage after a person gets sick if they are
found to have made inconsequential or irrelevant mistakes on an enrollment application
form (Hellinger, 2015; Rozin et al., 2015; U.S. Department of Health & Human Services,
2017n; Viall, McCray, Mermin, & Wortley, 2016). Prior to the passage of the ACA,
insurance companies used these strategies to minimize their claims exposure for PLWHA
and other high-cost medical conditions. Additional requirements of the ACA include
coverage for preventive health care services and the creation of a minimum medical loss
ratio mandating the insurance companies spend between 80% and 85% of their premium
dollars collected on health care claims (Kantarjian, 2017; The Henry J. Kaiser Family
Foundation, 2015).
The federal governmental has made a substantial financial investment to subsidize
the costs associated with purchasing ACA health insurance. The Congressional Budget
Office (as cited in Ferris, 2016) estimated that ACA subsidies cost the federal
government approximately $660 billion in 2016 and will cost an estimated $1.1 trillion
over the next 10 years. Because of this financial investment, the number of people
without health insurance has dramatically declined. From 2010 to 2016, the number of
people without health insurance coverage decreased from 47 million to 27 million (The
Henry J. Kaiser Family Foundation, 2016b, 2017a). Although the ACA reduced the
number of people without health insurance, the reform initiative has failed to control
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rising health care costs resulting in the proliferation of high-deductible health plans.
Patients enrolled in health insurance plans with high deductibles avoid seeking needed
medical care. To minimize paying out-of-pocket financial costs, patients with high
deductibles avoid getting physician-recommended diagnostic tests or procedures.
Medical care avoidance delays disease diagnosis; reduces treatment options and health
outcomes for a wide variety of health ailments including several types of cancer, heart
disease, stroke, and arthritis; and increases overall suffering and the rate of mortality
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016; Taber et al., 2015).
Considering the large financial investment spent on the ACA, it is important to
understand whether this legislation has enhanced the health of PLWHA.
HIV/AIDS is a serious health problem for people living in the United States and
specifically in the state of Florida. Nationally, there are more than 1.1 million PLWHA;
in 2014, Florida had the third largest number of residents diagnosed and living with HIV
at 110,000 (CDC, 2016b; Florida Department of Health, 2016b). The advent of ART
medications turned HIV/AIDS from a fatal disease into a chronic medical condition.
PLWHA who are compliant in taking their ART medications are more likely to become
virally suppressed, which increases overall survival rates and reduces the spread of the
disease (Drainoni et al., 2015; Greenberg, Purcell, Gordon, Barasky, & del Rio, 2015).
PLWHA who are virally suppressed can experience a life expectancy similar to people
who are not infected with the disease. Although ART medications are effective in
slowing the progression of the disease and prolonging the lives of PLWHA, they are
extremely expensive. The RWHAP, which was enacted in 1990, provides resources to
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low-income underinsured or uninsured PLWHA to cover HIV/AIDS expenses related to
medical services, food, housing, case management, support services, ART medications,
mental health, and substance abuse treatment (McQuade et al., 2015; Weiser et al., 2015).
As the third largest recipient of HIV/AIDS treatment funding behind Medicare and
Medicaid, the RWHAP provides care to 66% of PLWHA in the United States (The Henry
J. Kaiser Family Foundation, 2017b). PLWHA are more likely to become virally
suppressed if they receive care from RWHAP facilities (Morin, 2015).
Problem Statement
Several researchers have studied the impact of the services provided by the
RWHAP on the health of PLWHA. Morin (2015) and Weiser et al. (2015) demonstrated
improved health outcomes as measured by improved viral suppression for people
enrolled in the RWHAP. Researchers have attributed the improved health outcomes of
Ryan White PLWHA to the additional support services provided such as case
management and mental health (Morin, 2015). Cahill, Mayer, and Boswell (2015) found
that 73% of PLWHA enrolled in the RWHAP received continuous care (two physician
visits, at least 3 months apart, within the previous 12 months) as compared to 51% of
PLWHA who were not enrolled in the program.
Although the RWHAP has improved the health of PLWHA, the United States has
failed to meet global health goals for the detection and treatment of HIV/AIDS set by the
World Health Organization and the United Nations. The Joint United Nations Program on
HIV/AIDS (UNAIDS) launched the 90-90-90 campaign to increase HIV/AIDS detection
and treatment (Morin, 2015; UNAIDS, 2018). The objective of the program is to improve
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the detection rate of HIV to 90% of those infected, provide sustained ART treatment to
90% of those detected, and virally suppress 90% of the cases treated (Morin, 2015;
UNAIDS, 2018). Currently the HIV detection rate in the United States is 86%, while only
37% of PLWHA nationally are prescribed ART medications and only 30% are virally
suppressed (Greenberg et al., 2015; U.S. Department of Health & Human Services,
2016b).
Although the research regarding the health of PLWHA enrolled in the RWHAP
provided important findings, I found only three studies in which researchers examined
whether the comprehensive health insurance provided by the ACA improved the overall
health status of PLWHA compared to those receiving Ryan White Care. In a study of
PLWHA residing in Virginia who transitioned from the RWHAP to an ACAQHP,
McManus et al. (2016) and McManus et al. (2018) reported that ACA coverage was
associated with improved viral load suppression. Raifman et al. (2018) reported that
among PLWHA residing in the United States in 2015, 79% who were enrolled in an
ACAQHP were virally suppressed compared to 75% who were enrolled in the RWHAP.
Due to the small study size and narrow geographic focus of these studies, further research
was warranted to determine whether comprehensive health care coverage provided by the
ACA improves the health status of PLWHA compared to PLWHA receiving Ryan White
care.
Purpose of the Study
The purpose of this quantitative correlational cross-sectional research study was
to determine whether the comprehensive care provided by the ACA improves the health
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of PLWHA compared to PLWHA receiving Ryan White care. A cross-sectional design
was employed to measure multiple independent variables including demographic factors,
treatment compliance, and engagement in care on the health of PLWHA enrolled in an
ACAQHP compared to PLWHA enrolled in the RWHAP. Levin (2006) wrote that crosssectional research is commonly used in social-science studies because it facilitates an
understanding of the overall etiology of a disease and assists in the generation of research
hypotheses. My study provided information on the impact that ACA health insurance
coverage had on the health of PLWHA compared to the health of PLWHA in the
RWHAP. Based on the substantial investment of public funds, it is important to
understand whether PLWHA who enroll in an ACAQHP achieve improved health
compared to PLWHA who enroll in the RWHAP.
Research Questions and Hypotheses
RQ1: What is the relationship between demographic factors (race, gender, age,
education level, and federal poverty level), treatment compliance (as defined by the
number of ART missed doses in the past 30 days), engagement in care (as defined by the
number of HIV/AIDS-related physician visits within the previous 12 months), and
coverage status (enrolled in the RWHAP or an ACAQHP) and the health status of
PLWHA (as defined by viral suppression)?
Ho1: There is no statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
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months), and coverage status (enrolled in the RWHAP or an ACAQHP) and the health
status of PLWHA (as defined by viral suppression).
Ha1: There is a statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months), and coverage status (enrolled in the RWHAP or an ACAQHP) and the health
status of PLWHA (as defined by viral suppression).
RQ2: What is the difference in treatment compliance (as defined by the number of
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP?
Ho2: There is no statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
Ha2: There is a statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
RQ3: What is the difference in engagement in care (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
Ho3: There is no statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
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months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
Ha3: There is a statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
RQ4: What is the difference in health status (as defined by viral suppression)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
Ho4: There is no statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
Ha4: There is a statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
RQ5: What is the difference in difficulty in paying out-of-pocket medical
expenses (as defined by problems paying for any out-of-pocket medical or health
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP?
Ho5: There is no statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
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Ha5: There is a statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
Theoretical Framework
The theoretical framework that I used for my study was Andersen’s behavioral
model of health services use. Since its inception, the behavioral model of health services
use has become widely accepted and is the most commonly used framework to predict
and explain the factors that impact health care access, utilization, and health outcomes
(Graham, Hasking, Brooker, Clarke, & Meadows, 2017). Andersen and Newman (2005)
postulated that the volume of health care services consumed by an individual is
dependent on the predisposition of a person to utilize health care services, enabling
factors of the person that facilitate access to health care services, and the diagnosed
illness severity of the health care consumer. These three stages of the behavioral model of
health services use, combined with the subset of operational variables from each stage,
thematically complemented the dependent variable, independent variables, and research
questions in my study. The independent variables, which included gender, race, age, and
education level, were encompassed in the demographic and social structure
characteristics that are part of the predisposing stage of the model (see Andersen &
Newman, 2005). Other demographic independent variables such as income and patient
out-of-pocket medical cost sharing expenses were represented in the model as financial
aspects of enabling characteristics (see Andersen & Newman, 2005). Treatment
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compliance and engagement of care were classified as finance and community subgroups
of enabling characteristics (see Andersen & Newman, 2005). Finally, the dependent
variable (health status) was represented in the model as an evaluated symptom/diagnosis,
which is a subcomponent of illness level, the third stage of the model (see Andersen &
Newman, 2005).
Andersen’s behavioral model of health services use was suited to serve as a
theoretical foundation for this study because it is regularly used to study PLWHA.
Brennan, Morley, O’Leary, Bergin, and Horgan (2015) utilized Andersen’s model to
examine factors that influenced the utilization of HIV outpatient services, while
Holtzman et al. (2015) used the model to study factors that impacted treatment access,
adherence, and compliance. Additionally, Walter et al. (2016) applied the model to
examine the impact of decreased drug use on reduced HIV sexual risk behaviors. Ford,
Godette, Mulatu, and Gaines (2015) used the model to study HIV testing prevalence and
disparities among older adults in the United States. Finally, Haley et al. (2014) used
Andersen’s model to develop retention strategies to reduce the number of missed office
visits among low-income women residing in areas with a high prevalence of HIV. This
model is described in greater detail in Chapter 2.
Nature of Study
I used a quantitative correlational cross-sectional design to examine the
relationships between demographic factors, treatment compliance, engagement in care,
and the health of PLWHA enrolled in the RWHAP or an ACAQHP. Levin (2006) wrote
that cross-sectional research is commonly used in social-science studies to facilitate an
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understanding of the overall etiology of a disease because data regarding risk exposure
can be gathered and associations between risk factors can be determined. A crosssectional design is frequently used when scholars are trying to understand the impact of
multiple independent variables on a dependent variable, when measured at a specific
point in time (Frankfort-Nachmias, Nachmias, & DeWaard, 2015).
There are three principal advantages of a cross-sectional research design. First, a
cross-sectional design enables researchers to conduct studies in natural and real-world
situations using probability samples that increase the external validity of the study
(Frankfort-Nachmias et al., 2015). Second, the random assignment of study participants
to a control and experimental group is not needed in a cross-sectional design (FrankfortNachmias et al., 2015). This was an important consideration because the potential
assignment of patients to either group might result in an adverse health event, which
would be unethical because it would violate the responsibility of the researcher not to
harm their study participants. Third, cross-sectional studies are less costly and timeconsuming to conduct than other types of studies because data are collected at only one
point in time (Levin, 2006).
There are several disadvantages of a cross-sectional design. First, because data in
a cross-sectional study are collected at only one point in time, they may not be
representative of the overall participant being studied (Sedgwick, 2014). Second, it is
problematic to deduce a temporal relationship between an independent variable and an
outcome; therefore, causation is unable to be determined and can only be logically or
theoretically inferred (Frankfort-Nachmias et al., 2015; Sedgwick, 2014). Finally,
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researchers using a cross-sectional design are unable to control for alternative analytical
explanations, which is problematic in developing clear inferences from the data
(Frankfort-Nachmias et al., 2015).
A correlational design is also commonly used in social science and health care
research when researchers are interested in understanding the relationships between
multiple independent variables and a dependent variable in a population (Curtis,
Comiskey, & Dempsey, 2015). A correlational design is used to measure the
relationships between and among two or more variables (Field, 2013). One advantage of
a correlational design is it allows researchers to inexpensively and quickly achieve a large
sample size through the use of archived secondary data (Grand Canyon University,
2018). A second advantage of a correlational design is researchers can study the impact
of different independent variables in a naturally occurring event that may be unethical to
implement in an experimentally designed study (Curtis et al., 2015; Grand Canyon
University, 2018). For example, it would be unethical to withhold ART medications from
PLWHA to investigate the impact on viral load suppression. One disadvantage of a
correlational design is the inability to establish causation among the independent and
dependent variables (Grand Canyon University, 2018). Correlational research addresses
the strength of relationships and cannot be used to establish a cause-and-effect
relationship (Curtis et al., 2015). Additionally, a correlational design does not allow a
researcher to extrapolate findings to answer other research questions (Grand Canyon
University, 2018).
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The Florida Department of Health agreed to share data from the 2018 version of
the Medical Monitoring Project for use in the current study. This secondary data set
provided information on PLWHA who were enrolled in the RWHAP or an ACAQHP. To
protect the confidentiality of the study participants, all personal health data were deidentified. Financial, clinical, and socioeconomic variables including viral load rates,
office visit frequency, ART missed doses in the past 30 days, age, sex, race, educational
level, federal poverty level, and difficulty in paying out-of-pocket medical expenses were
analyzed using SPSS.
I employed a multiple linear regression, an independent samples t test, and a chisquare test to analyze the secondary data, A multiple linear regression analysis is used to
measure the level of statistical significance of association between different independent
variables and a continuous dependent variable (Field, 2013). Multiple linear regression is
frequently used in epidemiologic or health-related studies because it is often unsafe or
unethical to randomly assign study participants to an experimental and control group.
Instead, researchers include different independent variables and attempt to predict the
probability of them affecting the dependent variable. In the current study, a multiple
linear regression analysis was employed to examine the relationship between
demographic factors, treatment compliance, engagement in care, and coverage status and
the health status of PLWHA. Numerous researchers have used a multiple linear
regression analysis to study the impact of health care access on health and compliance,
engagement, and viral suppression among PLWHA (Carrico & Moskowitz, 2014;
Stringer et al., 2016; Turan et al., 2017).
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Second, an independent samples t test was used to examine the difference in mean
treatment compliance, engagement in care, and health status among PLWHA who were
enrolled in the RWHAP or an ACAQHP. The independent samples t test is an
appropriate statistical analysis to answer research questions because an independent
samples t test compares differences in the means between two unrelated groups (Field,
2013). Similar to a linear regression, an independent samples t test is commonly used in
health care research (Pandey, 2015). Furthermore, researchers have used an independent
samples t test to examine viral load suppression, medical care compliance, and
engagement in care among PLWHA, and to investigate the impact of health insurance
coverage on access to care and quality of care (Abuosi, Domfeh, Abor, & NketiahAmponsah, 2016; Drachler, Drachler, Teixeira, & de Carvalho Leite, 2016; Enriquez et
al., 2015; Maman et al., 2015).
Third, a chi-square test was used to measure the difference in difficulty in paying
out-of-pocket medical expenses between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP. A chi-square test is a suitable statistical analysis to answer
research questions because it measures the relationship between categorical variables
among two independent groups (Field, 2013). Researchers have used a chi-square test to
investigate viral load suppression, medical care compliance, and engagement in care
among PLWHA (Chang, Fleming, Nunez, & Dombrowski, 2019; Stitzer et al., 2018).
Definitions
90-90-90 campaign: A United Nations program to end the HIV/AIDs epidemic as
a public health threat by encouraging countries to ensure that 90% of PLWHA are aware
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of their diagnosis, 90% of people diagnosed with HIV regularly receive ART, and 90% of
people on ART become virally suppressed (UNAIDS, 2018).
ACA: An acronym for the Affordable Care Act, which was a piece of health care
reform legislation that was enacted in March of 2010. The main goal of the ACA was to
reduce the number of Americans without health insurance through more affordable
insurance premiums and an expansion of the Medicaid program (U.S. Centers for
Medicare & Medicaid Services, 2017a).
AIDS: An acronym for acquired immunodeficiency syndrome. AIDS is the last
phase of the HIV disease cycle. A diagnosis of AIDS is confirmed if the immune system
of a patient is significantly weakened and the number of CD4 cells drops below 200 cells
per cubic millimeter of blood or upon the contraction of an opportunistic infection (U.S.
Department of Health & Human Services, 2017f).
Antiretroviral therapy (ART): Medications taken by PLWHA to limit the HIV
virus from reproducing, which reduces the amount of HIV virus (viral load) in the body
and the rate of transmission to an uninfected individual (U.S. Department of Health &
Human Services, 2017c).
CD4 count: The number of CD4 cells in a person’s blood as measured by a
laboratory test. CD4 cells are a form of white blood cells that safeguard the body from
bacteria, infections, and a variety of diseases including many forms of cancer. A large
CD4 count indicates better health. The CD4 count of a person without HIV ranges
between 500 and 1,600 cells per cubic millimeter of blood. A CD4 count below 200 cells
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per cubic millimeter indicates that the HIV virus has progressed to AIDS (U.S.
Department of Health & Human Services, 2017g)
Coinsurance: A percentage of the costs incurred for health services or
prescription medications for a patient with health insurance after they met their
deductible (U.S. Centers for Medicare & Medicaid Services, 2017e).
Copayment: The amount of money a patient with health insurance pays each time
they consume a health care service such as a physician visit, emergency room visit,
hospitalization, or prescription (U.S. Centers for Medicare & Medicaid Services, 2017e).
Deductible: The amount of money a patient with health insurance pays for a
covered health care service before their insurance company begins to make payment
(U.S. Centers for Medicare & Medicaid Services, 2017e).
Engagement in care: A variable in this study, which was measured by the number
of HIV/AIDS-related physician visits within the previous 12 months.
Health insurance premium: The financial cost to purchase a health insurance
policy (U.S. Centers for Medicare & Medicaid Services, 2017b).
HIV: An acronym for human immunodeficiency virus. HIV is a virus that attacks
the body’s CD4 cells resulting in a weakened immune system, which is then unable
combat infections and disease. There is no cure for HIV, although appropriate medical
care and medication can control the virus and limit its transmission to other people (CDC,
2016b).
HIV continuum of care: A framework that depicts the successive steps of medical
care that PLWHA should receive and the proportion of PLWHA at each step. The four
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stages of the continuum of care include diagnosed, engaged in care, prescribed ART, and
virally suppressed (CDC, 2017e).
Out-of-pocket maximum: The annual maximum amount of money a patient with
health insurance will spend on deductibles, copayments, and coinsurance before their
health insurance company pays for 100% of the costs for all covered health expenses
(U.S. Centers for Medicare & Medicaid Services, 2018b).
Out-of-pocket medical expenses: The financial cost incurred by a patient to pay
for medical bills, health insurance premiums, deductibles, copayments, and coinsurance
(U.S. Centers for Medicare & Medicaid Services, 2018b).
PLWHA: An acronym for people living with HIV/AIDS (U.S. Department of
Health & Human Services, 2017k).
RWHAP: An acronym for the Ryan White HIV/AIDS Program, which was
established in 1990 when Congress passed the Ryan White Comprehensive AIDS
Resource Emergency (CARE) Act. The RWHAP provides comprehensive medical care
and other health care services on an outpatient basis to PLWHA who are poor, uninsured,
or underinsured (HRSA, 2017a).
Treatment compliance: A variable in this study, which was measured by the
number of missed ART doses in the past 30 days.
Viral load suppression: Viral load measures the amount of HIV particles, or
copies, in a milliliter of blood and is determined through a laboratory test. A high viral
load indicates a greater amount of HIV. The primary objective of HIV treatment is to
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become virally suppressed, which occurs when there are less than 200 copies of the HIV
virus in a sample of blood (U.S. Department of Health & Human Services, 2015a).
Assumptions
There were several assumptions in this study. The first assumption was that
comprehensive health insurance coverage would improve the health of PLWHA (see
Wagner, Wu, & Sood, 2014). Although the scientific literature indicated the health
benefits of having health insurance, a scarcity of information exists on the impact of the
ACA on the health of PLWHA. The second assumption was the sample size of survey
participants enrolled in the RWHAP and in an ACAQHP would be large enough to
generate meaningful results and the sample would be representative of the overall Florida
RWHAP. According to Chow, Shao, Wang, and Lokhnygina (2007), “in clinical
research, sample size calculation plays an important role for assuring validity, accuracy,
reliability, and integrity of the intended clinical study” (p. 1). The third assumption was
that all Medical Monitoring Project interviewers reported the collected data accurately
from the participants who participated in the health survey. The accuracy of the data
collection process is an important consideration in enhancing the validity of the results of
a study so that other researchers may replicate the study or compare the outcomes across
multiple studies; poor clinical documentation may retard the ability to accurately measure
treatment effectiveness and health care outcomes (De Moor et al., 2015; Springate et al.,
2014).
The fourth assumption was that the survey participants understood the questions
being asked of them by the survey data collectors, and provided answers that were
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reliable, accurate, and honest. DeLamater and Plante (2015) noted that asking people
sensitive questions about their sexuality (and associated health complications) may
increase survey response bias due to a larger number of nonresponses or misreported
answers motivated by social desirability to avoid overall embarrassment. The fifth and
final assumption was that the Medical Monitoring Project database included data on all of
the variables examined in this study.
Scope and Delimitations
The scope of a study indicates the topics that will be explored and the
specifications of the data set that will be used to substantiate the analytical findings and
study conclusions (Goes & Simon, 2013). The scope of the current study was limited to
PLWHA residing in Florida who were surveyed as part of the Medical Monitoring
Project and had coverage through the RWHAP or an ACAQHP. All PLWHA who met
the selection criteria were included in this study as long as health care utilization and
outcome data were available. Utilization and outcome data were analyzed using deidentified personal health information obtained by the Florida Department of Health as
part of the Medical Monitoring Project. Although the information contained in this
database is not published or available in the public domain, it was appropriate for use in
the current study because it contains the data needed to answer the research questions (E.
Spencer, personal communication, March 1, 2019). Comparing the health outcomes of
PLWHA enrolled in either the RWHAP or an ACAQHP would provide clarity on the
impact that demographic factors, difficulty in paying out-of-pocket medical expenses,
treatment compliance, and engagement in care have on health status.
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Delimitations occur as a result of the inclusion and exclusion criteria determined
by the researcher (Goes & Simon, 2013). The primary delimitation of the current study
was the focus on PLWHA who resided in Florida, participated in the Medical Monitoring
Project survey, and were enrolled in either the RWHAP or an ACAQHP. The health
outcomes of PLWHA who did not participate in this survey and who had other forms of
health insurance coverage were excluded from this study. A second delimitation was the
impact of comorbidities associated with HIV/AIDS on viral load suppression. The failure
for PLWHA to become virally suppressed may be a result of HIV/AIDS-related
comorbidities and not the failure of the ACA to improve the health of enrollees in the
program (Syed et al., 2016). These delimitations may prevent the findings of the current
study from being generalized to other populations of PLWHA.
Limitations
This study had several limitations. The first limitation was the potential for
inaccurate data and/or poor data entry in the patient’s medical record. Because secondary
data were used for this study, I was dependent on medical personnel to accurately assess,
diagnose, and document patient findings in the medical record. The second limitation was
weaknesses in the design of this study. A quasi-experimental design was used because it
would have been unethical to randomly assign participants to an experimental group and
a control group. However, the absence of adequate control over alternative explanations
limits my to draw clear inferences from the data (Frankfort-Nachmias et al., 2015). In
addition, the use of a correlational cross-sectional design allowed for the measurement of
viral load suppression at one point in time. The primary weakness of a correlational
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cross-sectional design is the inability to determine a cause-and-effect relationship
between the dependent and independent variables (Curtis et al., 2015; Grand Canyon
University, 2018; Setia, 2016; Solem, 2015). This limitation can be diminished through
the use of statistical analysis to approximate an experimental design (Frankfort-Nachmias
et al., 2015).
The third limitation of this study was the use of convenience purposive sampling
methodology. A convenience sample is a nonprobabilistic sampling strategy in which
study participants are selected based on the ease of access for the researcher (Laerd
Statistics, 2012a). Convenience sampling may exhibit bias, and the included participants
may not be representative of the overall population, which may limit the generalizability
of the findings to other populations (Laerd Statistics, 2012a). This is in contrast to
probabilistic sampling techniques, in which the selection of units is made randomly. The
sampling strategy used in the current study was also purposive because the inclusion
criteria required enrollment in either the RWHAP or an ACAQHP. A purposive sampling
strategy is also a nonprobabilistic methodology in which participants are selected based
on qualifications or characteristics selected by the researcher, which may limit the
generalizability of the findings due to researcher bias or a nonrepresentative sample of
participants (Laerd Statistics, 2012d).
Because the reasons why some PLWHA enrolled in either the RWHAP or an
ACAQHP were unknown, the findings of this study may not be generalizable to other
populations but may be representative of trends among PLWHA (see Etikan, Musa, &
Alkassim, 2016; Jager, Putnick, & Bornstein, 2017) The fourth limitation was the
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potential threat to external validity. Frankfort-Nachmias et al. (2015) defined external
validity as the extent to which the findings of a research study can be generalized to other
people or other settings. The sample of PLWHA who have ACAQHP coverage may not
be representative of other PLWHA with ACAQHP coverage in other parts of Florida or
throughout the United States.
The fifth limitation was the threat to internal validity, which may have
compromised the conclusions establishing a relationship between independent and
dependent variables. Threats to internal validity, including include history and
maturation, need to be controlled (Creswell, 2009). History refers to events that transpire
during the passage of time throughout the course of the treatment period that may impact
the results, while maturation refers to changes among study participants (Creswell, 2009).
Significance of the Study
A primary goal of the ACA is to improve health care outcomes for people
enrolled in qualified health plans. The federal government is projected to spend $716
billion annually by the year 2024 to reduce the number of people in the United States
without health insurance and improve the overall health of the population (Jeffrey, 2014).
There is a scarcity of research on the change in the health of people enrolled in an
ACAQHP. Considering the substantial investment in financial resources and time, it is
important for the federal government, politicians, public health leaders, health care
providers, and patients to understand whether people enrolled in ACAQHP achieve
improved health. My study provided an opportunity to examine the health of patients
enrolled in an ACAQHP.
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To measure the relationship between health outcomes and enrollment in an
ACAQHP, I selected the HIV/AIDS patient population for several reasons. First, I had
access to secondary data provided by the Florida Department of Health to assess quality
outcomes once IRB approval was obtained. Second, people with HIV residing in the
Florida have failed to meet the global health goals set by the World Health Organization
and the United Nations regarding the minimum percentage being subscribed ART
medications and becoming virally suppressed (Florida Department of Health, 2016a).
Through examination of the impact that the ACA has on improving the health of
PLWHA, this study has the potential to promote positive social change by assisting
marginalized populations in understanding whether ACA health insurance coverage
improves their overall quality of life. Marginalized populations, including African
Americans, Hispanics, and the poor, represent the largest group of people to receive
health care coverage through the ACA (Ferris, 2015). HIV also affects marginalized
populations because it has disproportionately infected racial, ethnic, and sexual minorities
and people with reduced financial means (Abara & Heiman, 2014; Yehia et al., 2014).
Because researchers have not examined the impact of the ACA on the health of PLWHA
in the state of Florida, the results from my study may provide important information to
close a gap in the literature among the scientific community. Furthermore, the findings
from my study may help raise awareness of the relationship between ACA health
insurance coverage and enhanced quality of life for PLWHA. The results will be shared
with Ryan White programs throughout the United States to help determine how RWHAP
financial resources can be optimized to improve the health of PLWHA.

27
Summary
The ACA was passed in 2010 and was the most substantial piece of health care
legislation enacted since the passage of Medicare and Medicaid in 1965. The primary
objective of the ACA is to increase the percentage of Americans with health insurance so
more people can access needed medical care and achieve an improved level of health.
Although federal expenditures on the ACA will exceed $716 billion by 2024, little
research has been conducted addressing the impact on health of this health care initiative.
The objective of my study was to compare the health of PLWHA enrolled in either the
RWHAP or an ACAQHP within the state of Florida. I also examined the relationships
between demographic factors, out-of-pocket medical expenses, treatment compliance,
and engagement in care on the health of this patient population. The results of this study
may provide quantitative data to determine the impact on health of the ACA and provide
strategies to optimize the percentage of PLWHA achieving viral suppression. The
literature review in Chapter 2 provides an overview of the HIV/AIDS virus, the ACA, the
RWHAP, and the impact that health insurance coverage has on the utilization of health
care services and health outcomes.
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Chapter 2: Literature Review
Introduction
HIV, the virus that causes AIDS, is an important global health problem. In 2015,
2.1 million people were newly diagnosed with HIV, which increased the total number of
infected worldwide to 36.7 million (U.S. Department of Health & Human Services,
2017l). Nearly 60% of people with HIV worldwide are unaware of their disease status,
and this can contribute to the spread of the disease (U.S. Department of Health & Human
Services, 2017f; World Health Organization, 2016a). There is no cure for HIV, and if
untreated, HIV can develop into AIDS, which damages the immune system and leads to
the development of opportunistic infections that are often fatal (U.S. Department of
Health & Human Services, 2017f). Approximately 35 million people globally have died
from complications associated with the disease (World Health Organization, 2016a). In
2015, more than 1.1 million people living with HIV died throughout the world (World
Health Organization, 2016a).
Since the first reported case of HIV/AIDS in the United States in 1981, an
estimated 1.9 million people have been diagnosed with HIV (The Henry J. Kaiser Family
Foundation, 2016a). Approximately 700,000 Americans have died from HIV/AIDSrelated complications, and an estimated 1.1 million people in the United States are
currently infected with the disease (CDC, 2016c, 2016d; The Henry J. Kaiser Family
Foundation, 2016a; U.S. Department of Health & Human Services, 2017m). In 2015,
39,513 new cases of HIV were reported while 6,721 PLWHA perished from the disease
(CDC, 2016c, 2016d; U.S. Department of Health & Human Services, 2017m).
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Although HIV continues to spread, the rate of new infections in the United States
is decreasing. From 2005 to 2014, the annual number of newly reported HIV cases
declined by 19% (CDC, 2016d; The Henry J. Kaiser Family Foundation, 2016a; U.S.
Department of Health & Human Services, 2017m). This decline has been attributed to the
increased utilization of routine HIV testing and the improved efficacy of ART
medications (Drainoni et al., 2015; The Henry J. Kaiser Family Foundation, 2016a). ART
medications have enabled virally suppressed PLWHA to achieve a life expectancy
comparable to the general population, rendering HIV a chronic medical condition as
opposed to a death sentence (Doshi et al., 2015; Drainoni et al., 2015; Maulsby et al.,
2015).
Comprehensive health insurance coverage has been found to be positively
associated with improved health status for PLWHA. Yehia et al. (2014) stated that
PLWHA who have health insurance coverage are less likely to develop AIDS and
experience premature death. PLWHA are often uninsured. In 2014, an estimated 30% to
40% of PLWHA did not have comprehensive health insurance and relied solely on
support from the RWHAP (Rozin et al., 2015). Although the RWHAP provides needed
HIV-related health care services to PLWHA and has been found to be related to
improved treatment outcomes, it does not provide comprehensive health care coverage
and is not a health insurance product (Bradley et al., 2016). The RWHAP offers HIVrelated care and support services on an outpatient basis and, as a payer of last resort, only
provides care after all other sources of insurance coverage have been exhausted (Morin,
2015).
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To improve insurance coverage access and benefit quality for the underinsured
and uninsured, the ACA was passed into law in 2010 (U.S. Department of Health &
Human Services, 2016b). Extensive resources have been committed by the United States
Federal Government to implement the ACA. However, I found no studies that addressed
whether the comprehensive health insurance provided by the ACA has improved the
overall health status of PLWHA compared to PLWHA who are enrolled in the RWHAP
within the state of Florida. Further research was warranted to examine whether
comprehensive health care coverage provided by the ACA improves the health status of
PLWHA within Florida. The purpose of this quantitative research study was to determine
whether the comprehensive care provided by the ACA improves the health of PLWHA
within Florida.
Chapter 2 is divided into the following sections. First, I provided a description of
the literature search strategy. Second, I provided a description and literature review of
Andersen’s behavioral model of health services use, which served as the theoretical
foundation for this study and a description of the appropriateness of Andersen’s model
for use in this study. Finally, I provided a literature review addressing the dependent and
independent variables, HIV/AIDS, the ACA, the RWHAP, and the impact that health
insurance coverage has on the utilization of health care services and health outcomes.
Literature Search Strategy
I conducted an online literature review using, CINAHL, Google, Google Scholar,
Medline, and PubMed to develop an understanding of the current information published
on the ACA, HIV/AIDS, the RWHAP, the health benefits of having health insurance, and
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Andersen’s behavioral model of health services use. The search terms included
Affordable Care Act (ACA), ACA out-of-pocket costs, access to care, AIDS,
Antiretroviral therapy (ART), ART adherence and viral suppression, behavioral model of
health services use, continuum of care, health benefits of health insurance, health care
reform, high deductible health plans, HIV, HIV engagement in care, HIV patient
demographics, HIV physician visits, HIV prescribed ART, HIV retention in care, HIV
treatment cost, HIV viral load suppression, Ronald Andersen, Ryan White HIV AIDS
Program (RWHAP), and RWHAP continuum of care.
The search terms were used individually and in combinations to narrow the search
results. Search results were restricted to peer-reviewed journals and the websites of
federal and state governmental agencies, international public health organizations,
universities, health care foundations, and HIV/AIDS organizations. The time frame of the
literature review was articles published between 2012 and 2018. Older references were
selected if they were considered seminal studies, were included in the citation lists of
other peer-reviewed references from within the restricted time frame, or were in other
studies with a similar focus.
Theoretical Foundation
Behavioral Model of Health Services Use
The theoretical foundation for study was Andersen’s behavioral model of health
services use. Andersen developed the behavioral model of health services use to
understand the factors that determine how and why health care services are utilized
(Babitsch, Gohl, & von Lengerke, 2012; Graham et al., 2017). Since the creation of the
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behavioral model of health services use in 1968, the model has gained widespread
acceptance and has become the most commonly used framework for exploring the factors
that impact health care access and utilization (Babitsch et al., 2012; Graham et al., 2017).
The model has been used to predict and explain the use of health care services (Andersen,
1995). Although the model has evolved since its development due to changes in the
health care delivery system, health policy, health care financing, and feedback from
academicians and health care professionals, the updates have expanded the scope of the
model and have not changed any of the essential elements or relationships among the
central variables (Andersen, 2008).
Figure 1 shows the behavioral model of health services use as revised by
Andersen and Newman (2005). This iteration of the model was selected because it was
the first to include financial factors that facilitate access to care, such as income and
patient out-of-pocket expenses, which served as independent variables in the current
study. As shown in Figure 1, the behavioral model of health services use incorporates
three stages including an initial predisposition to consume medical services, enabling
circumstances that facilitate or inhibit the use of health care services, and illness level
that represents a need for medical care (Andersen & Newman, 2005).
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Figure 1. Revised behavioral model of health services use: Individual determinants of
health services utilization. Adapted from Anderson and Newman (2005).
Predisposing characteristics. Individuals consume health care services at
differing rates. Health care services can be forecast by attributes that are present prior to
the onset of a medical condition (Andersen, 1968). Predisposing characteristics that
influence health care utilization include demographic factors, social structure, and health
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beliefs. Demographic factors include age, sex, marital status, and past illness (Andersen
& Newman, 2005). Social structure characteristics include traits such as education, race,
occupation, ethnicity, and religion (Andersen & Newman, 2005). Finally, health beliefs,
represent the perception of the treatment efficacy of medical care (Andersen & Newman,
2005). Individuals having positive feelings about their treatment plan or physician are
more likely to use health care services, while people that have less faith in their treatment
results are less likely to seek out medical care (Andersen, 1968).
Predisposing characteristics are influencers and not factors that directly cause the
use of health care services. For example, age is not a reason to use health care services,
yet older age was associated with increased levels of illness and an increased need for
medical care (Andersen, 1968). Social structure characteristics are correlated with
specific lifestyle choices and are impacted by behavior and the environment in which the
family lives, which ultimately influences the consumption of health care services
(Andersen & Newman, 2005). Predisposing characteristics are more likely to remain
constant over time and precede the enabling characteristics described in the second stage
of the model.
Enabling characteristics. Enabling characteristics, the second stage of the
behavioral model of health services use are a set of conditions that facilitate access to
health care services. Although an individual may be predisposed to utilize health care
services, they must possess the resources to receive medical care. Enabling components
include both financial and community resources (Andersen & Newman, 2005). Financial
resources are the attributes that facilitate access to care including income, savings, health
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insurance, regular source of care, and the accessibility of care (Andersen & Newman,
2005). Community resources that influence the utilization of health care services, include
the quantity, quality, and sophistication of health care facilities and providers and
locational convenience (Andersen & Newman, 2005). A community that has a physician
shortage may experience a reduced utilization of health services due to the inability of the
infirmed to receive or access needed care.
Illness level. Illness level represents the third stage of the model. Presuming that
both predisposing and enabling conditions are met, the consumption of health care
services will occur if a perceived or evaluated illness exist combined with the individuals
response to seek out care (Andersen & Newman, 2005). Characteristics of illness level
attributed to the behavioral model include a self-diagnosed health level and symptoms,
and an evaluated or clinically diagnosed medical condition.
Model Use in Research
The behavioral model of health services use is frequently cited as a theoretical
framework to examine the factors that impact health care access and utilization (Babitsch
et al., 2012; Graham et al., 2017; Holtzman, Shea, et al., 2015). The model has been
utilized in HIV-related studies where researchers examined topics including access to
medical care, linkage to and retention in care, and the access to and the use/adherence of
ART medications. Anthony, Gardner, Marks, Anderson-Mahoney, and Metsch (2007)
used the model to examine the utilization of HIV primary care services among people
recently diagnosed with HIV. Using data obtained from the Antiretroviral Treatment
Access Study (ARTAS), the authors examined the impact that age, gender, race, and
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education (predisposing factors), health insurance coverage, case management services,
and having a usual source of medical care (enabling factors) and the existence of HIV
symptoms (need factors) had on the probability of consuming health care services
(Anthony et al., 2007). They found that racial disparities, education level, gender,
insurance status, and experiencing HIV symptoms influenced the use of HIV primary
care services. The researchers confirmed that predisposing, enabling, and need factors
were associated with the utilization of health care services among people recently
diagnosed with HIV (Anthony et al., 2007).
Ulett et al. (2009) customized the model to examine the clinical outcomes
associated with timely linkage to and early retention in HIV care. Age, race, ethnicity,
poverty, education, mental illness, substance abuse, and stigma were categorized as
predisposing factors (Ulett et al., 2009). Enabling factors included insurance status,
transportation, housing, social support, and self-efficacy (Ulett et al., 2009). Symptoms
and health beliefs were classified as need factors. The independent variables were patient
sociodemographic information, medical history, and clinic visit utilization and the
dependent variables included early retention in outpatient HIV care and the time it took to
initiate ART (Ulett et al., 2009). The authors found that older patients and African
Americans took more time to receive a HIV diagnosis and younger patients, and people
abusing drugs and alcohol had a lower probability of being retained in care after timely
linkage to care (Ulett et al., 2009).
Holtzman et al. (2015) expanded the work of Ulett et al. (2009) by incorporating
additional factors into the model to study perceived barriers and facilitators that impacted
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retention in care and ART adherence for PLWHA. Holtzman et al. (2015) identified five
behavioral factors including health literacy, medication characteristics, reminder
strategies, competing life activities, and pharmacy services that impacted retention in care
and ART adherence that were not included in the work of (Ulett et al., 2009). Holtzman
et al. (2015) reported that barriers and facilitators that impacted retention in care included
transportation, clinic experiences, and appointment scheduling, while medication
characteristics, pharmacy services, health literacy, and health beliefs influenced ART
adherence. Factors that impacted both retention and adherence included stigma, mental
illness, substance abuse, social support, reminder strategies, housing, insurance,
symptoms, and competing life activities.
The behavioral model of health services use was also used as a theoretical
foundation for studies examining the access to and the use of ART medications. Smith
and Kirking (1999) concluded that women and PLWHA 15 to 24 years old have reduced
access to ART medications, while Andersen et al. (2000) reported that vulnerable
subgroups of people living with HIV including female drug users, African Americans,
and people with less than a high school education were less likely to receive access to
ART medications.
Appropriateness to Current Study
People living with HIV must be linked, engaged, and retained in care to achieve
viral suppression (Goldman, Juday, Linthicum, Rosenblatt, & Seekins, 2014; U.S.
Department of Health & Human Services, 2018d). Timely and appropriate access, and
utilization of health care services are paramount to decreasing HIV mortality rates
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(Goldman et al., 2014). Andersen’s behavioral model of health services use provides a
framework that examines how patient and environmental factors impact health care
access and outcomes (Andersen, 1968, 1995, 2008; Andersen, Davidson, & Baumeister,
2013; Andersen & Aday, 1978; Ogunsanya, Jiang, Thatch, Bamgbade, & Brown, 2016).
These factors represent the primary focus of this dissertation and reasons detailing the
appropriateness of using this model are listed below. First, researchers have successfully
used the model to predict and explain how people living with HIV access health care
services and ART medications (Andersen et al., 2000; Bozzette et al., 1998; Holtzman,
Shea, et al., 2015; Katz et al., 2001; Smith & Kirking, 1999). Second, the predisposing,
enabling, and illness factors used in the model align with the topic, study variables and
research questions I examined in this study. The key dependent and independent
variables in this study include insurance coverage, gender, race, age, education level,
income, out-of-pocket medical costs, access to ART medications and medical specialists,
and evaluated and diagnosed viral load/health outcomes. These variables have been
incorporated into previous HIV research and represent either predisposing, enabling, or
illness/outcome factors that are the foundational tenants of Andersen’s behavioral model
of health services use (Andersen & Newman, 2005). Ronald Andersen reviewed my
prospectus and informed me that his model was aligned with the objectives of this
dissertation and would be appropriate to use as a theoretical foundation (R. Andersen,
personal communication, October 11, 2016). My study expanded Andersen’s theory
because it was the first time the model was used comparing the impact the ACA had on
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the access to medical services and the health of PLWHA to those enrolled in the
RWHAP.
Literature Review Related to Key Variables and/or Concepts
This literature review provides an overview of the key variables and concepts
included in this study, and is organized into four sections. The first section provides an
overview of the ACA, while the second section summarizes the HIV/AIDS disease. The
third section contains background information on the RWHAP, and the final portion of
the literature review details the impact that health insurance coverage has on health care
access, utilization, and outcomes.
Affordable Care Act
On March 23, 2010, President Barack Obama signed the Patient Protection and
Affordable Care Act into law. The goals of the ACA are to reduce the number of
uninsured or underinsured Americans and improve the affordability, accessibility, and
quality of health care through improved coverage benefits and protections (U.S.
Department of Health & Human Services, 2017n). Also known as Obamacare, the ACA
was modeled after the universal coverage health reform initiative passed in
Massachusetts in 2006, and represented the first national health reform legislation since
the Medicare program was created in 1965 (Okoro, Dhingra, Coates, Zack, & Simoes,
2014; Sommers, Long, & Baicker, 2014).
Expansion of health insurance coverage. The ACA provides health insurance
coverage to the uninsured through the expansion of Medicaid and the sale of commercial
insurance policies through an online marketplace consisting of state and federal
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exchanges. As originally drafted, the ACA required states to ease eligibility requirements
for adults to enroll in Medicaid. These new Medicaid eligibility requirements expanded
coverage to families earning up to 138% of the federal poverty level (FPL) and removed
the categorical eligibility requirement which limited coverage to children, parents with
dependent children, pregnant women, and individuals with disabilities (Berry et al., 2016;
Sommers, Musco, et al., 2014). However, the U.S. Supreme Court, in a 2012 ruling,
declared that it was unconstitutional for the federal government to force states to expand
their Medicaid programs (Wagner, et al., 2014). States retained the option to expand
Medicaid eligibility if they desired and 32 states (including the District of Columbia)
expanded their Medicaid programs, while 19 states declined to do so (Levitt, Claxton, &
Cox, 2016; The Henry J. Kaiser Family Foundation, 2017c).
Online state and federal exchanges were created to help individuals purchase a
private ACA qualified health insurance plan (ACAQHP). The objective of these
exchanges were to enhance the competitiveness in the health insurance marketplace by
providing people greater transparency to compare the costs of the different health
insurance plans offered by multiple insurance companies (Kates et al., 2014;
Westmoreland, 2016). The ACA contains an individual mandate that requires all U.S.
citizens and legal residents, to obtain health insurance coverage or pay a fine by the year
2014 (Kates et al., 2014; Westmoreland, 2016). The penalty for remaining uninsured in
2017 was the greater of 2.5% of annual household income, or an annual per person
charge of $695 per adult, $347.50 per child with a maximum of $2,085 per family per
year (U.S. Centers for Medicare & Medicaid Services, 2017c). This fine served as an
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incentive to encourage millions of healthy Americans to sign up for ACA health
insurance.
The ACA created four different tiers of insurance coverage, bronze, silver, gold,
and platinum. Each tier of health insurance provides different levels of coverage, which
influence monthly premium amounts. Monthly health insurance premium costs are
primarily determined based on the percent of initially covered services paid by the
insurance company. Bronze level plans pay 60% of covered expenses, silver level plans
70%, gold plans 80%, and platinum plans 90% (U.S. Centers for Medicare & Medicaid
Services, 2017d). Generally, health insurance plans that pay the smallest percentage of
initially covered medical expenses have the highest deductibles and the smallest monthly
premiums (U.S. Centers for Medicare & Medicaid Services, 2017d). Conversely, health
insurance plans that pay the largest percentage of initially covered expenses have the
smallest deductibles and the highest monthly premiums. Bronze level plans typically
have the lowest monthly premium, while platinum level plans generally are the most
expensive (U.S. Centers for Medicare & Medicaid Services, 2017d). All ACA plans,
regardless of tier, have the same annual out-of-pocket expense limit. An annual out-ofpocket expense limit is the maximum cost a patient incurs for deductibles, copayments,
and coinsurance in any plan year before the insurance company begins to pay 100% of all
covered claims. The amount of money spent on health insurance premiums and any noncovered health expense is not included in the annual maximum out-of-pocket expense
limit. During the 2018 plan year the maximum out-of-pocket expense limit for an ACA
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plan for an individual was $7,350 and $14,700 for a family (U.S. Centers for Medicare &
Medicaid Services, 2018b).
Two types of tax subsidies were created to help lower income Americans
purchase and use their ACA health insurance coverage. First, the ACA provides subsidies
to reduce health insurance premium costs to individuals and families with incomes
between 100% and 400% of the FPL (The Henry J. Kaiser Family Foundation, 2017d;
Wagner et al., 2014). The amount of the premium subsidy is calculated based on a sliding
scale, so enrollees with incomes at 100% of the FPL level receive more financial support
than do people earning 400% of the FPL (Westmoreland, 2016). Second, the ACA
provides additional cost sharing assistance to reduce patient out-of-pocket expenses for
copayments, coinsurance, and deductibles for enrollees earning between 100% and 250%
of the federal poverty level (The Henry J. Kaiser Family Foundation, 2017d). Both of
these subsidies are classified as tax credits and are paid directly to the health insurance
companies (Martin & Schackman, 2012). ACA subsidies are only available to enrollees
who select silver level plans (The Henry J. Kaiser Family Foundation, 2017d).
The subsidies provided by the ACA represent an investment to help reduce the
number of people that do not have health insurance. Initial projections indicated that in
2014, the federal government would spend $17 billion on subsidies for people who
purchased insurance through the ACA exchanges (Jeffrey, 2014). In 2016, the
nonpartisan Congressional Budget Office (as cited in Ferris, 2016) reported that subsidy
costs increased an additional 11%. By 2023, it is estimated that the annual subsidy cost
for ACA health insurance policies will increase to $134 billion (Jeffrey, 2014).
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Impact of the ACA on the uninsured. Prior to the implementation of the ACA
in 2014, millions of people living in the United States did not have health insurance. In
2013, 44 million nonelderly people were uninsured (Foutz, Squires, Garfield, & Kaiser
Family Foundation, 2017; Garfield et al., 2016). By the end of 2016 more than 17 million
people gained access to health insurance coverage as the number of nonelderly uninsured
people were reduced to 27 million (Garfield et al., 2016; The Henry J. Kaiser Family
Foundation, 2016b).
This influx of 17 million newly covered individuals into the market due to the
ACA has helped to reduce the disparities in health insurance coverage among lowincome people and minorities. The largest groups of newly insured include young people
between 18 and 34 years old, poor people, Blacks, Hispanics, and people residing in rural
communities (Ferris, 2015). The ACA reduced the uninsured rate by 4.7% for Whites,
7.1% for Asians, 7.7% for Blacks, and 9.5% among Hispanics (Levins, 2015; The Henry
J. Kaiser Family Foundation, 2016b). The uninsured rate declined 10.1% for people
earning less than 100% of the FPL, 11.1% for those earning between 100% and 199%,
and 3.0% for people with an income greater than 200% of FPL (The Henry J. Kaiser
Family Foundation, 2016b). These demographic characteristics of the newly insured
ACA members are also representative of the population most likely to contract
HIV/AIDS. Zamani-Hank (2016) reported that 87% of PLWHA are young and earn less
than 400% of the FPL. The ACA has improved the rate of health insurance coverage
among populations that have historically been uninsured and may reduce the uninsured
rate among PLWHA.
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Features of the ACA. The ACA contains health insurance reforms that prevent
private insurance companies from denying coverage to those in need. The ACA prevents
insurance companies from denying coverage or raising the premium rates for people with
preexisting medical conditions (U.S. Department of Health & Human Services, 2017a).
Prior to the passage of the ACA, insurance companies could deny coverage or raise
premium rates to people who became sick. The ACA also prohibits insurance companies
from enacting annual or lifetime dollar limits on the payment of covered services (U.S.
Centers for Medicare & Medicaid Services, 2018a). Insurance companies used annual
and lifetime coverage limits to minimize their financial liability when paying claims for
people with medical conditions that are costly to treat. Removing these financial
coverage limits allow people in need of medical treatment to have their claims covered by
their health insurance company. The ACA also forbids insurance companies from
retroactively rescinding coverage due to an error or inadvertent mistake on a customer’s
health insurance application (U.S. Centers for Medicare & Medicaid Services, 2018c).
The ACA mandates that insurance companies extend coverage for dependent children up
to the age of 26 (Viall et al., 2016). Finally, the ACA prevents insurance companies from
discriminating and refusing to insure people based on their sexual orientation and gender
identity (U.S. Department of Health & Human Services, 2017o).
The ACA also includes mandates to improve the quality of medical care delivered
to patients. The ACA requires insurance companies to devote a minimum percentage of
their revenues on enrollee claims and initiatives to improve quality. The required medical
loss ratio of premium dollars spent on health care is 80% for health insurance plans sold
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to individuals and small businesses and 85% for large group plans (Kantarjian, 2017;
National Association of Insurance Commissioners, 2018). To improve health, an
adequate amount of money should be spent on health care as opposed to insurance
company corporate expenses and profits. Prior to the passage of the ACA, insurance
companies spent as little as 50% to 60% of their revenues on the payment of medical
claims as compared to Medicare which spent 97% of its revenues on health care services
(Kantarjian, 2017). Senior citizens are provided prescription drug pricing discounts of
50% when they purchase Medicare Part D approved brand name medications (U.S.
Department of Health & Human Services, 2017o). By 2020, the ACA will close the
Medicare prescription drug gap, also known as the ‘donut hole’, where beneficiaries are
required to pay the true out-of-pocket (TROOP) cost for covered medications until they
reach the catastrophic maximum payment level and Medicare drug coverage payments
resume (Livingston, 2017). The ACA also requires insurance companies to provide
coverage for comprehensive health care services that will improve the quality of medical
care offered to patients. Insurance companies under the ACA are required to provide
enrollees free preventive care services. Preventive services that patients can access
without cost include an assessment for obesity, blood pressure, cholesterol, depression,
diabetes, cervical cancer, breast cancer, colorectal cancer, HIV, drug use, tobacco use,
and sexually transmitted diseases (Han, Yabroff, Guy, Zheng, & Jemal, 2015; The Henry
J. Kaiser Family Foundation, 2015). Researchers have shown that preventive services,
offered to patients at no out-of-pocket cost remove barriers that inhibit utilization and
reduce mortality rates by helping medical providers diagnose diseases earlier and before
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they develop into more serious medical problems. Han et al. (2015) reported the
utilization of preventive tests increased after the ACA eliminated patient cost sharing for
these types of medical services. Finally, to ensure coverage consistency, access, and
improved health outcomes, the ACA mandated that all health insurance plans provide
coverage for a comprehensive set of ten essential health benefits including “ambulatory
patient services, emergency services, hospitalization, maternity and newborn care, mental
health and substance use disorder services including behavioral health treatment,
prescription drugs, rehabilitative services, laboratory services, chronic disease
management, and pediatric services” (U.S. Centers for Medicare & Medicaid Services,
2017f, para. 1). As part of the prescription drug mandate, the ACA requires qualified
health insurance plans to provide coverage for a minimum of one medication from each
US Pharmacopeia category (U.S. Centers for Medicare & Medicaid Services, 2017f).
This prescription mandate ensures that patients enrolled in ACA plans have access to a
variety of medications to treat their medical conditions.
Impact of ACA on Access to Care for PLWHA. For PLWHA, the primary
benefit of the ACA is improved access to comprehensive care. Crowley and Garner
(2015) reported that having health insurance enhances health security and that the
RWHAP should not be mistaken for health insurance coverage as it only covers
HIV/AIDS-related care on an outpatient basis and is expressly prohibited by law from
providing inpatient HIV/AIDS care and coverage for medical issues that are not HIVrelated. PLWHA achieve overall improved health when utilizing the defined benefits of a
commercial health insurance product. Prior to the enactment of the ACA, PLWHA had
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difficulty obtaining health insurance coverage as an estimated 24% to 30% were
uninsured (Rozin et al., 2015; Viall et al., 2016). The ACA improves access to health
insurance coverage among PLWHA by establishing safeguards to ensure they will not be
discriminated when applying for or using their health insurance benefits.
Commercial health insurance protections. PLWHA have historically
encountered obstacles in obtaining health insurance coverage. Provisions contained in the
ACA prevent health insurance companies from denying coverage for preexisting medical
conditions such as HIV/AIDS, retroactively rescinding coverage after a person becomes
infected with HIV/AIDS, and charging higher premium costs or raising rates to PLWHA
(Montague, 2012; U.S. Department of Health & Human Services, 2016a; Viall et al.,
2016). ACA insurance coverage must be offered to PLWHA as health care insurance
coverage must be made available to all people, regardless of health status, as long as they
pay their premiums. The ACA eliminates the annual and lifetime financial limits that
insurance companies often imposed on people with chronic diseases such as HIV/AIDS
(Abara & Heiman, 2014; U.S. Department of Health & Human Services, 2016a; Viall et
al., 2016). This provision is beneficial to PLWHA as treatment is costly and these annual
and lifetime were often quickly surpassed. In addition to eliminating lifetime benefit
expense limits, the ACA health insurance plans are required to cover at least one drug
from every US Pharmacopeia category (Abara & Heiman, 2014; U.S. Department of
Health & Human Services, 2016a). As PLWHA are often prescribed pharmaceutical
cocktails consisting of multiple ART medications, the ACA now ensures that at least one
medication from each of the combination classes is covered.
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HIV/AIDS
HIV and AIDS continue to be a substantial health problem for the United States
and countries throughout the world. Thirty-six point seven million people are afflicted
with HIV/AIDS globally, while more than 1.1 million people in the United States are
living with the disease (The Henry J. Kaiser Family Foundation, 2017f; U.S. Department
of Health & Human Services, 2017l). HIV is a disease that attacks a person’s immune
system and eventually inhibits the body from fighting infections and certain types of
cancer (CDC, 2016b; U.S. Department of Health & Human Services, 2017h). HIV
compromises the ability of the immune system to fight infection by targeting and
destroying CD4 cells, and over time, an infected person is unable to fight off viruses,
bacteria, and parasites that a healthy person could (CDC, 2016b; U.S. Department of
Health & Human Services, 2017h).
The health problems associated with a weakened immune system for people with
HIV are identified as opportunistic infections. A patient with HIV who develops an
opportunistic infection is then diagnosed with AIDS (U.S. Department of Health &
Human Services, 2017b). Opportunistic infections are the most common cause of death
for PLWHA and frequently occur when the CD4 count drops beneath 200 cells/mm3.
Opportunistic infections that often strike PLWHA include heart disease, tuberculosis,
pneumonia, lung disease, weight loss, cancer, meningitis, intestinal disease, and fungal
infections (CDC, 2016a; U.S. Department of Health & Human Services, 2017b).
HIV stages and symptoms. Without treatment, HIV progresses through three
stages of disease: acute HIV infection, clinical latency, and AIDS. The first stage of the

49
disease, acute HIV infection, typically occurs 2-4 weeks after infection (U.S. Department
of Health & Human Services, 2017i). People in the acute infection stage commonly
experience flu-like symptoms (fever, muscle ache, sore throat) because the body is
fighting the HIV infection. During the acute HIV infection stage, the risk of disease
transmission and infecting others is the highest because the body is producing a high
quantity of the virus (CDC, 2016b; U.S. Department of Health & Human Services,
2017i). Clinical latency is the second stage of the HIV disease. During this period, the
HIV virus continues to slowly spread throughout the body and patients may not
experience any symptoms of the disease (CDC, 2016b). HIV is transmissible throughout
the clinical latency stage and untreated patients will progress to aids in an average of 10
years (CDC, 2016b), AIDS is the final stage of HIV and occurs as the result of a
compromised immune system. Symptoms of AIDS include rapid weight loss, recurring
fever, extreme tiredness, diarrhea, prolonged swollen glands, pneumonia, colored skin
blotches, and neurological disorders such as memory loss and depression (U.S.
Department of Health & Human Services, 2017e). Left untreated, people with AIDS
survive about three years, unless they develop an opportunistic infection, which will
shorten life-expectancy to approximately one year (U.S. Department of Health & Human
Services, 2017i).
People with HIV may advance through the three disease stages at different rates
due to individualized factors. The characteristics of patients with HIV that may delay the
onset of AIDS include regularly taking ART medications, staying in care, and eating
healthy (U.S. Department of Health & Human Services, 2017i). Factors that may hasten
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an AIDS diagnoses include old age, stress, and comorbidities such as cancer, hepatitis C,
and tuberculosis.
HIV/AIDS testing. After a person is diagnosed with HIV, laboratory tests
measuring CD4 cell counts and viral load are ordered every 3-6 months. A CD4 count
measures the number of CD4 T lymphocytes in a blood sample and provides an
indication on the overall health of the immune system (U.S. Department of Health &
Human Services, 2017g). A higher CD4 count is indicative of a strong immune system as
a healthy adult typically has 500 to 1,600 cells per cubic millimeter (mm3) (U.S.
Department of Health & Human Services, 2017g). A person is diagnosed with AIDS
when the CD4 count falls below 200 cells/mm3 (U.S. Department of Health & Human
Services, 2017f). A viral load test measures the number of copies of HIV particles per
milliliter of blood (U.S. Department of Health & Human Services, 2015a). The objective
of HIV treatment is to reduce the viral load to an undetectable level, and become virally
suppressed. PLWHA that are virally suppressed are healthier and live longer than those
that are not virally suppressed and are less likely to transmit HIV to an uninfected sexual
or drug partner (Goldman et al., 2014; U.S. Department of Health & Human Services,
2018d).
HIV treatment and cost. Although there is no cure for HIV, the disease can be
controlled or virally suppressed with appropriate medical care and treatment (U.S.
Department of Health & Human Services, 2017f). The primary treatment for HIV is a
combination of antiretroviral medications. Antiretroviral therapy (ART) medications
prevent the HIV virus from multiplying and weakening a person’s immune system (U.S.
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Department of Health & Human Services, 2017c). Prior to the development of ART
medications in the 1990’s, people with HIV developed AIDS in just a few years (CDC,
2016b). A person diagnosed with HIV today, who is treated with ART medications, can
live nearly as long as a person who does not have HIV (CDC, 2016b; Drainoni et al.,
2015). To achieve the maximum health benefit, ART medications should be taken as
soon as a person is diagnosed with HIV (U.S. Department of Health & Human Services,
2018c). ART medications can also be taken on a preventative basis (pre-exposure
prophylaxis) to help minimize the chances that higher risk individuals contract HIV (U.S.
Department of Health & Human Services, 2017d).
Although treatment with ART medications are effective in controlling the HIV
virus, they are expensive. ART medications represent the single largest treatment expense
for PLWHA. The lifetime cost of treatment for PLWHA ranges between $300,000 and
$400,000 with ART medications comprising 60% to 70% of all incurred expenses
(Nakagawa et al., 2015; Schackman et al., 2015). An early HIV diagnosis and initiation
of treatment increases the total lifetime cost of ART medications but also improves
quality of life and overall life expectancy (Nakagawa et al., 2015; Schackman et al.,
2015).
Demographics of PLWHA in the United States. HIV/AIDS is a disease that
affects Americans of diverse backgrounds. Since the initial reported case of AIDS in June
of 1981, more than 1.9 million people in the United States have been infected with HIV,
1.1 million people are currently living with the disease, and more than 698,000 have
perished (The Henry J. Kaiser Family Foundation, 2016a; U.S. Department of Health &
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Human Services, 2017m). Among people living with HIV, 77% are male and 23% are
female (CDC, 2017b, 2017f, 2017g). Transgendered people have a high prevalence rate
for HIV but the exact number infected are unknown due to the lack of uniformly
collected data (CDC, 2017d, 2017f). In 2015, males represented 81% of all people newly
diagnosed with HIV, while females accounted for 19% (CDC, 2017f; U.S. Department of
Health & Human Services, 2017m)
HIV also affects Americans of all ages. Young people are most likely to become
infected with HIV, however, teenagers and people over 60 are also contracting the
disease (CDC, 2017a, 2018b). Of all people newly diagnosed with HIV in 2016, 66.3%
were between 13 and 39 years old, 28.6% were between the ages of 40 and 59, and 4.9%
were older than 60 (CDC, 2017f).
HIV and minority communities. While HIV and AIDS effects all types of
people, certain groups are more likely to become infected including men who have sex
with men (MSM) and racial and ethnic minorities. MSM represent the largest group of
people impacted by HIV and AIDS. Although MSM comprise an estimated 2% of the
total population in the United States, they represent 55% of all people living with HIV
(CDC, 2018a). Black and Hispanic/Latino populations also disproportionately have HIV
as compared to people from other racial and ethnic backgrounds. In 2016, Blacks totaled
12% of the U.S. population and 44% of all new HIV diagnoses, while Hispanics/Latinos
comprised 18% of the U.S. population and 25% of all new cases of HIV (CDC, 2017f;
U.S. Department of Health & Human Services, 2017m). The rate of newly diagnosed
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HIV cases in 2016 per 100,000 people was 43.6 for Blacks, 17.0 for Hispanics/Latinos,
and 5.2 for Whites (CDC, 2017f).
Racial and ethnic minorities also represent a disparate percentage of people with
HIV based on age, sexual orientation, and gender. Youth aged 13-24 are the most
common age based group with HIV and 80% are MSM (CDC, 2018b). In 2015, among
MSM aged 13-24 who were diagnosed with HIV, 58% were Black, 24% were
Hispanic/Latino, and 18% were white (CDC, 2018b). MSM from minority ethnic and
racial backgrounds, regardless of age, are also more likely to develop HIV. Among MSM
who were diagnosed with HIV in 2015, 10,315 were Black, 7,570 were White, and 7,013
were Hispanic/Latino (CDC, 2018a). HIV disproportionately affects men and women of
color. Among women diagnosed with HIV in 2016, 62.6% were black, 17.5% were
Hispanic/Latino and 19.9% were White (CDC, 2017f). The rate of HIV infection in 2016
per 100,000 women was 26.2 for Blacks, 5.3 for Hispanic/Latino women, and 1.7 for
Whites women (CDC, 2017f). Among men diagnosed with HIV in 2016, 42.5% were
Black, 29.3% were White, and 28.3% were Hispanic/Latino (CDC, 2017f). The rate of
HIV infection among men per 100,000 people was 24.8 for Blacks, 38.8 for
Hispanics/Latinos, and 10.6 for Whites (CDC, 2017f).
HIV and socioeconomic status. Socioeconomic factors including income,
poverty level, education, and employment create inequities in access to medical care and
treatment outcomes. Reduced socioeconomic status is associated with riskier health and
sexual behaviors, IV drug use, and health insurance status, and is associated with an
increased probability of becoming diagnosed with HIV/AIDS, a delay in the onset of
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treatment, and an increased rate of mortality (American Psychological Association,
2018). As part of the seminal National HIV Behavioral Surveillance System for
Heterosexuals Round 1 (NHBS-HET-1) study conducted by the CDC in 2006-2007,
researchers collected socioeconomic data from people diagnosed with HIV. Although the
study was limited to heterosexual participants and included only 188 participants with
HIV, lower socioeconomic status related to education, income, poverty, employment
status, and homelessness was associated with an increased prevalence of HIV (Denning
& DiNenno, 2015). The results from this research study revealed an inverse relationship
between HIV prevalence and socioeconomic status.
HIV continuum of care for PLWHA. The HIV continuum of care is a model
that was developed to define the stages of HIV treatment and assist in the measurement,
monitoring, and delivery of HIV care to PLWHA at each step in the treatment process.
The four stages of the continuum of care include diagnosis, engagement in care,
prescribed ART, and virally suppressed (CDC, 2017e; U.S. Department of Health &
Human Services, 2016b). The first stage of the HIV care continuum is diagnosis. People
who are unaware of their HIV infection status will not seek medical treatment, will more
likely transmit the virus and infect others, and experience an increased mortality rate
(Kay, Batey, & Mugavero, 2016; Mugavero, Amico, Horn, & Thompson, 2013). The
second stage of the continuum of care is engagement. As there is no cure for HIV,
treatment of the virus is a lifelong process which requires routine office visits with
medical providers (U.S. Department of Health & Human Services, 2016b). Poor
engagement in care is associated with a reduced CD4 count, lower chance of becoming
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virally suppressed, and an increased risk of death (Crawford, Sanderson, & Thornton,
2014; Horberg et al., 2013). The third stage of the continuum of care is access to and the
appropriate use of ART medications. ART medications, when properly used, decrease the
mortality rate of HIV and reduce the likelihood that the virus will be spread to uninfected
people (Maulsby et al., 2015; Skarbinski et al., 2015). The final stage of the HIV
continuum of care is viral suppression. PLWHA who are virally suppressed live longer
than those that are not virally suppressed and are less likely to transmit HIV to an
uninfected sexual or drug partner (Goldman et al., 2014; U.S. Department of Health &
Human Services, 2018d).
In 2011, 85% of people with HIV throughout the United States were diagnosed
with HIV, 40% were engaged in care, 37% were prescribed ART, and 30% were virally
suppressed (U.S. Department of Health & Human Services, 2016b). Although these
figures show improvement from previously collected data, they still fall below the global
health goals for the treatment and viral suppression of PLWHA set by the World Health
Organization and the United Nations. The Joint United Nations Program on HIV/AIDS
(UNAIDS) launched the 90-90-90 campaign to increase HIV/AIDS detection and
treatment (Greenberg et al., 2015; Morin, 2015; UNAIDS, 2018). The objective of the
campaign is to improve the detection rate of HIV to 90% of those infected, provide
sustained ART treatment to 90% of those detected, and to virally suppress 90% of the
cases treated (Morin, 2015; UNAIDS, 2018).
Impact of care engagement on the health of PLWHA. Engagement in care is
an important determinant of the health of PLWHA. The CDC determined that PLWHA
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were engaged in care if they had a minimum of two HIV-related medical appointments
during the previous 12 months that were separated by at least three months (CDC, 2017e;
Kay et al., 2016). Poor engagement in care is associated with a delay in the initiation of
ART medication, an increased rate of medication noncompliance, viral non-suppression,
and an increased risk of death (Asamsama et al., 2017; Berg et al., 2005; Mugavero et al.,
2013). PLWHA who remain consistently engaged in care are more likely to achieve and
maintain long-term viral suppression and experience reduced mortality rates (Crawford,
2014; Crawford et al., 2014).
Other researchers identified an association between the number of missed medical
visits and viral non-suppression. Brennan, Maskew, Sanne, and Fox, (2010) found the
failure rate to achieve viral suppression within the first six months of initiating ART
medications was 6.6% for patients who did not miss an appointment, 6.8% for those who
missed one appointment, 10.9% for patients who missed two appointments, and 15.1%
for patients who missed three or more appointments. Missed clinic visits are associated
with reduced health outcomes as each missed medical appointment increased the risk of
delayed viral load suppression by 17% (Mugavero et al., 2012). Poor engagement in care
increased the occurrence rate of AIDS related illness or death as the mortality rate per
100 person-year was 2.1 for patients with no missed appointments, 5.8 for patients with 1
missed appointment, 8.9 for patients who missed 2 appointments, and 11.7 for patients
who missed 3 or more visits (Park et al., 2007).
Impact of viral load suppression on the health of PLWHA. Viral load is the
amount of HIV virus in a sample of blood. A viral load test is completed in a laboratory
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and measures the number of HIV virus particles or copies in a milliliter of blood (U.S.
Department of Health & Human Services, 2015a). The goal of an effective HIV treatment
plan is to suppress the viral load down to an undetectable level. A PLWHA is considered
to be virally suppressed if their viral load is beneath 200 copies per milliliter (U.S.
Department of Health & Human Services, 2015a). Viral load is commonly used to
measure the health status of PLWHA. Both the World Health Organization and the CDC
recommend using viral load levels to benchmark the degree in which ART medications
control and suppress the HIV virus and to assess overall health status among PLWHA
(U.S. Department of Health & Human Services, 2016c; World Health Organization,
2016b).
PLWHA who are virally suppressed are less likely to develop a HIV related
opportunistic infection, transmit the virus to an uninfected sexual or drug partner, and are
more likely to live healthier and longer lives (Goldman et al., 2014; U.S. Department of
Health & Human Services, 2018d). Of the 1.1 million PLWHA in the United States, only
361,764 (30%) were virally suppressed (Bradley et al., 2014). Men, Blacks and
Hispanics/Latinos, younger PLWHA, and those with a low socioeconomic status were
less likely to become virally suppressed then women, Whites, older PLWHA, and those
with a higher socioeconomic standing (Adeyemi, Livak, McLoyd, Smith, & French,
2013; Bradley et al., 2014; Crawford et al., 2014).
Impact of ART medication adherence on the health of PLWHA. PLWHA
require long-term therapeutic intervention with ART medications to optimize their health
by becoming virally suppressed. Prior to the introduction of ART medications in 1996,
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HIV/AIDS was a terminal health condition resulting in certain death (Deeks, Lewin, &
Havlir, 2013; Goldman et al., 2014). Now, PLWHA who properly take their ART
medications can become virally suppressed and experience a life expectancy equal to that
of the general uninfected population (Deeks et al., 2013). ART medication adherence
directly impacts the effectiveness of ART treatment and viral load suppression and is the
strongest predictor of viral suppression failure (CDC, 2012). Inadequately adhering to an
ART regimen results in an increased rate of hospitalization, viral load, morbidity and
mortality (Olson et al., 2014).
ART medication adherence is defined as the degree to which a PLWHA takes
their ART medications at the correct dose and interval, and complies with other
instructions issued by the treating medical provider (U.S. Department of Health &
Human Services, 2018a). A sustained high level of ART medication adherence is crucial
to becoming virally suppressed. While early researchers indicated that ART adherence
rates of 90% were required to achieve viral suppression, due to the development of more
effective ART medications, viral suppression can now be achieved at ART adherence
rates as low as 80% (CDC, 2012; Kalichman et al., 2014; Machtinger & Bangsberg,
2018; U.S. Department of Health & Human Services, 2016c).
Holtzman, Brady, and Yehia, (2015) found that patient self-reported data over a
30 day period was an appropriate measure to determine ART treatment compliance. This
personal estimate of ART usage can be used to calculate the proportion of days a person
had access to ART medications and is instrumental in evaluating non adherence due to
late refills or discontinued care (Holtzman, Brady, et al., 2015). Machtinger and
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Bangsberg (2018) also suggested that patient self-reported data can be used to measure
overall treatment compliance.
Ryan White HIV/AIDS Program
The Ryan White HIV/AIDS program (RWHAP) was created by Congress as part
of the Ryan White Comprehensive AIDS Resource Emergency (CARE) Act of 1990 and
serves as a safety net by providing medical care and ART medications for lower income
PLWHA (The Henry J. Kaiser Family Foundation, 2017b). The legislation was named
after Ryan White, a 13 year old hemophiliac, who contracted aids in the 1980s from a
blood transfusion (Sood et al., 2014; Zamani-Hank, 2016). The RWHAP is administered
by the HIV/AIDS Bureau at the Health Resources and Services Administration (HRSA),
a division of the U.S. Department of Health and Human Services (HRSA, 2017a). In
2016, funds from the RWHAP provided comprehensive HIV/AIDS-related medical care
and treatment to more than 535,000 PLWHA, reaching an estimated 48% of all people
diagnosed with HIV in the United States (HRSA, 2017g; U.S. Department of Health &
Human Services, 2017m). RWHAP eligibility guidelines require a HIV or AIDS
diagnosis and either no health insurance coverage or limited coverage that does not fully
pay for all HIV/AIDS-related health care services (HRSA, 2016b). There are also
financial guidelines that regulate eligibility to enroll in the RWHAP. Although cities and
states individually determine their own enrollment guidelines and benefits offered,
participants must have a low annual income (Adimora, Ramirez, Schoenbach, & Cohen,
2014; HRSA, 2016b).

60
RWHAP funding. Since the creation of the RWHAP in 1990, Congress has
reauthorized program funding in 1996, 2000, and 2009 (Johnson & Heisler, 2015; The
Henry J. Kaiser Family Foundation, 2017b). The most recent Congressional authorization
for the RWHAP lapsed in 2013. However, the original law did not contain a sunset
provision or end date so funding for the RWHAP has been continually renewed based on
annual appropriations from Congress (Johnson & Heisler, 2015; The Henry J. Kaiser
Family Foundation, 2017b). Funding for the RWHAP has risen over time due to the
treatment success and wide use of ART medications. Federal funding for the RWHAP in
fiscal year 1991 was $257 million, $1 billion in 1998, and surpassed $2 billion in 2004
(Johnson & Heisler, 2015). The U.S Department of Health and Human Services allocated
$2.32 billion in funding to the RWHAP in fiscal year 2017 (HRSA, 2017h; The Henry J.
Kaiser Family Foundation, 2017e). With an annual budget of $2.32 billion, the RWHAP
was the largest recipient of financial resources focused exclusively on HIV/AIDS care,
and trailed only Medicare ($10.1 billion) and Medicaid ($6.1 billion) in HIV/AIDSrelated federal spending (The Henry J. Kaiser Family Foundation, 2017e).
RWHAP structure and covered services. The RWHAP is comprised of five
parts (A, B, C, D, and F):
Part A. Part A of the RWHAP provides funding grants to one of the 24 Eligible
Metropolitan Areas (EMAs) or 28 Transitional Grant Areas (TGAs) which are located in
the areas of the United States that are most severely affected by the HIV/AIDS epidemic
(Crowley & Kates, 2013; HRSA, 2017b). To qualify as an EMA, an area must have a
population of at least 50,000 people and have a minimum of 2,000 reported cases of
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AIDS in the previous five years (HRSA, 2017b). TGA eligibility criteria include 1,000 to
1,999 reported cases of AIDS over the past 5 years in an area with a population of 50,000
people (HRSA, 2017b). The 52 EMAs and TGAs are all different sizes and are
geographically dispersed throughout the United States. Some include only one city or
county, while others comprise portions of multiple states (HRSA, 2016c). Part A of the
RWHAP provides core medical and support services to PLWHA. Core medical services
include the AIDS Drug Assistance Program (ADAP), AIDS pharmaceutical assistance,
early intervention services, health insurance premium and cost sharing assistance for lowincome individuals, home and community-based services, home health care, hospice
services, medical case management services, including treatment-adherence services,
medical nutrition therapy, mental health services, oral health, outpatient and ambulatory
medical care, and substance abuse outpatient care (HRSA, 2017b). Support medical
services include caregiver respite care, medical transportation services, outreach services,
and translation services (HRSA, 2017b). Fiscal year 2017 RWHAP Part A funding was
$654.2 million (HRSA, 2017h).
Part B. Part B of the RWHAP authorizes monetary grants to each of the 50 states,
the District of Columbia, and all 8 U.S. Territories to improve the access and quality of
health care for PLWHA (HRSA, 2017c). The specific services provided by Part B are
determined by each state, and are generally similar to the core medical and support
services provided in Part A of the RWHAP (HRSA, 2017c; The Henry J. Kaiser Family
Foundation, 2017b). The second component of Part B funding provides RWHAP clients
access to medications to treat the HIV/AIDS virus and other comorbidities associated
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with the disease (HRSA, 2017c). Funds from the Part B ADAP may also be used to pay
the health insurance premiums and other out-of-pocket insurance costs such as
copayments, coinsurance, and deductibles for RWHAP clients (HRSA, 2017c; Johnson &
Heisler, 2015). Total fiscal year 2017 Part B funding was $1.31 billion, of which $900
million was allocated to the ADAP and the remaining $411 million was apportioned to
pay for core medical and support services (HRSA, 2017h).
Part C. Part C of the RWHAP provides funding for early intervention services
and capacity development and planning grants. Early intervention services offered under
Part C include HIV testing, case management services, and counseling to reduce risks to
people recently diagnosed with HIV/AIDS (HRSA, 2017d; The Henry J. Kaiser Family
Foundation, 2017b). Part C development and planning grants enable public and private
organizations to improve their organizational infrastructure to deliver higher quality HIV
primary health care services (HRSA, 2017d). Fiscal year 2017 Part C funding was $200.5
million (HRSA, 2017h).
Part D. Part D grants authorize funding to public and private nonprofit
organizations to provide HIV/AIDS health care services to women, infants, children, and
youth. Services offered under Part D include outpatient health care, case management,
referrals, clinical trials, and additional support services (HRSA, 2017e). The 2017 fiscal
year allocation to Part D was $74.9 million (HRSA, 2017h).
Part F. Finally, funding from Part F of the RWHAP supports AIDS education and
training centers, dental reimbursement programs, and special projects of national
significance (HRSA, 2017f, 2018a, 2018b). AIDS education and training centers offer
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professional development educational services to health care providers who treat patients
with HIV in clinics, hospitals, addiction treatment centers, mental health facilities, and
health departments. Dental schools and dentists are provided reimbursement for noncompensated oral health care services provided to PLWHA and additional funds are
allocated to support special projects of national significance to assist in the creation of
alternative models of HIV care delivery that enhance quality, reduce costs, and help
develop the health information systems within the RWHAP (HRSA, 2017f, 2018b). The
total grant awarded under Part F in fiscal year 2017 was $71.5 million (HRSA, 2017h).
RWHAP coverage status. The services provided to PLWHA by the RWHAP are
dissimilar to those provided by a health insurance company. The RWHAP does not
provide coverage for comprehensive health care services. The RWHAP covers only
outpatient HIV/AIDS-related medical care and treatment (Crowley & Garner, 2015;
Emory Health care, 2017; Westmoreland, 2016). Specifically excluded from coverage
under the RWHAP are medical services provided in an emergency room or a hospital
inpatient setting, medical care by general physicians and subspecialists, and prescription
medications unrelated to the treatment of the HIV/AIDS virus (Crowley & Garner, 2015;
Emory Health care, 2017). Unlike a health insurance company, the RWHAP does not
serve as the primary payer of HIV/AIDS-related medical claims. Federal statutes classify
the RWHAP as a payer of last resort. Funds from the RWHAP may not be used to pay
for any health care service in which payment has been rendered, or is expected to be
rendered, from any health insurance policy or federal or state health benefits program
(HRSA, 2014; Johnson & Heisler, 2015). Organizational recipients of RWHAP funds are
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required to access alternative sources of funds whenever possible and are required by law
to attempt to enroll their clients into alternative health care programs that they may be
eligible for, including private health insurance, Medicare, and Medicaid (HRSA, 2014;
Johnson & Heisler, 2015).
RWHAP insurance purchasing and cost sharing assistance. Increasing
numbers of PLWHA are obtaining health insurance coverage through ACA qualified
health plans (ACAQHP). Private health insurance coverage is expensive as enrollees are
often faced with large monthly premiums and high out-of-pocket expenses including
copayments, coinsurance, and deductibles. Provisions of the RWHAP permit the use of
RWHAP funds to cover ACA health insurance coverage premiums and any associated
out-of-pocket expenses (Eaton & Mugavero, 2016; Zamani-Hank, 2016). The HIV/AIDS
Bureau has authorized the use of RWHAP funds to purchase health insurance coverage
since its initial passage in 1990 (Dawson & Kates, 2015).
While language in the original CARE Act focused on maintaining continual
insurance coverage for PLWHA, updated policy guidelines and the 2006 reauthorization
legislation specifically affirmed that funds could be used for purchasing new health
insurance (Dawson & Kates, 2015). Although health insurance premium and cost sharing
assistance is allowable under multiple sections of the RWHAP (Parts A, B, C, and D) the
principal funding source is derived from the Part B ADAP (Dawson & Kates, 2015;
HRSA, 2014). Although Part B of the RWHAP was initially intended (and continues) to
provide medications for PLWHA, a greater emphasis has been placed on insurance
purchasing and cost sharing assistance. In 2003, ADAP funds were used to purchase
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health insurance coverage and provide cost sharing assistance to 6% of clients
nationwide, compared to 35% in 2013 (Dawson & Kates, 2015).
The proliferation of ACAQHPs has increased the complexity and importance of
insurance purchasing and cost sharing subsidies to PLWHA. HRSA issued guidance
notices to grantees strongly encouraging them to use RWHAP funds to help clients
purchase health insurance through ACAQHPs (Dawson & Kates, 2015). The Centers for
Medicare and Medicaid Services (CMS) also support the use of RWHAP funds to
purchase ACAQHPs. In response to a lawsuit against an insurer in Louisiana who refused
to accept RWHAP funds as payment for health insurance coverage, the CMS in 2014
issued interim final rule CMS-9943-IFC which required insurance companies
participating in the ACA to accept third party payments from the RWHAP for insurance
premiums and cost sharing assistance (Dawson & Kates, 2015). As of June 2014, the
RWHAP has facilitated the enrollment of 16,000 people into ACAQHPs (Dawson &
Kates, 2015).
RWHAP client demographics. In 2016, the RWHAP provided services to more
than half a million PLWHA who were generally older, male, from a racial or ethnic
minority population, and poor. At that time, 44.9% of PLWHA served by the RWHAP
were older than age 50 and an additional 23.9% were between the ages of 40 and 49,
while only 12.9% were younger than 30 years of age (HRSA, 2017g). Among the
PLWHA served by the RWHAP in 2016, 71.7% were male, 27.0% were female, and
1.3% were transgendered (HRSA, 2017g). Racial and ethnic minorities were also more
likely to use RWHAP services in 2016, as they represented 73.2% of the total number of
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clients served. In 2016, 46.9% of RWHAP clients with HIV/AIDS were black, 23.2%
were Hispanic/Latino, 26.8% were white, and the remaining 3.1% were American Indian,
Alaska Native, Asian, Native Hawaiian/Pacific Islander, and persons of multiple races
(HRSA, 2017g).
RWHAP clients with HIV/AIDS that used services in 2016 had low annual
incomes as 62.7% earned less than 100% of the FPL, while an additional 28.4% of clients
earned between 101% and 250% of the FPL. In 2016, only 8.9% of RWHAP clients
earned more than 251% of the FPL (HRSA, 2017g). Although RWHAP clients had low
annual incomes, approximately 80% had health insurance coverage. Among PLWHA
using RWHAP services in 2016, 32.4% had health insurance coverage through Medicaid,
16.5% were covered by a commercial carrier, 10.6% were insured through Medicare,
10.1% had several forms of coverage, and 20.5% were uninsured (HRSA, 2017g).
Impact of the RWHAP on care engagement and viral suppression rates.
RWHAP clients achieve increased rate of engagement in care, access to ART
medications, and viral suppression compared to PLWHA who do not receive services
through the program. Among PLWHA throughout the United States, 40% are engaged in
care, 37% are prescribed ART, and 30% are virally suppressed (U.S. Department of
Health & Human Services, 2016b). Among PLWHA enrolled in the RWHAP 81% are
engaged in care and 84% are virally suppressed (HRSA, 2016c).
Relationships Between Health Coverage and Outcomes for PLWHA
Health insurance provides a way to finance health care expenses and protects a
person who is utilizing health care services from paying the full cost of treatment. In
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exchange for a predetermined premium cost, a health insurer is contractually obligated to
pay a defined portion of covered medical expenses. Health insurance coverage enhances
health outcomes by decreasing disparities in access to health care services. Diminished
access to medical services reduces overall health and increases the mortality rate. Wilper
et al. (2009) determined that the lack of health insurance is a contributing factor in death
as the mortality rate was 40% lower for people with insurance coverage compared to
people without insurance coverage. In 2015, the lack of health insurance contributed to
the deaths of 44,789 Americans between 18 and 64 years old and would have been the
10th leading cause of mortality in the United States if classified as a medical disorder
(CDC, 2017c; Wilper et al., 2009). Health insurance coverage provides improved clinical
outcomes for patients with HIV/AIDS. Goldman et al. (2001) concluded that health
insurance reduced the 6-month baseline mortality rate by 71% and 85% at follow-up,
compared to those who were uninsured. Patients with commercial health insurance
coverage more frequently achieved sustained viral suppression compared to participants
who were uninsured (Yehia, Fleishman, Metlay, Moore, & Gebo, 2012) and health
insurance coverage for PLWHA has been associated with prolonged viral suppression
and a reduction in the progression of HIV to AIDS and premature death (Yehia et al.,
2014).
ACA coverage and outcomes. Three important changes have been identified in
the impact of the ACA on the health of PLWHA. First, provider-initiated HIV screenings
have increased due to improved access to care (Carter, Owens, & Lin, 2017). Second,
McManus et al. (2016), McManus et al. (2018), Raifman et al. (2018), and Dawson and
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Kates (2019) reported that the viral load suppression rate for PLWHA enrolled in an
ACAQHP was the same or higher than the viral load suppression rate for PLWHA
enrolled in the RWHAP. Third, Simon, Soni, and Cawley (2017) reported the expansion
of health insurance coverage due to the ACA increased the probability of having a HIV
test by 5%. HIV testing is essential to diagnose HIV and achieve viral load suppression,
which results in an improved overall health status and mortality rate.
The rate of hospitalization for PLWHA was higher in states that did not expand
Medicaid as part of the ACA compared to states that did expand their Medicaid
programs. The hospitalization rate of uninsured PLWHA dropped in ACA Medicaid
expansion states from 13.7% to 5.5%, while the hospitalization rate in non-Medicaid
expansion states increased from 14.5% to 15.7% (Hellinger, 2015). PLWHA who
enrolled in Medicaid coverage provided through the ACA were less likely to die during
their hospitalization as uninsured PLWHA experienced a 41% higher mortality rate while
in the hospital compared to patients with insurance (Hellinger, 2015). Finally, low
income adults with chronic medical conditions who enrolled in Medicaid coverage
provided through the ACA reported enhanced access to care, medication adherence, and
self-reported health (Simon et al., 2017; Sommers, Maylone, Blendon, Orav, & Epstein,
2017)
Health coverage, out-of-pocket expenses, and outcomes. The failure of the
federal government and the Affordable Care Act to include mechanisms to regulate
health care costs and decrease health care expenditures have compelled issuers of
ACAQHP policies to incorporate large deductibles to minimize the cost of health
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insurance premiums (Wharam, Ross-Degnan, & Rosenthal, 2013). Insurance policies
with high deductibles generally cost less than traditional health insurance, however, they
burden patients with considerable out-of-pocket medical expenses (Bebinger & Murphy,
2015; Wharam, Zhang, Landon, Soumerai, & Ross-Degnan, 2013). For calendar year
2018, the Internal Revenue Service set the minimum deductible for a high deductible
health plan at $1,350 for an individual and $2,700 for a family, while the maximum outof-pocket expense for an individual was $6,650 and $13,300 for a family (Internal
Revenue Service, 2017a).
As the cost of health insurance continues to increase, more people are selecting
health policies that contain high deductibles. Created in 2003, millions of people with
health insurance are now enrolled in high deductible health plans (Dolan, 2014; Grens,
2013). In 2009, 21% of people with group health insurance coverage and 47% of people
who purchased individual health policies enrolled in plans with high deductibles
(Beeuwkes-Buntin, Haviland, McDevitt, & Sood, 2011). By 2016, 35% of people with
employer sponsored group health insurance and 54% of people who purchased individual
health policies were enrolled in high deductible health plans (U.S. Department of Health
& Human Services, Cohen, & Zammitti, 2017). Nearly 90% of people who purchased
individual ACA policies through the marketplace were enrolled in a health insurance plan
with a large deductible (Murphy, 2016).
Health insurance plans with high deductibles adversely impact two important
principles of insurance coverage; to defend against large costs after needed medical
services are consumed and to reduce barriers that inhibit access to care in order to
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maximize health status (U.S. Department of Health & Human Services et al., 2017).
Researchers have shown that allocating greater financial costs to people enrolled in high
deductible health plans results in medical care avoidance and an overall reduction in the
utilization of medical care (Taber et al., 2015; U.S. Department of Health & Human
Services et al., 2017). Medical care avoidance is characterized as an intentional failure to
obtain timely treatment for a medical condition (Taber et al., 2015; U.S. Department of
Health & Human Services et al., 2017). Multiple researchers indicated that between 33%
and 43% of patients enrolled in a high deductible health plan deferred or skipped
physician recommended diagnostic tests or procedures due to large out-of-pocket
expenses and that adults with high deductibles were 2.7 times more like to delay or forgo
care than were adults with traditional health insurance (Galbraith et al., 2012; Kannan &
Veazie, 2014; Murphy, 2016).
The ability of a patient to afford medical care is impaired when the deductible
amount increases as a percentage of annual income. Murphy (2016) reported that patients
chose to avoid seeking needed medical care when deductibles reached 5% of their annual
income. Deductibles under the ACA are often greater than this threshold. In 2018 a
family of four enrolled in a high deductible health plan earning 200% of the FPL
($50,200 annually) would spend 26.5% of their annual household income on out-ofpocket payments for medical expenses before their insurance company began fully
paying for all covered claims (U.S. Department of Health & Human Services, 2018b).
The same sized family earning 300% of the FPL ($75,300 annually) would consume
17.7% of their income on health care expenses (U.S. Department of Health & Human
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Services, 2018b). Individuals with an annual income of less than $19,999 and between
$20,000 and $34,999 were 4.85 and 5.22 times more likely to avoid seeking medical care
due to cost than were people earning more than $100,000 per year (Galbraith et al., 2012;
Kannan & Veazie, 2014). Forty percent of families earning less than 400% of the FPL
with a high deductible health plan delayed or refused needed medical care, compared to
15% of people with similar annual income who had traditional health insurance coverage
(Galbraith et al., 2012; Kannan & Veazie, 2014)
Delayed access to care and outcomes. Severe health consequences can occur
when people avoid obtaining needed medical care when they are sick. Delayed care
results in a delayed diagnosis, an increase in overall suffering, reduced treatment options
for a wide variety of health diseases including HIV, cancer, heart disease, stroke, and
arthritis, and a rise in overall mortality (Kannan & Veazie, 2014; Taber et al., 2015). For
PLWHA, delayed engagement in HIV medical care or the start of ART medications
reduces the chances of viral load suppression and increases the overall rate of mortality
and the chances of transmitting the disease to non-infected people (Fatukasi et al., 2017;
U.S. Department of Health & Human Services, 2016b, 2018c). Patients with other
treatable chronic conditions also experience increased mortality rates due to delayed
access to medical care. Among patients with oral cancer, nearly 40% postponed seeing a
physician until the disease had progressed to stage 3 or 4, while 50% of patients
diagnosed with rectal cancer delayed seeking medical care for at least 6 months (Kannan
& Veazie, 2015). Finally, patients with curable illnesses that are not promptly treated
often end up seeking out care in more expensive settings such as hospitals and incur
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longer lengths of stay. Murphy (2016) stated that nearly 80% of emergency room
physicians reported treating patients for a preventable medical condition because they
delayed seeking care due to out-of-pocket costs that were unaffordable.
Summary and Conclusions
HIV and AIDS continues to be a considerable health problem in the United States
as more than 1.1 million people are living with the disease (The Henry J. Kaiser Family
Foundation, 2017f; U.S. Department of Health & Human Services, 2017l). HIV and
AIDS disproportionately impacts marginalized members of society including men who
have sex with men (MSM), racial and ethnic minorities, and people of lower
socioeconomic status (CDC, 2018a; Denning & DiNenno, 2015; U.S. Department of
Health & Human Services, 2017m). Viral load suppression is a commonly used measure
to assess the overall health status of a PLWHA (U.S. Department of Health & Human
Services, 2016c; World Health Organization, 2016b). PLWHA who are virally
suppressed live healthier and longer lives and are less likely to transmit the virus to others
(Goldman et al., 2014; U.S. Department of Health & Human Services, 2018d). Key
factors in becoming virally suppressed include engagement in care and ART medication
adherence. PLWHA who remain consistently engaged in care and properly take their
ART medications are more likely to achieve and maintain long term viral suppression,
experience reduced mortality rates, and experience a life expectancy equal to that of the
general uninfected population (Crawford, 2014; Crawford et al., 2014; Deeks et al.,
2013).
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For PLWHA, health insurance coverage is associated with viral load suppression
and a reduced likelihood of premature death (Goldman et al., 2001; Yehia et al., 2012,
2014). Prior to the passage of the ACA in 2010, between 30% and 40% of PLWHA did
not have comprehensive health insurance and received care solely provided by the
RWHAP (Rozin et al., 2015). The RWHAP was created in 1990 and provides
comprehensive HIV/AIDS-related medical care and support services on an outpatient
basis to approximately 48% of all people diagnosed with HIV in the United States
(HRSA, 2017g). RWHAP participants must be diagnosed with HIV or AIDS and either
have no health insurance coverage or limited coverage that does not fully pay for all
HIV/AIDS-related health care services (HRSA, 2016b). Although PLWHA who receive
care provided by the RWHAP are more likely to become virally suppressed than are
uninsured PLWHA who are not enrolled in the program, the RWHAP is not a health
insurance product, as it does not provide coverage for comprehensive health care
services. The RWHAP only provides outpatient HIV/AIDS-related medical care and
treatment and excludes coverage for medical services provided in an emergency room,
inpatient hospital setting, or for any other medical condition or medications unrelated to
the treatment of HIV/AIDS (Crowley & Garner, 2015; Dawson & Kates, 2015; Emory
Health care, 2017). Consequently, the health benefits associated with the comprehensive
care provided by an ACAQHP may improve the health of PLWHA. In addition, the ACA
provides several protections that will benefit PLWHA including the inability for
insurance companies to deny coverage or raise the premium rates for people HIV/AIDS
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and the elimination of annual or lifetime dollar limits on the payment of covered services
(U.S. Centers for Medicare & Medicaid Services, 2018a).
Little is known about the relationship between the ACA and the health of
PLWHA. I have found only five studies in which researchers examined whether the
comprehensive health insurance provided by the ACA has improved the overall health
status of PLWHA compared to those receiving Ryan White Care. Bradley et al. (2016)
found that PLWHA enrolled in an ACAQHP were 5% less likely to be virally suppressed
then those enrolled in the RWHAP. Dawson and Kates (2019) found the viral load
suppression rate was the same for PLWHA enrolled in the RWHAP and in an ACAQHP.
However, McManus et al. (2016), McManus et al. (2018), and Raifman et al. (2018)
reported the viral load suppression rate was higher for PLWHA enrolled in an ACAQHP
compared to those enrolled in the RWHAP. My study will help close a gap in the
research and expand scientific knowledge by providing seminal data on the relationship
between the RWHAP, the ACA, and the health of PLWHA in the state of Florida.
The next chapter, Chapter 3, provides an explanation of the research design that
will be used to help close the gap in this subject matter. Initially, the methodology of the
study will be described including an overview of the study population, study sampling
procedures, power analysis, sample size, data collection process, statistical assumptions,
and data analysis. Finally, the threats to the validity of this study and the ethical
procedures used to protect the participants and integrity of the data will be reviewed.
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Chapter 3: Research Method
Introduction
HIV and AIDS are significant health problems in the United States as 1.1 million
people are living with the disease (CDC, 2016d; U.S. Department of Health & Human
Services, 2017m). It is important for PLWHA, health care providers, and health policy
makers to understand the impact on HIV/AIDS health outcomes (viral load) when
comparing the care provided by the RWHAP to the care received from an ACAQHP. The
purpose of this quantitative correlational cross-sectional study was to explore the
relationship between demographic factors, treatment compliance, and engagement in care
on the health status (viral suppression) of PLWHA who were enrolled in the RWHAP
compared to those who were enrolled in an ACAQHP.
Both descriptive and inferential statistical measurements were used. Descriptive
statistics such as mean and percentages were used to measure categorical and continuous
independent variables. Three inferential statistical methodologies were used to analyze
the relationship and differences between the health of PLWHA who were enrolled in the
RWHAP and those who were enrolled in an ACAQHP: multiple linear regression, chisquare, and an independent samples t test. Field (2013) recommended a multiple linear
regression model to establish the statistical significance of association between multiple
independent variables and one continuous dependent variable, and recommended an
independent samples t test to compare differences in the means of two categorical
unrelated groups. Field (2013) also recommended a chi-square test to determine whether
a relationship exists between two independent groups.
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Chapter 3 presents the research approach used in this study. A detailed description
of the research design and rationale is provided, followed by the methodology of the
study including the study population and setting, sampling procedures, data collection,
variable description, variable operationalization, power analysis and sample size,
statistical analysis and assumptions, and data analysis. The final sections include a
description of the potential threats to validity, protection of participants, and a transition
to Chapter 4.
Research Design and Rationale
This study addressed the relationships between independent and dependent
variables of PLWHA enrolled in the RWHAP and in an ACAQHP, as well as differences
in dependent variables between groups. The independent variables in the first research
question were gender, race, age, education level, federal poverty level, coverage status,
treatment compliance, and engagement in care, while the dependent variable was health
status. The independent variable in the second research question was coverage status,
while the dependent variable was treatment compliance. The independent variable in the
third research question was coverage status, while the dependent variable was
engagement in care. The independent variable in the fourth research question was
coverage status, while the dependent variable was health status. The independent variable
in the fifth research question was coverage status, while the dependent variable was the
difference in difficulty in paying out-of-pocket medical expenses.
A quantitative design was appropriate because numerical data were used to
measure the relationship among multiple independent and single dependent variables as
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well as differences between dependent variables across groups. Additional elements of
this study that justified a quantitative approach included the use of a structured research
instrument to collect data and the development of research questions with fixed
responses, which were objectively answered (see Labaree, 2017). A quantitative design is
a suitable choice when the objective of the study is to generalize the findings to larger
populations (Creswell, 2009; Labaree, 2017).
Frankfort-Nachmias et al. (2015) noted that a cross-sectional design is frequently
used in public health and social science research, while Levin (2006) and Setia (2016)
indicated that a cross-sectional design is helpful in public health planning and enhancing
the understanding of disease etiology. A cross-sectional study is observational, and a
researcher can compare multiple variables and health outcomes simultaneously at a single
point (Setia, 2016). This approach matched the current study objectives in measuring the
relationships between independent variables and the viral load of PLWHA who receive
care from the RWHAP and those who receive care from an ACAQHP as well as
differences in the dependent variables between groups. This design does not require
participants to be randomly assigned to control or comparison groups, which is often
considered unethical in public health research due to the serious nature of withholding
treatments/interventions (Frankfort-Nachmias et al., 2015). Cross-sectional studies can be
both descriptive in examining disease frequency and distribution in a population and
analytical in investigating the association among multiple factors and health outcomes
(Barratt & Kirwan, 2010). The three primary disadvantages of a cross-sectional study
include the inability to investigate a behavior over a period of time, the inability to
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establish a cause-and-effect relationship, and the lack of generalizability of findings to
other points in time (Frankfort-Nachmias et al., 2015; Setia, 2016).
A correlational design is used to determine whether a relationship exists between
two or more variables. Advantages of a correlational design include the ability to collect
data on a large number of participants and to study a diverse set of variables and their
interrelations (Field, 2013). A correlational design offers a researcher the ability to
measure variables in health science studies that cannot be manipulated due to ethical
reasons (Field, 2013). The primary disadvantage of a correlational study is that it only
reveals the existence of a relationship and cannot provide a definitive reason for why the
relationship exists (Frankfort-Nachmias et al., 2015). A correlational study cannot be
used to draw inferences about the causal relationships between and among variables
(Frankfort-Nachmias et al., 2015).
A correlational cross-sectional design provides a low level of internal validity and
a high level of external validity, while the generalizability of the results may be limited
due to the sampling methodology (Carlson & Morrison, 2009). Additionally, a
correlational cross-sectional design provides a greater level of reliability than an editorial
or a case report, yet is less reliable than a case control study or a randomized controlled
study (Berezow, 2017). Reliability in a cross-sectional study is impacted by the inability
of the researcher to control for the impact of competing alternative explanations on the
results (Frankfort-Nachmias et al., 2015).
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Methodology
Population
The study population was PLWHA residing in Florida who participated in the
2015–2017 Medical Monitoring Project surveys, and were enrolled in the RWHAP or an
ACAQHP.
Sampling and Sampling Procedures
Sampling strategy. Because secondary data were collected in this study, a
purposive convenience sampling strategy was used. A purposive sampling strategy is a
nonprobabilistic methodology in which participants are selected based on qualifications
or characteristics selected by the researcher, while a convenience sample is a
nonprobabilistic sampling strategy in which participants are selected based on the ease of
access and inclusion for the researcher (Laerd Statistics, 2012a, 2012d). Advantages of a
purposive sampling strategy include the ability to quickly reach a targeted population and
cost effectiveness (Laerd Statistics, 2012d). Disadvantages of purposive sampling are a
vulnerability to errors in judgement by the researcher, researcher bias (which could
reduce the internal validity and reliability of the study), and a potentially reduced level of
external validity in that research findings may not be generalizable to other populations
(Barrat, Ferris, & Lenton, 2015; Laerd Statistics, 2012d).
The benefits of a convenience sampling methodology include the ease of
implementation and the ability to quickly achieve the needed sample size in a costeffective manner while (Laerd Statistics, 2012a). Disadvantages of a convenience
sampling strategy include a potential for bias in collecting data which could reduce the
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internal validity and reliability of the study, the possibility of a sampling error, and
reduced external validity in that the study results may not be generalizable to other
populations (Laerd Statistics, 2012a).
Sampling frame. All patients who have had continual RWHAP coverage for a
minimum of one year and patients who have had coverage through an ACAQHP for at
least one year (without any lapse in care enrollment) and have available medical and
sociodemographic data will be included in this study. The one-year threshold of
continuous insurance coverage for both groups of PLWHA was selected based on the
results of other similar studies. Baicker et al. (2013) found one-year of continuous health
insurance coverage was an appropriate length of time to measure whether patients
achieved improved health (as measured by blood pressure, cholesterol, and glycated
hemoglobin) due to their new insurance coverage. Sommers, Gawande, and Baicker
(2017) reported the impact of health insurance coverage on life-threatening conditions
such as HIV/AIDS may take at least one year to occur. The availability of medical and
sociodemographic data will also determine eligibility for participation in this study.
Patient data specific to the focus of each individual research question was also required
and only PLWHA with the needed information for each individual research question was
included in this study.
RQ1: The intent of the first research question is to analyze the relationship
between demographic factors, treatment compliance, engagement in care, coverage
status, and the health status of PLWHA. Necessary data for participant inclusion for this
research question included demographic data including race, gender, age, education level,
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and federal poverty level, and medical record data from PLWHA who had either one year
of continuous coverage from the RWHAP or from an ACAQHP, the number of ART
missed doses in the past 30 days and physician office visit dates for a minimum of 12
months. PLWHA without this information were excluded from participation in this study.
RQ2: The aim of the second research question is to examine the difference in
treatment compliance between PLWHA enrolled in an ACAQHP and PLWHA enrolled
in the RWHAP. Participant inclusion criteria required documentation of either one year
of continuous coverage from the RWHAP or from an ACAQHP and the number of ART
missed doses in the past 30 days. PLWHA without this information were excluded from
participation in this study.
RQ3: The goal of the third research question is to examine the difference in
engagement in care between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP. Participant inclusion criteria required documentation of either one year of
continuous coverage from the RWHAP or from an ACAQHP and physician office visit
dates for a minimum of 12 consecutive months. PLWHA without this information were
excluded from participation in this study.
RQ 4: The focus of the fourth research question is to examine the difference in
health status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP. Participant inclusion criteria required documentation of either one year of
continuous coverage from the RWHAP or from an ACAQHP and viral load test results
(to measure health status). PLWHA without this information were excluded from
participation in this study.
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RQ5: Finally, the objective of the fifth research question is to examine the
difference in difficulty in paying out-of-pocket medical expenses between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Participant inclusion
criteria required documentation of either one year of continuous coverage from the
RWHAP or from an ACAQHP and documentation of the difficulty in paying out-ofpocket medical expenses. PLWHA without this information were excluded from
participation in this study.
Power analysis and sample size. An accurate sample size is needed to generate
reliable study findings that can be generalized to a larger population. Sample size in a
study is determined by three factors: effect size, alpha level, and statistical power (Field,
2013; Frankfort-Nachmias et al., 2015). Effect size is a numerical value that identifies the
strength of the differences or relationships among multiple variables in a research study
(Creswell, 2009). A larger effect size requires a smaller sample size to identify the
strength of the relationships among study variables, while a smaller effect size
necessitates a larger sample size to reveal the magnitude of the relationships among the
same variables (Creswell, 2009). While effect size values are classified as small, medium,
or large, Cohen (1988) suggested that social science researchers use a medium effect
size. For a multiple linear regression, Cohen (1988) defined a value of 0.15 as a medium
effect size. Alpha (α), the second determinant of sample size, should be set at a low level
in order to minimize the chances of a type 1 error. A type 1 error (false positive) occurs
when a researcher perceives there is a statistically significant impact on a study
population when it actually does not exist resulting in the incorrect rejection of the true
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null hypothesis (Field, 2013). An Alpha level of .05 was used in this research study. Both
Field (2013) and Frankfort-Nachmias et al. (2015) recommended that the alpha level be
set at .05 signifying that the probability of incorrectly rejecting a true null hypothesis will
occur 5% of the time.
Power is inversely related with the probability of committing a type II error. A
type II error (false negative) occurs when a researcher deems there is not a statistical
significance when it actually does exist, resulting in the incorrect rejection of the null
hypothesis (Field, 2013). The formula to determine power is 1- Beta (β). As power
increases, the likelihood of committing a type II error decreases (Cohen, 1988). The
Pennsylvania State University Eberly College of Science (2017) recommended a power
level between 80% and 95% in order to identify a precise effect in clinical research.
Therefore, β in this research study will be set at .20 resulting in a power level of 80%,
signifying an 80% probability of avoiding a type II error.
Sample size calculation. The required sample size for each research question was
calculated using GPower version 3.1.9.2. GPower is a commonly used free software
application designed to calculate sample size (Faul, Erdfelder, Lang, & Buchner, 2007).
The first research question was: What is the relationship between demographic
factors (race, gender, age, education level, and federal poverty level), treatment
compliance (as defined by the number of ART missed doses in the past 30 days),
engagement in care (as defined by the number of HIV/AIDS-related physician visits
within the previous 12 months), coverage status (enrolled in the RWHAP or an
ACAQHP) and the health status of RWHAP consumers (as defined by viral
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suppression)? This research question will be analyzed using a multiple linear regression.
The GPower parameters for these research questions are: Test family = F test, Statistical
test = Linear multiple regression: Fixed model, R2 deviation from zero, Type of power
analysis = A priori: compute required sample size given alpha, power, and effect size,
Effect size = 0.15, Alpha = 0.05, power = 0.80, and Number of predictors = 8. Based on
the aforementioned sampling criteria, the minimum total sample size needed was 109
participants. Research questions two, three, and four will be analyzed using an
independent samples t test. The GPower parameters for these research questions are: Test
family = t test, Statistical test = Means: Difference between two independent means (two
groups), Type of power analysis = A priori: Compute required sample size given alpha,
power, and effect size, Tails = 2, Effect size = 0.50, Alpha = 0.05, Power = 0.80, and
Allocation ratio (n2/n1) =.20 (D. Segal, personal communication, May 19, 2018). The
sample size for each research question is listed below.
The second research question was: What is the difference in treatment compliance
(as defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP? Based on the
aforementioned sampling criteria for an independent samples t test, the minimum total
sample size needed was 228, of which 190 participants were enrolled in the RWHAP and
38 participants were enrolled in an ACAQHP.
The third research question was: What is the difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the

85
RWHAP? The results of the aforementioned sampling criteria for an independent
samples t test required a minimum total sample size of 228, of which 190 participants
were enrolled in the RWHAP and 38 participants were enrolled in an ACAQHP.
The fourth research question was: What is the difference in health status (as
defined by viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP? Based on the aforementioned sampling criteria for an
independent samples t test, the minimum total sample size needed was 228, of which 190
participants were enrolled in the RWHAP and 38 participants were in enrolled in an
ACAQHP.
Finally, the fifth research question was: What is the difference in difficulty in
paying out-of-pocket medical expenses (as defined by problems paying for any out-ofpocket medical or health insurance costs) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP? This research question was analyzed using a chisquare test. The GPower parameters for these research questions are: Test family = z
tests, Statistical test = Proportions: Difference between two independent proportions,
Type of power analysis = A priori: compute required sample size given alpha, power, and
effect size, Tails = 2, Proportion p2 = .40, proportion p1 = .15 (Galbraith et al., 2012),
Alpha = 0.05, power = 0.80, and Allocation ratio (n2/n1) =.20 (D. Segal, personal
communication, May 19, 2018). Based on the aforementioned sampling criteria, the
minimum total sample size needed was 157 participants, of which 131 participants were
enrolled in the RWHAP and 26 participants were enrolled in an ACAQHP.
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The minimum sample size for this research study was 228. This minimum sample
size was selected because it represented the largest number generated by GPower for all
five of the research questions and was the appropriate number when utilizing a multiple
linear regression, an independent samples t test, and a chi-square test. Additionally, when
conducting the independent samples t test analysis, the sample population required a
minimum of 190 participants who were enrolled in the RWHAP and 38 participants were
enrolled in an ACAQHP.
Weighted data. The Florida Department of Health required the use of individual
case weighted data in this study. For each study participant, the CDC weighted the
individual response based upon demographic variables including age, birth gender, and
race in order to ensure that survey participants were representative of PLWHA
throughout the state of Florida (CDC, 2020). The primary benefit of using weighted data
in my study was to enhance external validity. The results of my study are now
generalizable to all PLWHA residing in Florida.
Data Collection Procedures
My dissertation used secondary data, which was made available from the Florida
Department of Health after IRB approval was granted by Walden University. Study
participants did not need to sign informed consent for their data to be included in this
study. Individual level demographic, financial and health outcome data was obtained
from the 2018 version of the Medical Monitoring Project survey for use in this study.
This survey compiled HIV service care data for PLWHA enrolled in the RWHAP and in
an ACAQHP. This database was populated with viral load test results, medical visits,
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ART medication compliance, and information identifying the difficulty PLWHA had in
paying out-of-pocket medical expenses.
I considered the dataset as secondary data because I did not personally collect the
information that I analyzed. Boslaugh (2007) wrote that secondary data including clinical
information obtained from surveys and medical records is commonly used in public
health research. The use of secondary research offers numerous advantages to public
health researchers. Frankfort-Nachmias et al. (2015) stated secondary data may provide a
conceptual-substantive advantage in that it may be the only data available to use in a
research study. This was the case for my study. The only data available to examine the
health of PLWHA in Florida enrolled in the RWHAP and enrolled in an ACAQHP was
collected by the HIV/AIDS Section, Bureau of Communicable Diseases, Florida
Department of Health. Reliable and accurate data obtained from secondary sources
allows other researchers an opportunity to replicate the findings of a study (FrankfortNachmias et al., 2015). The findings of a scientific study are enhanced when other
researchers are able to obtain similar results when using the same dataset. A final
advantage of using secondary data is the realization of improved efficiencies, which
result in savings of both time and money (Boslaugh, 2007). An added benefit was the deidentified dataset was provided to me in an electronic format, which minimized my time
spent digitizing the information and maximized my time spent analyzing the data.
There are three principal limitations in using secondary data in scientific research
and each of these limitations has been minimized in the design of this study. The first
limitation of using secondary data is gaining access to the relevant data (Frankfort-
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Nachmias et al., 2015). Fortunately, this obstacle was removed, as Emma Spencer, Ph.D.,
Surveillance Program Manager, HIV/AIDS Section, Bureau of Communicable Diseases,
Florida Department of Health executed a Data Use Agreement and provided me the deidentified, blinded secondary dataset that I used in this study. A second limitation in
using secondary data in a research study is the information was collected by other
individuals to answer their own specific research questions and may not be completely
applicable or transferable for use in other research settings (Frankfort-Nachmias et al.,
2015). This potential limitation in the use of secondary data in this study was addressed,
as the Florida Department of Health collected this data to monitor client-level outcomes
for evaluation of disease status and health outcomes and would benefit from
understanding the impact that the ACA has on the health of PLWHA. A third and final
limitation of the use of secondary data is the researcher generally does not know how
well the data was collected or the accuracy of the data entry process (Frankfort-Nachmias
et al., 2015). Although I did not know the individuals collecting and entering data from
the participants in the Medical Monitoring Project, clinical guidelines established by
HRSA and the Florida Department of Health both required the documentation of all
patient information without personal bias or error.
Instrumentation and Operationalization of Constructs
As shown in Table 1, I used four dependent variables in this study. The first,
health status, was measured by viral load. The second, treatment compliance, was
measured by the number of missed ART doses in the past 30 days. The third,
engagement in care, was measured by the total number of HIV/AIDS-related physician
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visits within the previous 12 months. The fourth, difficulty in paying out-of-pocket
medical expenses, was measured by the self-reported financial affordability data
collected from study participants.
I also used four independent variables in this study. The first independent
variable, demographic factors, included gender, race, age, education level, and federal
poverty level. The second, treatment compliance, was measured by the number of missed
ART doses in the past 30 days. The third, engagement in care, was measured by the total
number of HIV/AIDS-related physician visits within the previous 12 months. The fourth,
coverage status, was determined based on whether care was provided by the RWHAP or
from an ACAQHP.
Viral load was selected as the determinant of health status for PLWHA for several
reasons. First, the RWHAP, in November of 2013, identified viral load as a core
performance measure that should be used to evaluate the care and treatment of PLWHA
(U.S. Department of Health & Human Services, 2017j). Consequently, the HIV/AIDS
Bureau recommends the use of viral load in the assessment of clinical outcomes and
overall improvement in health (U.S. Department of Health & Human Services, 2017j). As
the examination of changes in health among PLWHA was an integral component of this
research study, the use of viral load was an appropriate proxy for health outcomes.
Second, viral load has been used in other similar research studies by Crawford et al.
(2014) and Mugavero et al. (2012) to assess the health status of PLWHA.
Viral load. Viral load, a continuous variable, was the dependent variable in this
study, and was used to assess the health of PLWHA. The test date and numerical viral
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load count results were identified in the dataset as “Viral Load Count Date” and “Viral
Load Count”. To simplify the nomenclature I renamed these study variables in SPSS, as
“VLCOUNT” and “VLDATE”. I entered VLCOUNT into SPSS as a numerical value,
while I entered VLDATE into SPSS using the mm/dd/yyyy format. I named the
difference in viral load results “VLCHANGE”. I recoded study participants with
unknown or missing viral load data in the SPSS data set as missing and excluded these
participants from this study.
Gender. Gender, a categorical independent variable was identified in the dataset
as “BIRTGEN”. In SPSS, I renamed this variable “GENDER” and coded 1 = Male, 2 =
Female, 3 = Intersex/Ambiguous. I recoded study participants with unknown or missing
gender data in the SPSS data set as missing and excluded these participants from this
study.
Race. Race is also a categorical independent variable and was identified in the
dataset as “HISPA_13” = Hispanic or Latino, “Race 9A” = American Indian or Alaska
Native, “Race 9B” = Asian, “Race 9C” = Black or African American, “Race 9D” =
Native Hawaiian or Other Pacific Islander, and “Race 9E” = White. To simplify the
dataset codes, I renamed these variables in SPSS as “RACE” and will be coded as 0 =
White, 1 = Black of African American, 2 = Hispanic or Latino, 3 = Asian, 4 = Native
Hawaiian/Other Pacific Islander, 5 = American Indian/Alaska Native, 6= Multiracial.
After I reviewed the racial identity of each study participant, I recoded 0 = each
individual racial group and 1= white to create a dichotomous variable to focus on the
group that was most impacted by HIV. I recoded study participants with unknown or
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missing racial data in the SPSS data set as missing and excluded these participants from
this study.
Age. Age is a continuous ratio independent variable designated as “DOB_13” in
the dataset. I retitled Age in SPSS as “AGE” and recorded the number as a numerical
value. I recoded study participants with unknown or missing age data in the SPSS data set
as missing and excluded these participants from this study.
Education. Education is an ordinal independent variable, referenced in the dataset
as “EDUC” I renamed this variable in SPSS as “EDUCATION” and coded the responses
as 1 = Never attended school, 2 = Grades 1 through 8, 3 = Grades 9 through 11, 4 =
Grade 12 or GED, 5 = Some college, associate’s degree, or technical degree, 6 =
Bachelor’s degree, 7 = Any post-graduate studies. I recoded study participants with
unknown or missing education data in the SPSS data set as missing and excluded these
participants from this study.
Federal poverty level. Federal poverty level is an additional ordinal independent
variable that was used in this research study. Termed “INCOME_8” in the dataset, I
renamed this variable “POVERTY” in the SPSS data set and coded as data as 1 = below
100% of the federal poverty level, 2 = 100-139% of the federal poverty level, 3 = 139400% of the federal poverty level, 4 = more than 400% of the federal poverty level. I
coded study participants with unknown or missing federal poverty level data as missing
and excluded these participants from this study.
Difficulty in paying out-of-pocket medical expenses. Difficulty in paying outof- pocket medical expenses is a dichotomous variable in this study and was labeled
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“PAY_N5” in the dataset. I renamed this variable in SPSS as “Financial” and coded the
data 0 = no, 1 = yes as a numerical value. I coded study participants with unknown or
missing data on difficulty in paying out-of-pocket medical expenses as missing and
excluded these participants from the study.
Treatment compliance. Treatment compliance in this study is a continuous ratio
variable that was assessed based on the number of missed ART doses in the past 30 days.
The number of missed ART doses in the past 30 days was identified as “ADH1_N5” in
the data set, which I renamed as “ARTMissed”. I coded study participants with unknown
or missing treatment compliance data indicating the number of days missed taking ART
as missing and excluded these participants from the study.
Engagement in care. Engagement in care, a continuous ratio variable was
measured in this research study as the total number of HIV/AIDS-Related physician visits
within the previous 12 months. The dataset contained the field named “ApptDate” and
“ApptType” which track appointment frequency. The number of these appointments from
the calendar year prior to the year the participant completed the MMP survey were
entered as a numerical value into SPSS in a field that I appropriately named “HIVVisits”.
I recoded study participants with unknown or missing engagement in care data as missing
and excluded these participants from the study.
Table 1
Summary of Research Variables
Research Variable Name
Question

Variable Type

Coding
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1

Health Status

Dependent
Variable

Numerical result of most
recent viral load test
results less viral load test
results at time 0.

Demographic
Factors
race, gender,
age, education
level, and
federal poverty
level

Independent
Variable

Race - 0 = White, 1 =
Black of African
American, 2 = Hispanic or
Latino, 3 = Asian, 4 =
Native Hawaiian/Other
Pacific Islander, 5 =
American Indian/Alaska
Native, 6 = Multiracial

Gender - 1 = Male, 2 =
Female, 3 = Intersex or
Ambiguous
Age - as a numerical
value
Education - 1 = Never
attended school, 2 =
Grades 1 through 8, 3 =
Grades 9 through 11, 4 =
Grade 12 or GED, 5 =
Some college, associate’s
degree, or technical
degree, 6 = Bachelor’s
degree, 7 = Any postgraduate studies

94
Federal poverty level - 1 =
below 100% of the federal
poverty level, 2 = 100 139% of the federal
poverty level, 3 = 139 400% of the federal
poverty level, 4 = more
than 400% of the federal
poverty level

2

3

Treatment
Compliance

Independent
Variable

Numerical value for the
number of missed ART
doses in the past 30 days

Engagement in
Care

Independent
Variable

Numerical value for the
number of HIV/AIDSrelated physician visits in
the past 12 months

Coverage Status

Independent
Variable

PLWHA enrolled in the
RWHAP or in an
ACAQHP

Treatment
Compliance

Dependent
Variable

Numerical value for the
number of missed ART
doses in the past 30 days

Coverage Status

Independent
Variable

PLWHA enrolled in the
RWHAP or in an
ACAQHP

Engagement in
Care

Dependent
Variable

Numerical value for the
number of HIV/AIDSrelated physician visits in
the past 12 months

Coverage Status

Independent
Variable

PLWHA enrolled in the
RWHAP or in an
ACAQHP
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4

5

Health Status

Dependent
Variable

Numerical result of most
recent viral load test
results less viral load test
results at time 0.

Coverage Status

Independent
Variable

PLWHA enrolled in the
RWHAP or in an
ACAQHP

Difficulty in
paying out-ofpocket medical
expenses

Dependent
Variable

Difficulty in paying outof-pocket medical
expenses - 0 = no, 1 = yes

Coverage Status

Independent
Variable

PLWHA enrolled in the
RWHAP or in an
ACAQHP

Data Analysis Plan
I used the Statistical Package for the Social Sciences (SPSS) version 25 to
complete the descriptive and inferential statistical analysis. The descriptive analysis I
conducted included measures of central tendencies (mean and standard deviation) for all
independent continuous variables and frequency distributions and percentage
distributions for all independent categorical variables. Inferential statistical analysis is
conducted to test hypotheses to derive answers to research questions based on study
participants or populations. The objective of this research study was to understand the
relationship between the health status of PLWHA enrolled in an ACAQHP and the health
status of PLWHA enrolled in the RWHAP. To elucidate this impact, statistical analysis
were completed on the following research questions:
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RQ1: What is the relationship between demographic factors (race, gender, age,
education level, and federal poverty level), treatment compliance (as defined by the
number of ART missed doses in the past 30 days), engagement in care (as defined by the
number of HIV/AIDS-related physician visits within the previous 12 months), coverage
status (enrolled in the RWHAP or an ACAQHP and the health status of PLWHA (as
defined by viral suppression)?
Ho1: There is no statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status
of PLWHA (as defined by viral suppression)
Ha1: There is a statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status
of PLWHA (as defined by viral suppression).
A multiple linear regression was used to analyze the data output from research
question one. A multiple linear regression is used to examine if relationships exist
between one continuous dependent variable and multiple independent variables (Field,
2013) A multiple linear regression analysis can also determine if confounding exists
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among the independent variables (Boston University School of Public Health, 2013). By
estimating the relationship between a single independent variable, while holding other
independent variables constant, a multiple linear regression can control for confounding
variables in a model and allow a researcher to better understand the impact that one or
more independent variables have on a dependent variable (Boston University School of
Public Health, 2013). A multiple linear regression was the appropriate statistic to use
because the dependent variable in this research question is continuous (Field, 2013).
RQ2: What is the difference in treatment compliance (as defined by the number of
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP?
Ho2: There is no statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
Ha2: There is a statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
An independent samples t test was used to analyze research question two. This
test was appropriate to answer this research question because an independent samples t
test compares differences in the means between two unrelated groups while a dependent t
test measures related groups and indicates that the same participants are included in both
groups (Field, 2013). This statistical test was suitable for this research question as the
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dependent variable is continuous and the independent variable has two different
categorical groups (Laerd Statistics, 2018b).
RQ3: What is the difference in engagement in care (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
Ho3: There is no statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
Ha3: There is a statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
An independent samples t test was used to analyze research question three. This
test was an appropriate statistical analysis to answer this research question because an
independent samples t test compares differences in the means between two unrelated
groups while a dependent t test measures related groups and indicates that the same
participants are included in both groups (Field, 2013). This statistical test was suitable for
this research question as the dependent variable is continuous and the independent
variable has two different categorical groups (Laerd Statistics, 2018b).
RQ4: What is the difference in health status (as defined by viral suppression)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
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Ho4: There is no statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
Ha4: There is a statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
An independent samples t test was used to analyze the fourth research question.
This test was an appropriate statistical analysis to answer this research question because
an independent samples t test compares differences in the means between two unrelated
groups while a dependent t test measures related groups and indicates that the same
participants are included in both groups (Field, 2013). This statistical test was suitable for
this research question as the dependent variable is continuous and the independent
variable has two different categorical groups (Laerd Statistics, 2018b).
RQ5: What is the difference in difficulty in paying out-of-pocket medical
expenses (as defined by problems paying for any out-of-pocket medical or health
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP?
Ho5: There is no statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
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Ha5: There is a statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
A chi-square was used to analyze the fifth research question. This test was an
appropriate statistical analysis to answer this research question because both the
dependent and independent variables are categorical and are being measured among two
independent groups (Laerd Statistics, 2018a).
Threats to Validity
Validity is an indication that the results of a study measure what is purported to be
measured (Field, 2013). The two primary types of validity are external validity and
internal validity. External validity represents the extent to which study findings can be
generalized to other broader populations (Frankfort-Nachmias et al., 2015). The results of
this study may be generalizable to PLWHA enrolled in the RWHAP and enrolled in an
ACAQHP throughout the United States as the benefits provided by ACA plans are
uniform regardless of geographic locale. However, the findings of this study are not
generalizable to people with other types of insurance coverage and consequently, the
impact on overall health may be dissimilar between these different types of patient
populations.
Internal validity is affected by the methods in which the research data is collected
and the design of the research study. The impact on internal validity from the collection
of this research data were minimal as viral load results, the number of ART missed doses,
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and HIV office visit dates were transactional in nature, contained in lab reports and
insurance claims forms, and were less likely to be impacted by bias or input error.
However, due to the increased complexity of the data entry process, patient demographic
information may have been less accurate than the clinical information contained in the
medical record. The design of the research study also impacted internal validity as the
observed variances in the dependent variable must be caused by the independent variable
and not by another unintended, confounding, or covariate variable (Trochim, 2006).
Before conducting multiple linear regression analyses, correlations were conducted to
determine if any variables were highly correlated. If any variables were highly
correlated, one or more of them would have been removed from the model to avoid
multicollinearity.
Two additional factors associated with the individual participants in this research
study that may have reduced internal validity include maturation and experimental
mortality. Maturation occurs when there is a change in the health of study participants
over time, while experimental mortality refers to participants that drop out of an ongoing
study and are no longer included (Laerd Statistics, 2012b, 2012c). Maturation may have
occurred in this study if the health of a participant changed and they no longer felt the
need to engage in care or remain compliant in care. Finally, experimental mortality may
have transpired among a study participant if they no longer desired to participate in the
study, became angry, apathetic, or frustrated with their disease or care they received, or
died.
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Ethical Procedures
Obtaining informed consent from the study participants was not necessary due to
the absence of any direct or indirect communication or interaction. Walden University
required IRB approval to be obtained before accessing secondary data. The data set was
not accessed until this approval was received. Finally, the data used to conduct this
research study as well as the findings of this research study will be stored for seven years
on a password protected computer network that is monitored by virus scanning software
and secured by both a hardware and software firewall. At the conclusion of the sevenyear data retention period, the electronic information will be erased using commercially
available software such as Eraser or Cyberscrub.
I received the de-identified secondary data from the Florida Department of Health
after Walden IRB approval was granted. I will provide documentation of this approval to
the organization for their records. The dataset used in this study was supplied in a HIPAA
approved de-identified format. Data that is de-identified per HIPAA guidelines does not
contain any personal identifiers such as name, address, telephone number, social security
number, date of birth, email address, medical record number, or another number or code
that could be used to identify the study participant (U.S. Department of Health & Human
Services, 2015b). Medical information that is de-identified per HIPAA guidelines is not
considered protected health information and can be shared and/or used without restriction
(U.S. Department of Health & Human Services, 2015b).
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Summary
Chapter 3 provided an overview of this quantitative correlational cross-sectional
designed study. The research design and rationale, methodology, threats to validity, and
ethical procedures used to examine the relationships between the independent and
dependent variables were described in significant detail. The next chapter, Chapter 4, will
provide a presentation, interpretation, and explanation of the analyzed data.
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Chapter 4: Results
Introduction
The purpose of this quantitative study was to determine the relationship between
demographic factors (race, gender, age, education level, and federal poverty level),
treatment compliance (as defined by the number of ART missed doses in the past 30
days), engagement in care (as defined by the number of HIV/AIDS-related physician
visits within the previous 12 months), and coverage status (enrolled in the RWHAP or an
ACAQHP) and the health status of PLWHA (as defined by viral suppression). I also
examined the difference in treatment compliance, engagement in care, and coverage
status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
The research questions and hypotheses were developed to determine whether a
relationship existed between the health of PLWHA, the ACA, and the RWHAP. The
research questions and hypotheses were the following:
RQ1: What is the relationship between demographic factors (race, gender, age,
education level, and federal poverty level), treatment compliance (as defined by the
number of ART missed doses in the past 30 days), engagement in care (as defined by the
number of HIV/AIDS-related physician visits within the previous 12 months), coverage
status (enrolled in the RWHAP or an ACAQHP) and the health status of PLWHA (as
defined by viral suppression)?
Ho1: There is no statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
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defined by the number of HIV/AIDS-related physician visits within the previous 12
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status
of PLWHA (as defined by viral suppression)
Ha1: There is a statistically significant relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status
of PLWHA (as defined by viral suppression).
The independent variables for this research question were demographic factors,
treatment compliance, engagement in care, and coverage status. The dependent variable
was health status.
RQ2: What is the difference in treatment compliance (as defined by the number of
ART missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP?
Ho2: There is no statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
Ha2: There is a statistically significant difference in treatment compliance (as
defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.

106
The independent variable for this research question was coverage status, and the
dependent variable was treatment compliance.
RQ3: What is the difference in engagement in care (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
Ho3: There is no statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
Ha3: There is a statistically significant difference in engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP.
The independent variable for this research question was coverage status, and the
dependent variable was engagement in care.
RQ4: What is the difference in health status (as defined by viral suppression)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
Ho4: There is no statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
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Ha4: There is a statistically significant difference in health status (as defined by
viral suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in
the RWHAP.
The independent variable for this research question was coverage status, and the
dependent variable was health status.
RQ5: What is the difference in difficulty in paying out-of-pocket medical
expenses (as defined by problems paying for any out-of-pocket medical or health
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP?
Ho5: There is no statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
Ha5: There is a statistically significant difference in difficulty in paying out-ofpocket medical expenses (as defined by problems paying for any out-of-pocket medical
or health insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA
enrolled in the RWHAP.
The independent variable for this research question was coverage status, and the
dependent variable was difficulty in paying out-of-pocket medical expenses. Chapter 4
includes the data collection methodology, a discussion of the statistical results, and a
discussion of the results related to each research question.
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Data Collection
Approval to conduct the study (IRB Number 03-28-19-0573087) was granted by
Walden University on October 1, 2019. Data were requested from the Florida Department
of Health on February 8, 2019 and were received on December 2, 2019. On January 15,
2020, the Florida Department of Health resent the same data set that included a new case
weight variable for each individual respondent who participated in the study.
Initial Collection of Secondary Data
The data used were provided by the Florida Department of Health and were
originally collected by the Centers for Disease Control and Prevention in conjunction
with the Florida Department of Health as part of the Medical Monitoring Project in the
2015, 2016, and 2017 cycle years. In each of these 3 years, the Centers for Disease
Control and Prevention randomly selected 800 PLWHA residing in Florida from the
enhanced HIV/AIDS reporting system database. The overall response rate for the survey
varied from year to year (2015 = 37.4%; 2016 = 41.6%; 2016 = 36.5%; U.S. Department
of Health & Human Services, 2019). The number of cases that were provided for each
year and the total number of cases are presented in Table 2.
Table 2
Number of Responses by Year

Original data set cases
Original data set RWHAP
Original data set ACA

2015
299
179
30

Included in Data set
2016
2017
333
292
192
152
33
28

Total
924
523
91
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Data Cleaning
Of the 924 cases provided, some needed to be removed from the data set before
conducting further analyses. Six were eliminated because the respondents lived outside
the state of Florida. Three hundred and sixty eight were excluded because the respondents
did not have coverage from the RWHAP or an ACAQHP. Three were omitted because
they were duplicates completed by the same individual. Two hundred and sixty four were
removed because data were missing from one or more of the variables.
After cleaning the data set, I determined that 283 individual cases were eligible
for inclusion. Among the 283 individual cases, 238 were participants enrolled in the
RWHAP and 45 were participants with coverage from an ACAQHP. According to the
statistical power analyses, to reach the appropriate statistical power for each of the
research questions, 228 cases were needed with 190 from participants enrolled in the
RWHAP and 38 from participants enrolled in an ACAQHP. The calculated power
requirements were met.
Required Use of Weighted Secondary Data
After cleaning the secondary data and reducing the number of individual cases to
283, I was notified by the Florida Department of Health that the data set they sent to me
did not include the individual case weighting variable that was required for me to include
in my analysis. For each participant in the study, the Centers for Disease Control and
Prevention (2020) weighted the individual response based on demographic variables
including age, birth gender, and race to ensure the survey participants were representative
of PLWHA throughout the state of Florida. As shown in Table 3, after rerunning the
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statistical analysis in SPSS with the individual case weighting variable included in the
data set, I determined that the number of participants increased to 30,670. Among these
30,670 participants, 25,834 were enrolled in the RWHAP and 4,836 were enrolled in an
ACAQHP (see Table 3). The primary benefit of using the weighted data was an
enhancement in external validity. The results were now generalizable to all PLWHA
residing in Florida. A post hoc power analysis was completed using the sample of 30,670
participants that was generated from the weighted sample size. As shown in Appendix C,
the power achieved in this study was 100%, which meant there was a 100% probability of
avoiding a Type II error, which occurs when a researcher fails to reject a false null
hypothesis.
Table 3
Weighted Data Sample Size

Sample Size

Weighted
N
30670

Data Collection Discrepancies
There were some discrepancies between what was planned in Chapter 3 and what
occurred during data collection. The individual data set cases provided by the Florida
Department of Health were weighted by the Centers for Disease Control and Prevention
based upon demographic variables including age, birth gender, and race (S. Geary,
personal communication, January 24, 2020). The primary benefit of using the weighted
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data in this study was an enhancement in external validity. The results were now
generalizable to all PLWHA residing in Florida.
Several clarifications in the coding and analysis of the operationalized data were
necessary. First, multiracial was added as an additional code in the race/ethnicity
descriptors. Second, federal poverty level was coded as 1 = below 100% of the federal
poverty level, 2 = 100-139% of the federal poverty level, 3 = 139-400% of the federal
poverty level, and 4 = more than 400% of the federal poverty level. Third, all surveys
were coded as completed on July 1 of each response year. Fourth, an ACAQHP was
coded as the primary health care coverage for all PLWHA who had both ACAQHP and
RWHAP coverage.
Results
Demographics of Sample
As can be seen in Table 4, a majority of survey respondents were Black or
African American (55.6%, n = 17,050) and male (68.0%, n = 20,859). Additionally, most
respondents were between 40 and 59 years old (60.2%, n = 18,411) and the majority
attended some college or received an Associate or Technical degree, received a
bachelor’s degree, or participated in any Post-Graduate studies (52.8%, n = 16,193).
Finally, most respondents had an annual household income of less than 139% of the FPL
(63.7%, n = 19,536). Among the survey participants, 84.2% (n = 25,834) had RWHAP
coverage while 15.8% (n= 4,836) had coverage through an ACAQHP. Additionally,
73.6% of respondents (n = 22,567) indicated they did not have financial difficulty in
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paying out-of-pocket medical expenses while 26.4% (n = 8,103) did have financial
difficulty in paying out-of-pocket medical expenses.
Table 4
Variable Descriptives – Demographic and Financial Difficulty

RQ Associated
1 (IV - Demographic)

Variable
Race

Category
White
Black/African
American
Hispanic/Latino
Asian
Native
Hawaiian/Other
Pacific Islander

Weighted
N
7668

Percent
25.0

17050

55.6

-

-

-

-

American Indian/
Alaska Native
Multiracial

290

0.9

5662

18.5

1 (IV - Demographic)

Gender

Male
Female
Intersex/Ambiguous

20859
9811
-

68.0
32.0
-

1 (IV - Demographic)

Age (Mean = 49.2)

Under 30
30-39
40-49
50-59
60-69
70+

1571
5245
7105
11306
4430
940

5.1
17.1
23.2
37.0
14.5
3.1

1 (IV - Demographic)

Education Level

Never Attended
School
Grades 1-8
Grades 9-11
Grade 12 or GED

294

1.0

1642
4151
8390

5.4
13.5
27.4
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Some College,
Associate Degree,
or Technical Degree
Bachelor’s Degree
Any Post-Graduate
Studies

1 (IV - Demographic)

Federal Poverty
Level

11578

37.8

3008

9.8

1607

5.2

< 100% FPL

15488

50.5

100% - 139% FPL
> 139% - 400%
FPL
> 400% FPL

4048

13.2

10919

35.6

216

0.7

1 through 5
(IV - Demographic)

Coverage Status

RWHAP
ACA

25834
4836

84.2
15.8

1 (IV) & 5 (DV)

Difficulty in paying
out-of-pocket
medical expenses

Yes

8103

26.4

No

22567

73.6

As shown in Table 5, the change in viral load suppression mean (n = 30,670) was
-24.956 (s = 121,073), while the number of ART missed doses mean in the past 30 days
(n = 30,670) was 1.6 doses (s = 4.5), and the average number of HIV/AIDS-related
physician visits within the previous 12 months was 3.5 (s = 2.3; n = 30,670).
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Table 5
Variable Descriptives - Health Status, Treatment Compliance, and Engagement in Care

RQ Associated
1 (DV) & 4 (DV)

Variable
Health
Status

Category
Change in
Viral Load
Suppression

1 (DV) & 2 (DV)

Treatment
Compliance

1 (DV) & 3 (DV)

Engagement
in Care

# ART
Missed Doses
in Past 30
Days
# HIV/AIDSRelated
Physician
Visits in Past
12 Months

Weighted
N
30670

Mean
-24956.4

Std.
Deviation
121073

30670

1.6

4.5

30670

3.5

2.3

Sample Representativeness of Population
As shown in Table 6, data in the PLWHA sample were comparable to the national
2017 Cycle HIV Surveillance Report (CDC, 2019). In my study, Whites represented
25.0% of the sample size, while the remaining 75.0% of participants were people of
color. Nationally, Whites represent 28.8% of PLWHA, while people of color account for
the remaining 71.2% (CDC, 2019). Among study participants in my research study,
68.0% were male and 32% were female, compared to 74.6% male and 23.6% female
nationally (CDC, 2019). In my study, 22.2% of participants were between the ages of 1839, 60.2% were aged 40-59, and 17.6% were over 60 years old. Nationally, 26.0% of
PLWHA are between the ages of 18-39, 55.7% are aged 40-59, and 18.3% were are 60
years old (CDC, 2019). Furthermore, in my study, 19.9% of PLWHA had less than a high
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school education compared to 16.6% nationally, 27.4% had a high school diploma or
GED compared to 27.3% nationally, and 52.7% had more than a high school degree
compared to 56.1% nationally (CDC, 2019). Finally, in my study, 50.5% of participants
lived at or below the FPL and the remaining 49.5% lived above the FPL threshold.
Nationally, 41.6% of PLWHA live at or below the federal poverty level and 58.4% live
above (CDC, 2019).
The clinical data from my research study was also comparable to the national data
reported in the 2017 Cycle HIV Surveillance Report (CDC, 2019). First, 68.3% of
participants in my study achieved sustained viral suppression (all viral load results were
less than 200 copies/ML) compared to 63.2% nationally (CDC, 2019). Second, 60.5% of
participants in my study reported not missing an ART dose in the past 30 days compared
to 60.8% nationally (CDC, 2019). Third, 83.3% of participants in my study reported
having 2 or more HIV related medical appointments in the past twelve months compared
to 78.0% nationally (CDC, 2019). Fourth, 73.6% of participants in my study reported no
problems in paying out-of-pocket medical expenses, however, the CDC (2019) failed to
include this data point in their report the results, so no comparative national benchmark
exists. Finally, 15.8% of participants in my study reported having coverage from an
ACAQHP compared to 20% nationally (D. Segal, personal communication, May 19,
2018).
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Table 6
Sample Representativeness of Population

Whites
People of Color
Male
Female
Age - 18-39
Age - 40-59
Age - 60+
Education - < High School
Education - High School Diploma/GED
Education - > High School
Poverty Level - Equal to or Below
Poverty Level – Above
Viral Load Suppression Achieved
ART Doses - None Missed in Past 30 Days
HIV Visits - 2+ in Past 12 Months
PLWHA with ACA Coverage

Study National
Data
Data
25.0
28.8
75.0
71.2
68.0
74.6
32.0
23.6
22.2
26.0
60.2
55.7
17.6
18.3
19.9
16.6
27.4
27.3
52.7
56.1
50.5
41.6
49.5
58.4
68.3
63.2
60.5
60.8
83.3
78.0
15.8
20.0

Assumptions
Multiple linear regression (RQ 1). I used a multiple linear regression to examine
the relationship between demographic factors (race, gender, age, education level, and
federal poverty level), treatment compliance (as defined by the number of ART missed
doses in the past 30 days), engagement in care (as defined by the number of HIV/AIDSrelated physician visits within the previous 12 months), coverage status (enrolled in the
RWHAP or an ACAQHP) and the health status of PLWHA (as defined by viral
suppression). There are eight assumptions that need to be considered when completing a
multiple linear regression analysis. These assumptions include 1) a continuous dependent

117
variable, 2) two or more continuous or categorical independent variables, 3) an
independence of observations/residual values, 4) a linear relationship between the
independent and dependent variables (collectively and individually), 5) homoscedasticity
of the data, 6) no multicollinearity, 7) no significant outliers, and 8) residuals that are
approximately normally distributed (Laerd Statistics, 2018d).
The first two assumptions (1, 2) have been met as the dependent variable in this
research question, viral load change, is continuous, while the independent variables
including race, gender, age, education level, federal poverty level, treatment compliance,
engagement in care, and coverage status are all either continuous or categorical variables.
The third assumption, independence of observations/residual was confirmed as the use of
weighted data in this study eliminated the possibility of autocorrelation between the
variables (Laerd Statistics, 2018d). The fourth assumption, the verification of linearity
between the dependent variable and the independent variables, was confirmed by visual
evaluation of the scatterplot of the studentized residuals against the unstandardized
predicted value (Laerd Statistics, 2018d). The fifth assumption, homoscedasticity of the
residuals, was also confirmed by visual evaluation of the scatterplot of the studentized
residuals against the unstandardized predicted value (Laerd Statistics, 2018d). The sixth
assumption, a lack of multicollinearity, was confirmed after removing the multiracial
variable from the analysis. After the removal of this variable, Pearson correlation values
for all remaining variables were less than .80, tolerance values for all variables were
greater than 0.1 and VIF values for all variables were all less than 10 (Laerd Statistics,
2018d). The seventh assumption, the lack out outliers, was not met as visual evaluation of
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the studentized deleted residuals revealed data points greater than ±3 standard deviations.
As these data points represented the change in viral load among PLWHA and were not
abnormal outliers, they were appropriate to leave in the study when completing the
statistical analysis (Laerd Statistics, 2018d). The eighth and final assumption, the
normality of the distributions of residuals, was met as assessed by visual evaluation of the
Q-Q Plot (Laerd Statistics, 2018d). Additional information on the analysis of these
assumptions is provided in Exhibit D.
Independent samples t test (RQ 2). I used an independent samples t test to
analyze the second, third, and fourth research questions. In the second research question,
I examined the difference in treatment compliance (as defined by the number of ART
missed doses in the past 30 days) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP. There are six assumptions that must be satisfied to run
an independent samples t test. These assumptions include 1) a dependent variable that is
continuous, 2) an independent variable that consists of two independent categorical
groups, 3) an independence of observations, 4) a homogeneity of variances, 5) normality
in the distribution of the dependent variable around the independent variables, and 6) no
significant outliers (Laerd Statistics, 2018b).
The first three assumptions (1, 2, 3) for this research question were met through
the overall design of the research study. The dependent variable, number of ART
prescription refills is continuous. The independent variable is comprised of two
independent categorical groups and an independence of observations has been achieved
by ensuring that each participant has been assigned to a group of PLWHA that have
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coverage from either the RWHAP or the ACA. The fourth assumption, a homogeneity of
variances, was not confirmed based on visual evaluation of the results of the Levene’s
test (Laerd Statistics, 2018b). The fifth assumption, the normality of the distributions of
residuals, was not met as assessed by visual evaluation of all Q-Q Plots (Laerd Statistics,
2018d). The sixth assumption, the lack of outliers, was not met, as assessed by inspection
of the boxplot output (Laerd Statistics, 2018b).
Due to violations of the assumptions of homogeneity, normality of the
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a
nonparametric test used to determine if statistically significant differences exist between
two groups when data from an independent samples t fails to meet the required
assumptions (Laerd Statistics, 2018c). The Mann-Whitney U test has three assumptions
that must be met which include a continuous or ordinal dependent variable, a categorical
independent variable with two groups, and an independence of observations (Laerd
Statistics, 2018c). As all three of these assumptions were met based on the design of my
study, I ran a Mann-Whitney U test to determine if there were differences in treatment
compliance (as defined by the number of ART missed doses in the past 30 days) between
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Additional
information on the analysis of these assumptions can be found in Appendix E.
Independent samples t test (RQ 3). I used an independent samples t test to
assess the difference in engagement in care (as defined by the number of HIV/AIDSrelated physician visits within the previous 12 months) between PLWHA enrolled in an
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ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions of an
independent samples t-test that were previously discussed must also be met in this
research question. The initial three assumptions (a dependent variable that is continuous,
an independent variable that consists of two independent categorical groups, and an
independence of observations) were met through the overall design of the research study.
The fourth assumption, a homogeneity of variances, was not confirmed based on visual
evaluation of the results of the Levene’s test (Laerd Statistics, 2018b). The fifth
assumption, the normality of the distributions of residuals, was not met as assessed by
visual evaluation of all Q-Q Plots (Laerd Statistics, 2018d). The sixth assumption, the
lack of outliers, was not met, as assessed by inspection of the boxplot output (Laerd
Statistics, 2018b).
Due to violations of the assumptions of homogeneity, normality of the
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a
nonparametric test that is used to determine if statistically significant differences exist
between two groups when data from an independent samples t fails to meet the required
assumptions (Laerd Statistics, 2018c). The Mann-Whitney U test has three assumptions
that must be met prior to running the statistical test which include a continuous or ordinal
dependent variable, a categorical independent variable with two groups, and an
independence of observations (Laerd Statistics, 2018c). As all three of these assumptions
were met based on the design of this research study, I ran Mann-Whitney U test to
determine if there were differences in engagement in care (as defined by the number of
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HIV/AIDS-related physician visits within the previous 12 months) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. Additional information
on the analysis of these assumptions can be found in Appendix F.
Independent samples t test (RQ 4). I used an independent samples t test to
assess the difference in health status (as defined by viral suppression) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. The same six
assumptions of an independent samples t-test that were previously discussed must also be
met in this research question. The initial three assumptions (a dependent variable that is
continuous, an independent variable that consists of two independent categorical groups,
and an independence of observations) were met through the overall design of the research
study. The fourth assumption, a homogeneity of variances, was not confirmed based on
visual evaluation of the results of the Levene’s test (Laerd Statistics, 2018b). The fifth
assumption, the normality of the distributions of residuals, was not met as assessed by
visual evaluation of all Q-Q Plots (Laerd Statistics, 2018b). The sixth assumption, the
lack of outliers, was not met, as assessed by inspection of the boxplot output (Laerd
Statistics, 2018b).
Due to violations of the assumptions of homogeneity, normality of the
distributions, and outliers, I used a Mann-Whitney U to analyze the data instead of an
independent samples t test (Laerd Statistics, 2018b). The Mann-Whitney U test is a
nonparametric test that is used to determine if statistically significant differences exist
between two groups when data from an independent samples t fails to meet the required
assumptions (Laerd Statistics, 2018c). The Mann-Whitney U test has three assumptions
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that must be met prior to running the statistical test which include a continuous or ordinal
dependent variable, a categorical independent variable with two groups, and an
independence of observations (Laerd Statistics, 2018c). As all three of these assumptions
were met based on the design of this research study, I ran a Mann-Whitney U test to
determine if there were differences in health status (as defined by viral suppression)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
Additional information on the analysis of these assumptions can be found in Appendix G.
Chi-square (RQ 5). I used a chi-squared test to examine the difference in
difficulty in paying for out-of-pocket medical expenses (as defined by problems paying
for any out-of-pocket medical or health insurance costs) between PLWHA enrolled in the
RWHAP and PLWHA enrolled in an ACAQHP. A chi-square test has three assumptions
that must be satisfied to run this test. The first two assumptions (categorical variables and
an independence of observations) were met based on the design of the study. The third
assumption of a chi-square test is that all cells in the SPSS cross-tabulation output table
must have expected counts that are greater than five (Field, 2013). Additional information
on the analysis of these assumptions can be found in Appendix H.
Research Question Results
Research Question 1. What is the relationship between demographic factors
(race, gender, age, education level, and federal poverty level), treatment compliance (as
defined by the number of ART missed doses in the past 30 days), engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
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months), coverage status (enrolled in the RWHAP or an ACAQHP) and the health status
of PLWHA (as defined by viral suppression)?
As shown in Table 7, the adjusted R2 value (.050) for the model indicated that
only 5.0% of the dependent variable was related to the independent variables, which
suggests there are other factors that need to be considered. In future studies, researchers
may want to employ a different statistical model that may provide an enhanced level of
predictive ability.
Table 7
Multiple Linear Regression Analysis Resultsb,c,d

Model

R

R
Square

Adjusted
R Square

Std. Error of
the Estimate

R Square
Change

F
Change df1

df2

Sig. F
Change

1
.278a .077
.050
1230444.526
.077
2.868
8
274
.004
a. Predictors: (Constant), Insurance. Age, GENDER, ARTMissed, EDUCATION,
HIVVisits, RACE, PovertyLevel
b. Dependent Variable: VLCHANGE
c. Weighted Least Squares Regression - Weighted by Weight
d. The enter method was used to conduct this analysis. Entering all independent variables into
the model simultaneously is appropriate when there is uncertainty in understanding which
variables will generate the best regression equation and the research desires to see how all of
the variable interact with one another (Statistics Solutions, 2020).

A multiple linear regression was conducted and, as shown in Table 8, only
engagement in care (as defined by the number of HIV/AIDS-related physician visits
within the previous 12 months) was related at a statistically significant level to viral load
change (β = -9774.960, t = -3.141, p = < .05). Based on these results, the null hypothesis
would need to be retained as only one of the independent variables was related to the
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dependent variable at a statistically significant level when all variables were included in
the model.
Table 8
Multiple Linear Regression – Coefficients
Coefficientsa,b
Unstandardized
Standardized
Coefficients
Coefficients
Variable
B
Std. Error
Beta
Constant
-63246.110
52742.879
Race
-24193.849
16648.524
-0.089
Gender
-2055.865
15884.668
-0.008
Age
1090.960
621.554
0.103
Education
3250.199
6246.503
0.033
Poverty Level
15880.569
8392.543
0.122
ART Missed
-217.72
1622.718
-0.008
HIV Visits
-9774.96
3112.364
-0.187
Insurance
-5448.301
20119.053
-0.016
a. Dependent Variable: VL Change
b. Weighted Least Squares Regression - Weighted by Weight

t
-1.199
-1.453
-0.129
1.755
0.520
1.892
-0.134
-3.141
-0.271

Sig.
0.232
0.147
0.897
0.080
0.603
0.060
0.893
0.002
0.787

Research Question 2: What is the difference in treatment compliance (as defined by
the number of ART missed doses in the past 30 days) between PLWHA enrolled in an
ACAQHP and PLWHA enrolled in the RWHAP?
A Mann-Whitney U test was run to determine if there was a statistically
significant difference in treatment compliance (as defined by the number of ART missed
doses in the past 30 days) between PLWHA enrolled in the RWHAP and PLWHA
enrolled in an ACAQHP. Distributions of the ART missed doses in the past 30 days for
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP were not
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similar, as assessed by visual inspection of the SPSS output. As depicted in Table 9, the
mean number of missed ART doses was higher for RWHAP clients (mean = 1.72) when
compared to PLWHA enrolled in an ACAQHP (mean = 0.81). This is a statistically
significant difference (p = .000), so the null hypothesis is rejected and the alternative
accepted.
Table 9
Mann Whitney U Results – Treatment Compliance
Treatment Compliance for PLWHA Enrolled in the RWHAP and an ACAQHP

Treatment Compliance - ACAQHP
Treatment Compliance - RWHAP
Treatment Compliance

N
4836
25834

Mean

U

Z

p

0.81
1.72
53404348.500 -18.121

.000

Research Question 3. What is the difference in engagement in care (as defined
by the number of HIV/AIDS-related physician visits within the previous 12 months)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP?
A Mann-Whitney U test was run to determine if there was a statistically
significant difference in engagement in care (as defined by the number of HIV/AIDSrelated physician visits within the previous 12 months) between PLWHA enrolled in the
RWHAP and PLWHA enrolled in an ACAQHP. Distributions of the number of
HIV/AIDS-related physician visits within the previous 12 months were not similar, as
assessed by visual inspection of the SPSS output. As seen in Table 10, the mean number
of HIV/AIDS-related physician visits was higher for RWHAP clients (mean = 3.56)
when compared to PLWHA enrolled in an ACAQHP (mean = 3.19). This is a statistically
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significant difference (p = .000), so the null hypothesis is rejected and the alternative
accepted.
Table 10
Mann Whitney U Results – Engagement in Care
Engagement in Care for PLWHA Enrolled in the RWHAP and an ACAQHP

Engagement in Care - ACAQHP
Engagement in Care - RWHAP
Engagement in Care

N
4836
25834

Mean

U

Z

p

59708211.500

-4.843

.000

3.19
3.56

Research Question 4. What is the difference in health status (as defined by viral
suppression) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP?
A Mann-Whitney U test was run to determine if there was a statistically
significant difference in health status (as defined by viral suppression) between PLWHA
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. Distributions of viral
load suppression were not similar, as assessed by visual inspection of the SPSS output.
As shown in Table 11, the change in viral load was greater for PLWHA enrolled in an
ACAQHP (mean = -28661.290) when compared to RWHAP clients (mean = -5165.271).
This is not a statistically significant difference (p = .696), so the null hypothesis is
retained.
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Table 11
Mann Whitney U Results – Viral Load Change
Viral Load Change for PLWHA Enrolled in the RWHAP and an ACAQHP

Viral Load Change - ACAQHP
Viral Load Change – RWHAP
Viral Load Change

N
4836
25834

Mean

U

z

P

62187443.000

-.391

.696

-5165.271
-28661.290

Research Question 5. What is the difference in difficulty in paying out-of-pocket
medical expenses (as defined by problems paying for any out-of-pocket medical or health
insurance costs) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP?
A chi-square test was conducted in order to determine if there was a statistically
significant difference in difficulty in paying out-of-pocket medical expenses (as defined
by problems paying for any out-of-pocket medical or health insurance costs) between
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. As shown in
Table 12, there was a statistically significant difference between the two groups in
relation to being able to pay for out-of-pocket medical expenses (p=.000) with a higher
percentage in the RWHAP group (28.9%, n = 25,843) reporting difficulty than the
ACAQHP group (13.1%, n = 4,835). Therefore, the null hypothesis is rejected and the
alternative accepted.
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Table 12
Chi-square Results- Financial Difficulty
Financial Difficulty in Paying Out-of-Pocket Medical Expenses
Value

Df

Asymptotic Significance (2-sided)

Pearson Chi-Square
521.577a
1
.000
a. 0 cells (0.0%) have expected count less than 5. The minimum expected count is
1277.67.
Summary
This chapter provided the statistical results for the research questions included in
this study. A multiple linear regression was used to test the hypothesis in the first
research question and only engagement in care (as defined by the number of HIV/AIDSrelated physician visits within the previous 12 months) was related at a statistically
significant level to viral load change (β = -9774.960, t = -3.141, p = < .05). The adjusted
R2 value (.050) indicated that only 5.0% of the dependent variable was related to the
independent variables, which suggests there are other factors that need to be considered.
A Mann-Whitney U test was run on the second, third, and fourth research questions. The
results of the Mann-Whitney U test indicated a statistically significant relationship in
treatment compliance (p = .000) as the mean number of missed ART doses was higher for
RWHAP clients (mean = 1.72) compared to PLWHA enrolled in an ACAQHP (mean =
0.81). Additionally, the Mann-Whitney U test also showed a statistically significant
relationship in engagement in care (p = .000) as the mean number of HIV/AIDS-related
physician visits was higher for RWHAP clients (mean = 3.56) compared to PLWHA
enrolled in an ACAQHP (mean = 3.19). Furthermore, the Mann-Whitney U found no
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statistically significantly difference in viral load change (p = .696) between PLWHA
enrolled in an ACAQHP (mean = -28661.29) and PLWHA enrolled in the RWHAP
(mean = -5165.27). Finally, a chi-square test was run on the fifth research question to
determine if there was a significant association between financial difficulty in paying for
out-of-pocket medical expenses and health coverage status. The results of the chi-square
test revealed a statistically significant association between these variables, χ2(1) =
521.577, p = .001.
In Chapter 5, the final chapter of this study, I will provide an interpretation of the
statistical findings and a review of the limitations of the study. I will also discuss
recommendations for further research as well as the implications of study findings.
Finally, I will discuss the impact of the study findings on social change, community
health, and public policy.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of my study was to determine the relationship between demographic
factors (race, gender, age, education level, and federal poverty level), treatment
compliance (as defined by the number of ART missed doses in the past 30 days),
engagement in care (as defined by the number of HIV/AIDS-related physician visits
within the previous 12 months), and coverage status (enrolled in the RWHAP or an
ACAQHP) and the health status of PLWHA (as defined by viral suppression).
Additionally, I examined the difference in treatment compliance, engagement in care, and
coverage status between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP. I provided information on the relationship between ACA health insurance
coverage and the health of PLWHA compared to the relationship between RWHAP
coverage and the health of PLWHA. Based on the substantial investment of resources and
public funds on the ACA, it is important to understand whether care provided by an
ACAQHP is related to better health outcomes of plan participants (Ferris, 2016). Five
research questions were addressed in my study. Using secondary data provided by the
Florida Department of Health, I analyzed the data for each of the five research questions.
For RQ1, a multiple linear regression was conducted and only engagement in care
(as defined by the number of HIV/AIDS-related physician visits within the previous 12
months) was related at a statistically significant level to viral load change (β = -9774.960,
t = -3.141, p = < .05). Based on these results, the null hypothesis was retained because
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only one of the independent variables was related to the dependent variable at a
statistically significant level when all variables were included in the model.
For RQ2, a Mann-Whitney U test was run to determine whether there was a
statistically significant difference in treatment compliance (as defined by the number of
ART missed doses in the past 30 days) between PLWHA enrolled in the RWHAP and
PLWHA enrolled in an ACAQHP. The mean number of missed ART doses was higher
for RWHAP clients (mean = 1.72) when compared to PLWHA enrolled in an ACAQHP
(mean = 0.81). This was a statistically significant difference (p = .000), so the null
hypothesis was rejected and the alternative hypothesis was accepted.
For RQ3, a Mann-Whitney U test was run to determine whether there was a
statistically significant difference in engagement in care (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) between PLWHA
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. The mean number of
HIV/AIDS-related physician visits was higher for RWHAP clients (mean = 3.56) when
compared to PLWHA enrolled in an ACAQHP (mean = 3.19). This was a statistically
significant difference (p = .000), so the null hypothesis was rejected and the alternative
hypothesis was accepted.
For RQ4, a Mann-Whitney U test was run to determine whether there was a
statistically significant difference in health status (as defined by viral suppression)
between PLWHA enrolled in the RWHAP and PLWHA enrolled in an ACAQHP. The
change in viral load was greater for PLWHA enrolled in an ACAQHP (mean = -
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28661.290) when compared to RWHAP clients (mean = -5165.271). This was not a
statistically significant difference (p = .696), so the null hypothesis was retained.
For RQ5, a chi-square test was conducted to determine whether there was a
statistically significant difference in difficulty in paying out-of-pocket medical expenses
(as defined by problems paying for any out-of-pocket medical or health insurance costs)
between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. There
was a statistically significant difference between the two groups in relation to being able
to pay for out-of-pocket medical expenses (p = .000) with a higher percentage in the
RWHAP group (28.9%, n = 25,843) reporting difficulty than the ACAQHP group
(13.1%, n = 4,835). Therefore, the null hypothesis was rejected and the alternative
hypothesis was accepted.
Chapter 5 includes a discussion of the findings. First, I interpret the findings of
each research question by comparing the results to current peer-reviewed literature and to
Andersen’s behavioral model of health services use, which was the theoretical framework
used in this study. Second, I describe the limitations of this study with respect to
generalizability, trustworthiness, validity, and reliability. Third, I provide
recommendations for further study on this topic that are grounded in the strengths and
limitations of this study as well as the literature reviewed in Chapter 2. Fourth, I explain
the potential social change impact and practical implications of the findings of this study.
Fifth, I conclude with remarks that capture the essence of the study.
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Interpretation of the Findings
Research Question 1
The first research question addressed the relationship between demographic
factors (race, gender, age, education level, and federal poverty level), treatment
compliance (as defined by the number of ART missed doses in the past 30 days),
engagement in care (as defined by the number of HIV/AIDS-related physician visits
within the previous 12 months), and coverage status (enrolled in the RWHAP or an
ACAQHP) and the health status of PLWHA (as defined by viral suppression). Only
engagement in care was related at a statistically significant level to viral load change.
Engagement in care is an important determinant of the health of PLWHA (U.S.
Department of Health & Human Services, 2016b). There is currently no cure for HIV,
and treatment for the virus is a lifelong process that requires routine office visits with
medical providers (U.S. Department of Health & Human Services, 2016b). PLWHA who
remain consistently engaged in care are more likely to achieve and maintain long-term
viral suppression and experience reduced mortality rates (Crawford, 2014; Crawford et
al., 2014). In my study, 83.7% of PLWHA enrolled in the RWHAP and 81.0% of
PLWHA enrolled in an ACAQHP were engaged in care. The results were favorable
compared to Cahill et al. (2015) who found that 73% of PLWHA enrolled in the RWHAP
and 51% of PLWHA not enrolled in the RWHAP were engaged in care. Current study
findings were also favorable compared to the United States government report that 81%
of RWHAP clients were engaged in care compared to 40% of PLWHA throughout the
United States (HRSA, 2016c; U.S. Department of Health & Human Services, 2016b).
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Research Question 2
The second research question addressed the difference in treatment compliance
(as defined by the number of ART missed doses in the past 30 days) between PLWHA
enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. There was a statistically
significant difference in treatment compliance as the mean number of missed ART doses
for RWHAP clients (1.72) was higher than the mean number for PLWHA enrolled in an
ACAQHP (0.81). A sustained high level of ART medication adherence is crucial for
virus suppression; inadequately adhering to an ART regimen results in an increased rate
of hospitalization, viral load, morbidity, and mortality (Olson et al., 2014). The results of
my study compared favorably to the work of other researchers who estimated that 45% of
PLWHA in North America were not adherent to their prescription regimen (Gardner,
McLees, Steiner, del Rio, C., & Burman, 2011; Kay et al., 2006). I found that 31.0% of
PLWHA enrolled in an ACAQHP and 41.1% of PLWHA enrolled in the RWHAP were
not adherent to their prescription regimen. Because little is known about the overall ART
medication adherence rate among PLWHA enrolled in an ACAQHP, my findings may
extend the knowledge related to ART medication adherence.
Research Question 3
The third research question addressed the difference with engagement in care (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP. There is no cure for HIV and treatment of the virus is a lifelong process which
requires routine office visits with medical providers (U.S. Department of Health &
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Human Services, 2016b). PLWHA who remain consistently engaged in care are more
likely to achieve and maintain long term viral suppression and experience reduced
mortality rates (Crawford, 2014; Crawford et al., 2014). Previous studies by Cahill et al.,
(2015) found that 73% of PLWHA enrolled in the RWHAP and 51% of PLWHA who
were not enrolled in the RWHAP were engaged in care while the United States
government reported that 81% of RWHAP clients were engaged in care compared to
40% of PLWHA throughout the United States (HRSA, 2016c; U.S. Department of Health
& Human Services, 2016b). My study results compared favorably to these researchers as
83.7% of PLWHA enrolled in the RWHAP and 81.0% of PLWHA enrolled in an
ACAQHP were engaged in care. My results also expand upon the findings of other
research studies by demonstrating significantly higher engagement in care for PLWHA
enrolled in RWHAP (3.56 average visits) compared to PLWHA enrolled in an ACAQHP
(3.19 average visits).
Research Question 4
The fourth research question addressed the difference in health status (as defined
by viral suppression) between PLWHA enrolled in the RWHAP and PLWHA enrolled in
an ACAQHP. I found no statistically significant difference in viral load between
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP. I found that
66.8% of PLWHA enrolled in the RWHAP and 66.7% of PLWHA enrolled in an
ACAQHP were virally suppressed. The goal of HIV treatment is to reduce viral load to
an undetectable level and become virally suppressed (U.S. Department of Health &
Human Services, 2015a). PLWHA that are virally suppressed experience a life
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expectancy equal to that of the general uninfected population and are less likely to
transmit HIV to an uninfected sexual or drug partner (Deeks et al., 2013; Goldman et al.,
2014; U.S. Department of Health & Human Services, 2018d). Bradley et al. (2016)
examined the viral load suppression rates by coverage status of 18,095 participants from
the 2009 – 2013 Medical Monitoring Project survey and found that PLWHA enrolled in
an ACAQHP were 5% less likely to be virally suppressed then those enrolled in the
RWHAP.
While Bradley et al. (2016) reported that PLWHA enrolled in the RWHAP were
more likely to be virally suppressed than PLWHA enrolled in an ACAQHP, McManus et
al. (2018), Raifman et al. (2018), and Dawson and Kates (2019) reached an alternative
conclusion. McManus et al. (2018) reported that among PLWHA residing in Virginia in
2015, 83.3% who were enrolled in an ACAQHP were virally suppressed compared to
79.9% who were enrolled in the RWHAP. Raifman et al. (2018) reported that among
PLWHA residing in the United States in 2015, 79% who were enrolled in an ACAQHP
were virally suppressed compared to 75% who were enrolled in the RWHAP. Although
there was an improvement in viral load suppression among PLWHA enrolled in an
ACAQHP type insurance plan, the results were not statistically significant and they
concluded that transitioning from the RWHAP to an ACAQHP type insurance plan was
not associated with a change in viral load suppression (Raifman et al., 2018). Dawson
and Kates (2019) explored viral load suppression and insurance coverage among 3,645
nonelderly PLWHA in the United States who participated in the 2015 Medical
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Monitoring Project survey and found that 66% of study participants enrolled in the
RWHAP and in an ACAQHP were virally suppressed.
My study results were consistent with McManus et al. (2018), Raifman et al.
(2018), and Dawson and Kates (2019) who reported that viral load suppression rates
among PLWHA enrolled in an ACAQHP were equal to or better than PLWHA enrolled
in the RWHAP. However, the findings of my study were inconsistent with the results of
Bradley et al. (2016) who reported reduced viral load suppression rates among PLWHA
enrolled in an ACAQHP compared to PLWHA enrolled in the RWHAP. My results may
have been comparable to the findings of McManus et al. (2018), Raifman et al. (2018),
and Dawson and Kates (2019) because these studies compared the viral load suppression
rate of PLWHA enrolled in the RWHAP to the viral load suppression rate of PLWHA
enrolled in the ACA after it was fully enacted in 2014. My study results may have been
dissimilar to the findings reported by Bradley et al. (2016) because they examined viral
load suppression rates from PLWHA enrolled in the RWHAP and ACA during 2009 to
2013, prior to full ACA implementation. An analysis of viral load suppression rates
among PLWHA enrolled in the ACA prior to its full implementation in 2014, may have
under reported the actual health benefits of this comprehensive insurance coverage. My
results are important because they show PLWHA living in Florida can gain access to the
comprehensive services provided by the ACA, while simultaneously maintaining their
rate of viral load suppression achieved from the care provided by the RWHAP.
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Research Question 5
The fifth research question addressed the difference in difficulty in paying for outof-pocket medical expenses (as defined by problems paying for any out-of-pocket
medical or health insurance costs) between PLWHA enrolled in an ACAQHP and
PLWHA enrolled in the RWHAP. I found a statistically significant difference as
PLWHA enrolled in the RWHAP were 2.690 times more likely of having difficulty in
paying out-of-pocket medical expenses than PLWHA enrolled in an ACAQHP. The
ability of PLWHA to pay out-of-pocket medical expenses is an important consideration
in becoming virally suppressed as higher out-of-pocket costs results in medical care
avoidance, and an overall reduction in the use of health care services and in overall health
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016).
Multiple researchers indicated that between 33% and 43% of patients enrolled in a
high deductible health plan deferred needed medical care and that adults with high
deductibles were 2.7 times more like to delay or forgo care than were adults with
traditional health insurance (Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy,
2016). Severe health consequences can occur when people avoid obtaining needed
medical care when they are sick (Galbraith et al., 2012; Kannan & Veazie, 2014;
Murphy, 2016). Delayed care can result in an increase in overall suffering and reduced
treatment options and health outcomes (Kannan & Veazie, 2014; Taber et al., 2015). For
PLWHA, delayed access to care that hinders the timely engagement in HIV medical care
and the start of an ART medication regimen reduces the chances of viral load suppression

139
and increases the overall rate of mortality (Fatukasi et al., 2017; U.S. Department of
Health & Human Services, 2016b, 2018c).
Researchers have identified health care related expenses as an impediment to
accessing care (Dombrowski, Simoni, Katz, & Golden, 2015; Yehia et al., 2015). Yehia
et al. (2015) found that out-of-pocket medical expenses deterred study participants from
seeking care while Dombrowksi et al. (2015) reported that health care costs, or the
perception of those costs resulted in a barrier to care among insured PLWHA. I have been
unable to find quantitative data comparing the difficulty in paying for out-of-pocket
medical expenses between PLWHA enrolled in the RWHAP and PLWHA enrolled in an
ACAQHP. Gardner et al. (2011) reported that few researchers have evaluated the degree
to which health care expenses have inhibited access to care for PLWHA. As little is
known about the financial difficulty that PLWHA have in paying out-of-pocket medical
expenses, my study results are the first to quantify financial burden and may extend the
overall knowledge related to potential financial barriers that PLWHA face when seeking
medical care.
Interpretation of the Findings in Relation to the Theoretical Framework
The theoretical framework I used in this study was the behavioral model of health
services use. Andersen developed the behavioral model of health services use to explain
the factors that determine how and why health care services are utilized (Babitsch et al.,
2012; Graham et al., 2017). Predisposing characteristics related to health care utilization
include age, sex, marital status, past illness, education, race, occupation, ethnicity,
religion, and the perception of the benefit of treatment efficacy (Andersen & Newman,

140
2005). Andersen et al. (2000) found that PLWHA with predisposing characteristics
associated with vulnerable and marginalized groups were less likely to have access to
medical care and ART medications, and become virally suppressed. My study results
showed participants who were male, white, older, more educated, and had higher annual
income were more likely to access care and become virally suppressed (Andersen et al.,
2000). My study findings followed the relationship patterns of predisposing
characteristics represented in the behavioral model of health services use. In my study,
health status for PLWHA was better for whites compared to non-whites, males compared
to females, older compared to younger, more educated compared to the less educated, and
participants with higher income levels compared to those with lower income levels.
The second stage of the behavioral model of health services is enabling
characteristics which are a set of conditions that facilitate access to health care services
(Andersen & Newman, 2005). Although an individual may be predisposed to utilize
health care services, they must possess the needed resources to receive medical care.
Enabling components are characterized by financial attributes that facilitate access to care
including income, savings, health insurance, and the accessibility of care (Andersen &
Newman, 2005). The ability of PLWHA to pay out-of-pocket medical expenses is an
enabling characteristic and is an important consideration in an individual’s ability to
become virally suppressed (Andersen & Newman, 2005). Yehia et al. (2015) found that
out-of-pocket medical expenses deterred individuals from seeking care, while
Dombrowksi et al. (2015) reported that health care costs, or the perception of what those
costs would be, created a barrier to care that prevented individuals from seeking out care
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even when insured. For PLWHA, a delay in seeking care or the start of ART medications
reduces the probability of viral load suppression and increases the overall rate of
mortality and morbidity (Fatukasi et al., 2017; U.S. Department of Health & Human
Services, 2016b, 2018c). I found that PLWHA enrolled in the RWHAP were 2.69 times
more likely to have financial difficulty in paying for out-of-pocket medical expenses than
were PLWHA enrolled in an ACAQHP. PLWHA enrolled in the RWHAP are more
likely to face real or perceived financial barriers to accessing necessary health care,
which are representative of the enabling characteristic as described in the model.
The third and final stage of the behavioral model of health services use is illness
level, which can influence an individual’s belief that they need to pursue medical care
(Andersen & Newman, 2005). A medical diagnosis is needed for an individual to have a
perceived or evaluated illness that would influence the use of health care services
(Andersen & Newman, 2005). Engagement in care (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) is an important
determinant of health, as PLWHA who remain consistently engaged in care are more
likely to achieve and maintain long term viral suppression and experience reduced
mortality rates (Crawford, 2014; Crawford et al., 2014). My study showed that PLWHA
who were enrolled in the RWHAP (mean = 3.56) had a greater number of HIV/AIDSrelated physician visits than were PLWHA enrolled in an ACAQHP (mean = 3.19).
However, PLWHA enrolled in the RWHAP or an ACAQHP exceeded the recommended
minimum of 2 HIV/AIDS-related physician visits within the previous 12 months (Cahill
et al., 2015; Crawford et al., 2014). Consequently, the findings of my research study were
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aligned with the relationship patterns of illness level characteristics espoused by the
behavioral model of health services use.
Limitations of the Study
The limitations that I raised earlier in this study were successfully resolved. First,
I assumed that comprehensive health insurance would improve the health of PLWHA.
The results of my study and the findings of other researchers including McManus et al.
(2018), Raifman et al. (2018), and Dawson and Kates (2019) confirmed that
comprehensive health insurance is associated with improved health for PLWHA. Second,
I assumed the sample size of participants would be large enough to generate meaningful
study results. I met this assumption as the weighted sample size of sample size 30,670
participants exceeded the 228 participants needed to meet the desired statistical power of
the study. Third, I assumed that the data set would contain the data points needed to
answer the research questions in this study. This assumption was confirmed after I
received the data set from the Florida Department of Health and verified the needed
information was included. Fourth, my use of a purposeful convenience sampling
methodology could have reduced the external validity of the study and the potential
generalizability of the results (Laerd Statistics, 2012a). However, the provision of
weighted data by the organization enhanced the external validity, so the results can be
generalizable to all PLWHA residing in Florida.
Fifth, challenges with the internal validity of my study could have compromised
the conclusions establishing a relationship between independent and dependent variables
(Creswell, 2009; Labaree, 2017). One common factor in research studies that reduces
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internal validity is selection bias which occurs when the study sample is not
representative of the overall population (Creswell, 2009; Labaree, 2017). I maintained the
internal validity of my study by using weighted data that was representative of all
PLWHA residing in Florida. Sixth, my study used secondary data that was amassed as
part of the Medical Monitoring Project survey, which was collected from survey
participants directly, and from data abstracted directly from the participant’s medical
records. I assumed that survey participants understood the questions being asked of them
by the survey data collectors, and provided answers that were reliable, accurate, and
honest. While DeLamater and Plante (2015) noted that asking people sensitive questions
about their sexuality (and associated health complications) may increase survey response
bias due to a larger number of nonresponses, or misreported answers motivated by social
desirability to avoid overall embarrassment, Conway, Jako, and Goodman (1995) found
that the use of standardized questions while collecting data provided the highest overall
reliability. Additionally, I assumed that the data collectors accurately completed the data
collection process. Mi, Collins, Lerner, Losina, and Katz (2013) found that data
abstracted by non-physicians from a medical record resulted in excellent reliability.
Recommendations
The data I used in this research study was collected from respondents who resided
in the state of Florida. As HIV/AIDS are diseases of national concern, additional research
is needed to compare the relationship between the health of PLWHA, the ACA, and the
RWHAP within different states and regions from across the United States. It is important
to understand if the results of my study can be consistently replicated on a national level,
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which would provide PLWHA a better awareness of potential changes in health outcomes
by transitioning care from the RWHAP to an ACAQHP.
Additional research also needs to be conducted examining the relationship that the
duration of enrollment in the RWHAP or an ACAQHP has on engagement in care,
treatment compliance, and viral load suppression. Participants in my study were enrolled
in the RWHAP or an ACAQHP for a minimum of 12 months, yet the actual duration of
coverage was unknown. Although Sommers et al., (2017) stated the impact of health
insurance coverage on life-threatening conditions such as HIV/AIDS may take at least
one year to occur, it would be important to understand how the results of this study would
have differed based on the number of years of ACAQHP or RWHAP coverage. Further
research may need to be delayed for several years to allow enough time to pass so a
greater volume of ACAQHP data can be collected to assess changes in engagement in
care, treatment compliance, and viral load suppression.
Future researchers should study the relationship that the RWHAP has on the
engagement in care, treatment compliance, and viral load suppression of PLWHA who
are also enrolled in an ACAQHP. A considerable number of PLWHA enrolled in an
ACAQHP also continue to receive services through the RWHAP (Adamson, Lipira, &
Katz, 2019; Bradley et al., 2016; Furl, Watanabe-Galloway, Lyden, & Swindells, 2018;
McManus et al., 2018; Raifman et al., 2018). The RWHAP services provided to PLWHA
enrolled in an ACAQHP include financial support for insurance premiums and cost
sharing assistance for other out-of-pocket financial costs including deductibles,
copayments, and coinsurance (Adamson et al., 2019; Bradley et al., 2016; Furl et al.,
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2018; McManus et al., 2018; Raifman et al., 2018). The RWHAP also provides wrap
around services not typically covered by commercial health insurance carriers including
mental health counseling and treatment, substance abuse counseling and treatment, dental
care, housing assistance, and transportation services. Consequently, continued research is
needed to understand how to maximize the effectiveness of the RWHAP post ACA
implementation.
My recommendations for future research are similar to the recommendations
proposed by other authors who have conducted similar studies. Bradley et al. (2016),
suggested that additional information about the RWHAP support services PLWHA
enrolled in the ACA receive is needed to understand the relationship between coverage
status and health status. McManus et al. (2018) also recommended that future researchers
examine the role that RWHAP wrap around services have on health outcomes for
PLWHA enrolled in an ACAQHP and that studies should be conducted throughout the
country so health outcomes could be understood on a larger scale. Raifman et al. (2018)
advised that future researchers should assess how financial considerations and the length
(in years) of insurance coverage influence viral load suppression. Finally, Ginossar et al.
(2019) recommended additional information is needed to assess health outcomes for
PLWHA enrolled in an ACAQHP.
Implications
Implications for Social Change
My study results may promote social change as PLWHA who enroll in an
ACAQHP can gain access to the comprehensive health care services provided by health
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insurance coverage while simultaneously maintaining a high viral load suppression rate.
PLWHA that are virally suppressed are generally healthier and live longer than those that
are not virally suppressed HIV (CDC, 2016b; Drainoni et al., 2015; Goldman et al., 2014;
U.S. Department of Health & Human Services, 2018d). Furthermore, the lifespan of a
person with HIV who is treated with ART medications is nearly the same as a person
who does not have HIV (CDC, 2016b; Drainoni et al., 2015; Goldman et al., 2014; U.S.
Department of Health & Human Services, 2018d) so having access to information and
services that promote viral suppression would be desirable. My study results may also
promote social change by encouraging PLWHA to enroll in an ACAQHP, as PLWHA
who receive care from the RWHAP were more likely of having a greater difficulty in
paying out-of-pocket medical expenses than those enrolled in an ACAQHP. The ability
of PLWHA to pay out-of-pocket medical expenses is an important consideration in
becoming virally suppressed as higher out-of-pocket costs results in medical care
avoidance, an overall reduction in the utilization of medical care, and in overall health
(Galbraith et al., 2012; Kannan & Veazie, 2014; Murphy, 2016). For PLWHA, delayed
access to care that hinders the timely engagement in HIV medical care and the start of an
ART medication regimen reduces the chances of viral load suppression and increases the
overall rate of mortality (Fatukasi et al., 2017; U.S. Department of Health & Human
Services, 2016b, 2018c).
Implications for Practice
I found that PLWHA enrolled in an ACAQHP were statistically more likely to
remain compliant with their ART treatment regimen and were statistically less likely to
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have financial problems in paying for out-of-pocket medical expenses than were PLWHA
enrolled in the RWHAP. I also found no statistically significant differences in change in
viral load suppression between PLWHA enrolled in the RWHAP or enrolled in an
ACAQHP. These findings are important as they show that ACAQHP coverage may offer
PLWHA a viable treatment alternative beyond the care that is provided by the RWHAP.
In an era of the ACA, there is some uncertainty with respect to the future of the RWHAP.
Numerous researchers including Cahill et al. (2015), Crowley and Garner (2015),
Dawson and Kates (2015) Johnson and Heisler (2015), and Morin (2015), have advocated
for changes in the RWHAP to ensure its survival post ACA implementation. As the most
recent Congressional authorization for the RWHAP lapsed in 2013, there is no guarantee
the funding that has been renewed based on annual appropriations from Congress will
continue (Johnson & Heisler, 2015; The Henry J. Kaiser Family Foundation, 2017b).
In an era of the ACA, it may be beneficial for administrators from the Health
Resources and Services Administration and the Florida Department of Health to refocus
the RWHAP in Florida from funding care to subsidizing the costs of ACAQHP health
insurance premiums and other out-of-pocket expenses such as coinsurance, copayments,
and deductibles. Subsidizing health care costs associated with enrollment in an ACAQHP
will help PLWHA gain access to the comprehensive services provided by the ACA, while
simultaneously maintaining their rate of viral load suppression achieved from care
provided by the RWHAP (Bradley et al., 2016; Furl et al., 2018; McManus et al., 2018;
U.S. Centers for Medicare & Medicaid Services, 2018a). The RWHAP should also
continue to provide wrap around services that are not typically covered by commercial
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health insurance carriers such as mental health care, substance abuse treatment, dental
care, housing assistance, and transportation services because access to these supplemental
services help PLWHA become virally suppressed (Berry et al., 2016; Morin, 2015).
PLWHA who enroll in an ACAQHP and lose access to these services may experience a
decline in health status (Berry et al., 2016; Morin, 2015). Finally, Ginossar et al. (2019)
noted that by enrolling PLWHA into an ACAQHP, Virginia reduced their health care
expenses nearly 50% compared to keeping the patients in the RWHAP. Similar financial
savings in Florida could be used to help an even greater number of PLWHA become
virally suppressed.
Practitioners including physicians, social workers, and public health workers
could use this information to encourage PLWHA to enroll in an ACAQHP, which would
provide the comprehensive health care benefits associated with health insurance coverage
while also achieving viral load suppression rates comparable to that of the RWHAP.
PLWHA who enroll in an ACAQHP will receive access to health care services that are
specifically excluded from coverage under the RWHAP including hospital care provided
in an emergency room or inpatient setting, and medical care by physicians for services
unrelated to the treatment of the HIV/AIDS (Crowley & Garner, 2015; Emory Health
care, 2017). Access to comprehensive health care as part of the ACA is becoming more
important for virally suppressed PLWHA as they now live long enough to encounter
other chronic conditions unrelated to HIV that are not covered by the RWHAP (Deeks et
al., 2013; Goldman et al., 2014; U.S. Department of Health & Human Services, 2018d).
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Conclusion
Advances in ART medications have increased the viral load suppression rate and
PLWHA that are virally suppressed experience a life expectancy equal to that of the
general uninfected population (Deeks et al., 2013; Goldman et al., 2014; U.S. Department
of Health & Human Services, 2018d). Although the RWHAP is not an insurance
company and only covers outpatient HIV/AIDS-related medical care and treatment, it has
served as a safety net by providing medical care and ART medications for lower income
PLWHA that were uninsured or underinsured (HRSA, 2016b; The Henry J. Kaiser
Family Foundation, 2017b). RWHAP clients have been more likely to be engaged in
care, have access to ART medications, and become virally supressed than were PLWHA
who have not received services through the program (U.S. Department of Health &
Human Services, 2016b).
The passage of the ACA offered PLWHA enrolled in the RWHAP an opportunity
to maintain and potentially enhance their rate of viral load suppression and receive
comprehensive health insurance that may improve overall health and life expectancy. I
found a statistically significant difference in treatment compliance and difficulty in
paying for out-of-pocket medical expenses between PLWHA enrolled in an ACAQHP
and PLWHA enrolled in the RWHAP. PLWHA enrolled in the RWHAP missed a greater
number of ART doses in the past 30 days than did PLWHA enrolled in an ACAQHP. I
also found that PLWHA enrolled in the RWHAP were more likely to have financial
difficulties in paying out-of-pocket medical expenses than those enrolled in an ACAQHP.
Finally, the most important finding of my study was the lack of a statistically significant
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difference in the change in viral load between PLWHA enrolled in the RWHAP and
PLWHA enrolled in an ACAQHP.
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Appendix A: G Power Sample Size Calculation
[1] -- Saturday, August 31, 2019 -- 11:13:11
F tests - Linear multiple regression: Fixed model, R² deviation from zero
Analysis:

A priori: Compute required sample size

Input:

Effect size f²

= 0.15

α err prob

= 0.05

Power (1-β err prob)

= .8

Number of predictors

= 8

Noncentrality parameter λ

= 16.3500000

Critical F

= 2.0323276

Numerator df

= 8

Denominator df

= 100

Total sample size

= 109

Actual power

= 0.8040987

Output:

[2] -- Saturday, August 31, 2019 -- 11:15:57
t tests - Means: Difference between two independent means (two groups)
Analysis:

A priori: Compute required sample size

Input:

Tail(s)

= Two

Effect size d

= 0.5

α err prob

= 0.05

Power (1-β err prob)

= .80

Allocation ratio N2/N1

= .2

Noncentrality parameter δ

= 2.8136572

Critical t

= 1.9705162

Df

= 226

Sample size group 1

= 190

Sample size group 2

= 38

Total sample size

= 228

Actual power

= 0.8000279

Output:

[3] -- Saturday, August 31, 2019 -- 11:16:07
t tests - Means: Difference between two independent means (two groups)
Analysis:

A priori: Compute required sample size

Input:

Tail(s)

= Two

Effect size d

= 0.5

α err prob

= 0.05

Power (1-β err prob)

= .80

Allocation ratio N2/N1

= .2

Noncentrality parameter δ

= 2.8136572

Critical t

= 1.9705162

Df

= 226

Sample size group 1

= 190

Sample size group 2

= 38

Output:
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Total sample size

= 228

Actual power

= 0.8000279

[4] -- Saturday, August 31, 2019 -- 11:16:09
t tests - Means: Difference between two independent means (two groups)
Analysis:

A priori: Compute required sample size

Input:

Tail(s)

= Two

Effect size d

= 0.5

α err prob

= 0.05

Power (1-β err prob)

= .80

Allocation ratio N2/N1

= .2

Noncentrality parameter δ

= 2.8136572

Critical t

= 1.9705162

Df

= 226

Sample size group 1

= 190

Sample size group 2

= 38

Total sample size

= 228

Actual power

= 0.8000279

Output:

[5] -- Saturday, August 31, 2019 -- 11:29:08
z tests - Proportions: Difference between two independent proportions
Analysis:

A priori: Compute required sample size

Input:

Tail(s)

= Two

Proportion p2

= .4

Proportion p1

= .15

α err prob

= 0.05

Power (1-β err prob)

= .8

Allocation ratio N2/N1

= .2

Critical z

= 1.9599640

Sample size group 1

= 131

Sample size group 2

= 26

Total sample size

= 157

Actual power

= 0.7984614

Output:
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Appendix B: Data Use Agreement
See the attached data use agreement, which has been executed by the Florida
Department of Health.
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Appendix C: Post Hoc Power Analysis

[1] – Saturday, February 01, 2020 – 23:59:33
t tests – Means: Difference between two independent means (two groups)
Analysis:

Post hoc: Compute achieved power

Input:

Tail(s)

= Two

Effect size d

= 0.5

α err prob

= 0.05

Sample size group 1

= 25834

Sample size group 2

= 4836

Noncentrality parameter δ

= 31.9118579

Critical t

= 1.9600413

Df

= 30668

Power (1-β err prob)

= 1.0000000

Output:
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Appendix D: Research Question 1 - Multiple Linear Regression Assumptions
In the first research question, I addressed the relationship between demographic
factors (race, gender, age, education level, and federal poverty level), treatment
compliance (as defined by the number of ART missed doses in the past 30 days,
engagement in care (as defined by the number of HIV/AIDS-related physician visits,
within the previous 12 months), coverage status (enrolled in the RWHAP or an
ACAQHP) and the health status of PLWHA (as defined by viral suppression). I used a
multiple linear regression to analyze this research question. There are eight assumptions
that need to be considered when completing a multiple linear regression analysis. These
assumptions include 1) a continuous dependent variable, 2) two or more continuous or
categorical independent variables, 3) an independence of observations/residual values, 4)
a linear relationship between the independent and dependent variables (collectively and
individually), 5) homoscedasticity of the data, 6) no multicollinearity, 7) no significant
outliers, and 8) residuals that are approximately normally distributed (Laerd Statistics,
2018d).
I met the first two assumptions (1, 2) as the dependent variable in this research
question, viral load change is continuous, while the independent variables including race,
gender, age, federal poverty level, out-of-pocket medical expenses, treatment compliance,
and engagement in care are all continuous or categorical variables. The third assumption,
an independence of observations/residual values can be checked using the DurbinWatson statistic. Although the Durbin-Watson statistic can range from between 0 and 4, a
value around 2.0 indicates an independence of observations and no correlation between
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the residual values (Laerd Statistics, 2018d). As I used weighted data in this study, the
Durbin-Watson statistic for this research question was not generated by SPSS and I was
unable to assess the independence of observations/residual. However, the DurbinWatson statistic was not needed because the use of weighted data eliminated the
possibility of autocorrelation between the variables in the study.
The fourth assumption, the verification of linearity between the dependent
variable and the independent variables can be checked by examining a scatterplot of the
studentized residuals against the unstandardized predicted value and by reviewing the
partial regression plots between the dependent variable and each independent variable
(Laerd Statistics, 2018d). I visually evaluated the scatterplot and confirmed there was a
linear relationship between the variables. However, as weighted data was used in this
research study, SPSS did not produce partial regression plots. Consequently, I confirmed
the assumption of linearity based solely on the visual examination of the scatterplot.
I also used the simple scatter plot of studentized residuals by unstandardized
predicted values presented in Figure 2 to assess the fifth assumption, the
homoscedasticity of the residuals. Homoscedasticity is achieved when the variance is the
same for all values of the predicted dependent variable (Laerd Statistics, 2018d). I
confirmed homoscedasticity by visually evaluating the scatterplot of studentized residuals
versus unstandardized predicted values.
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Figure 2. Scatter plot of the studentized residuals against the unstandardized predictive
values depicting linearity of the dependent variable and all independent variables.
The sixth assumption of a multiple linear regression is the data must not
demonstrate multicollinearity, which occurs when multiple independent variables are
correlated with one another (Laerd Statistics, 2018d). The existence of multicollinearity
is determined by reviewing the Pearson correlation results in the correlations table and
the tolerance and VIF statistics in the coefficients table generated by SPSS.
Multicollinearity is present if the Pearson correlation values are equal to or greater than
0.80 (Field, 2013) and if the tolerance value is less than 0.1 or the VIF is greater than 10
(Laerd Statistics, 2018d). I confirmed there was no multicollinearity as all tolerance
values were less than 0.1, all VIF values were less than 10, and the Pearson correlation
values for all variables as shown in Table 13 were less than 0.80.
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Table 13
Pearson Correlation Values

VLCHANGE
Race
Gender
Age
Education
Poverty Level
ART Missed
HIV Visits
Insurance

VLCHG
1.000
-0.101
-0.073
0.077
0.068
0.165
0.032
-0.195
-0.071

Race Gender
-0.101 -0.073
1.000
0.165
0.165
1.000
0.040
0.035
0.051 -0.176
-0.062 -0.236
0.118 -0.067
0.024
0.104
0.229
0.032

VLCHANGE
Race
Gender
Age
Education
Poverty Level
ART Missed
HIV Visits
Insurance

Poverty
ART
Level
Missed
0.165
0.032
-0.062
0.118
-0.236 -0.067
-0.009
0.044
0.338
0.057
1.000
0.178
0.178
1.000
-0.128 -0.125
-0.148
0.073

Age
Education
0.077
0.068
0.040
0.051
0.035
-0.176
1.000
-0.029
-0.029
1.000
-0.009
0.338
0.044
0.057
0.104
0.001
-0.020
0.063

HIV
Visits Insurance
-0.195
-0.071
0.024
0.229
0.104
0.032
0.104
-0.020
0.001
-0.063
-0.128
-0.148
-0.125
0.073
1.000
0.058
0.058
1.000

The seventh assumption of a multiple linear regression test is there should be no
significant outliers or extreme values in the dataset. The presence of data outliers can be
determined by inspecting the casewise diagnostics and studentized deleted residuals for
values great than ±3 standard deviations (Laerd Statistics, 2018d). Upon visual evaluation
of the casewise diagnostics and studentized deleted residuals values, I confirmed the
assumption of no significant outliers was violated as values exceeded ±3 standard
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deviations. Although outlier data should be removed if caused by a data entry error, the
data may remain in the study if valid (Laerd Statistics, 2018d). As the data points
represent the change in viral load among PLWHA and are not abnormal outliers, I
purposely did not remove them when I ran the analysis. These outlier data points
demonstrated large changes in viral load and eliminating them would bias the study
against PLWHA who realized significant viral load changes.
The eighth and final assumption of a multiple linear regression test is a normal
distribution of residuals, which can be evaluated using a normal Q-Q plot of studentized
residuals. Normally distributed residuals are confirmed when the data points are closely
proximate to the diagonal line (Laerd Statistics, 2018d). As can be seen in figure 3, the
assumption of normally distributed residuals was met, as assessed by a Q-Q Plot.

Figure 3. Normal Q-Q Plot showing residuals that are normally distributed.
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Appendix E: Research Question 2 - Independent Samples t test Assumptions
In the second research question, I used an independent samples t test to address
the difference in treatment compliance (as defined by the number of ART missed doses in
the past 30 days) between PLWHA enrolled in an ACAQHP and PLWHA enrolled in the
RWHAP. There are six assumptions that must be satisfied to run an independent samples
t test. These assumptions include: a dependent variable that is continuous, an independent
variable that consists of two independent categorical groups, an independence of
observations, a homogeneity of variances, normality in the distribution of the dependent
variable around the independent variables, and no significant outliers (Laerd Statistics,
2018b). I met the first three assumptions for this research question based on the overall
design of the research study. The dependent variable, number of ART prescription refills
is continuous, the independent variable is comprised of two independent categorical
groups and an independence of observations has been achieved by ensuring that each
study participant has been assigned to a group of PLWHA that have coverage from either
the RWHAP or the ACA.
I used SPSS to determine if the final three assumptions of an independent samples
t test were met. First, a Levene’s test of equality of error variances was run to determine
if there was homogeneity of variances. A homogeneity of variance exists when the
variance within each group in the independent variable is equal (Field, 2013).
Homogeneity is confirmed if the Levene’s test produces a non-statistically significant
result which occurs when the p-value (significance level) is greater than .05 (Field, 2013).
The results of the Levene’s test in Table 14 showed there was a heterogeneity in the

224
variances in treatment compliance between PLWHA enrolled in the RWHAP and
PLWHA enrolled in an ACAQHP as F(1,9461.358) = 310.602, p < .001.
Table 14
Levene’s Test for Equality of Variances – Treatment Compliance

Treatment
Compliance

Equal variances not assumed

F
310.602

Sig.
t
.000 -16.883

df
9461.358

Second, I used SPSS to confirm the normal distribution of the data which occurs when
the dependent variable is normally distributed by each level of the independent variable
(Field, 2013). Two methodologies were used to determine if the study data was normally
distributed. These two approaches included analyzing the results of the Shapiro-Wilk’s
test and interpreting the shape of the Normal Q-Q Plots (Laerd Statistics, 2018b). The
Shapiro-Wilk’s test confirms normality of distribution when the result is not statistically
significant (Field, 2013). As I used weighted data in this study, SPSS did not generate the
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA
enrolled in the RWHAP and enrolled in an ACAQHP to graphically assess the normality
of the data distribution. Normally distributed data will appear as round dots located near
the diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the
Normal Q-Q Plots presented in Figure 4 and Figure 5, treatment compliance (as defined
by the number of ART missed doses in the past 30 days) data for both PLWHA enrolled
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in the RWHAP and in an ACAQHP was not normally distributed.

Figure 4. Scatter plot depicting treatment compliance data (as defined by the number of
ART missed doses in the past 30 days) that is not normally distributed for PLWHA
enrolled in an ACAQHP.

Figure 5. Scatter plot depicting treatment compliance data (as defined by the number of
ART missed doses in the past 30 days) that is not normally distributed for PLWHA
enrolled in the RWHAP.
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Finally, I used SPSS to determine if the dataset contained a significant number of
outliers. Outliers are single data points that vary from the others and can reduce the
validity of the test results and were assessed by examining the box-whisker plot produced
from SPSS (Field, 2013). Outliers are data points plotted above the top whisker or below
the bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the
boxplot shown in Figure 6, I confirmed outliers were present in the data for PLWHA who
were enrolled in the RWHAP and enrolled in an ACAQHP.

Figure 6. Box plot showing the presence of outliers for treatment compliance data (as
defined by the number of ART missed doses in the past 30 days) for PLWHA enrolled in
the RWHAP and enrolled in an ACAQHP.
Due to heterogeneity in the equality of variances, violations in the assumptions of
normality in the distribution of the dependent variable around the independent variables,
and the presence of significant outliers in the dataset, I used a Mann-Whitney U to
analyze the data instead of an independent samples t test (Laerd Statistics, 2018c). The
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Mann-Whitney U test is a nonparametric test used to determine if statistically
significance differences exist between two groups when an independent samples t test
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The MannWhitney U test has three assumptions that must be met prior to running the statistical test
which include a continuous or ordinal dependent variable, a categorical independent
variable with two groups, and an independence of observations (Laerd Statistics, 2018c).
As I met all three assumptions based on the design of my study, I used a Mann-Whitney
U test to determine if there were differences in treatment compliance (as defined by the
number of ART missed doses in the past 30 days) between PLWHA enrolled in an
ACAQHP and PLWHA enrolled in the RWHAP.
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Appendix F: Research Question 3 - Independent Samples t test Assumptions
In the third research question, I used an independent samples t test to address the
difference in engagement in care (as defined by the number of HIV/AIDS-related
physician visits within the previous 12 months) between PLWHA enrolled in an
ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions must also be
met in this research question which include a dependent variable that is continuous, an
independent variable that consists of two independent categorical groups, an
independence of observations, a homogeneity of variances, normality in the distribution
of the dependent variable around the independent variables, and no significant outliers
(Laerd Statistics, 2018b).
I met the initial three assumptions (a dependent variable that is continuous, an
independent variable that consists of two independent categorical groups and an
independence of observations) based on the overall design of the research study. I used
SPSS to determine if the three remaining assumptions (a homogeneity of variances,
normality in the distribution of the dependent variable around the independent variables,
and no significant outliers) were met. First, I ran a Levene’s test of equality of error
variances to determine if there was a homogeneity of variances. A homogeneity of
variance exists when the variance within each group in the independent variable is equal
(Field, 2013). Homogeneity is confirmed if the Levene’s test produces a non-statistically
significant result which occurs when the p-value (significance level) is greater than .05
(Field, 2013). The results of the Levene’s test shown in Table 15 indicated there was a
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difference in the variances in engagement in care between PLWHA enrolled in the
RWHAP and PLWHA enrolled in an ACAQHP as F(1,9621.887) = 258.616, p < .001.
Table 15
Levene’s Test for Equality of Variances - Engagement in Care

Engagement in
Care

Equal variances not assumed

F
258.616

Sig.
t
.000 -13.542

Df
9621.887

Second, I used SPSS to confirm the normal distribution of the data which occurs
when the dependent variable is normally distributed by each level of the independent
variable (Field, 2013). As I used weighted data in this study, SPSS did not generate the
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA
enrolled in the RWHAP and in an ACAQHP to graphically assess the normality of the
data distribution. Normally distributed data will appear as round dots located near the
diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the Normal
Q-Q Plots presented in Figure 7 and Figure 8, engagement in care data (as defined by the
number of HIV/AIDS-related physician visits within the previous 12 months) for
PLWHA enrolled in the RWHAP was not normally distributed.
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Figure 7. Scatter plot depicting engagement in care data (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) that is normally
distributed for PLWHA enrolled in an ACAQHP.

Figure 8. Scatter plot depicting engagement in care data (as defined by the number of
HIV/AIDS-related physician visits within the previous 12 months) that is not normally
distributed for PLWHA enrolled in the RWHAP.

231

Finally, I used SPSS to generate a box-whisker plot to determine the presence of
any data outliers. Outliers are data points plotted above the top whisker or below the
bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the boxplot
shown in Figure 9, I confirmed outliers were present in the data for PLWHA who were
enrolled in the RWHAP and not in the data for PLWHA enrolled in an ACAQHP.

Figure 9. Box plot showing the presence of outliers for engagement in care data (as
defined by the number of HIV/AIDS-related physician visits within the previous 12
months) for PLWHA enrolled in the RWHAP and no outliers for PLWHA enrolled in an
ACAQHP.
Due to heterogeneity in the equality of variances, violations in the assumptions of
normality in the distribution of the dependent variable around the independent variables,
and the presence of significant outliers in the dataset, I used a Mann-Whitney U to
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analyze the data instead of an independent samples t test (Laerd Statistics, 2018c). The
Mann-Whitney U test is a nonparametric test used to determine if statistically
significance differences exist between two groups when an independent samples t test
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The MannWhitney U test has three assumptions that must be met prior to running the statistical test
which include a continuous or ordinal dependent variable, a categorical independent
variable with two groups, and an independence of observations (Laerd Statistics, 2018c).
As I met all three assumptions based on the design of my study, I used a Mann-Whitney
U test to determine if there were differences in engagement in care (as defined by the
number of HIV/AIDS-related physician visits within the previous 12 months) between
PLWHA enrolled in an ACAQHP and PLWHA enrolled in the RWHAP.
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Appendix G: Research Question 4 - Independent Samples t test Assumptions
In the fourth research question, I used an independent samples t test to address the
difference in health status (as defined by viral suppression) between PLWHA enrolled in
an ACAQHP and PLWHA enrolled in the RWHAP. The same six assumptions must also
be met in this research question which include a dependent variable that is continuous, an
independent variable that consists of two independent categorical groups, an
independence of observations, a homogeneity of variances, normality in the distribution
of the dependent variable around the independent variables, and no significant outliers
(Laerd Statistics, 2018b).
The same six assumptions must also be met in this research question which
include a dependent variable that is continuous, an independent variable that consists of
two independent categorical groups, an independence of observations, a homogeneity of
variances, normality in the distribution of the dependent variable around the independent
variables, and no significant outliers (Laerd Statistics, 2018b).
I met the initial three assumptions (a dependent variable that is continuous, an
independent variable that consists of two independent categorical groups and an
independence of observations) based on the overall design of the research study. I used
SPSS to determine if the three remaining assumptions (a homogeneity of variances,
normality in the distribution of the dependent variable around the independent variables,
and no significant outliers) were met. First, I ran a Levene’s test of equality of error
variances to determine if there was a homogeneity of variances. A homogeneity of
variance exists when the variance within each group in the independent variable is equal
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(Field, 2013). Homogeneity is confirmed if the Levene’s test produces a non-statistically
significant result which occurs when the p-value (significance level) is greater than .05
(Field, 2013). The results of the Levene’s test shown in Table 16 revealed there was a
difference in the variances in health status between PLWHA enrolled in the RWHAP and
PLWHA enrolled in an ACAQHP as F(1,30566.262) = 583.703, p < .001.
Table 16
Levene’s Test for Equality of Variances – Health Status

Health Status

Equal variances not
assumed

F
583.703

Sig.
.000

t
26.740

Df
30566.262

Second, I used SPSS to confirm the normal distribution of the data which occurs
when the dependent variable is normally distributed by each level of the independent
variable (Field, 2013). As I used weighted data in this study, SPSS did not generate the
Shapiro-Wilk’s test for this research question, so it was not used to assess the normality
of distribution. Instead, I used the Normal Q-Q Plot output from SPSS for PLWHA
enrolled in the RWHAP and in an ACAQHP to graphically assess the normality of the
data distribution. Normally distributed data will appear as round dots located near the
diagonal line (Laerd Statistics, 2018b). Based on my graphical assessment of the Normal
Q-Q Plots presented in Figure 10 and Figure 11, health status (as defined by viral load
suppression) for both PLWHA enrolled in the RWHAP and enrolled in an ACAQHP
were not normally distributed.
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Figure 10. Scatter plot depicting health status data (as defined by viral load suppression)
that is not normally distributed for PLWHA enrolled in an ACAQHP.

Figure 11. Scatter plot depicting health status data (as defined by viral load suppression)
that is not normally distributed for PLWHA enrolled in the RWHAP.
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Finally, I used SPSS to determine if the dataset contained a significant number of
outliers. Outliers are single data points that vary from the others and can reduce the
validity of the test results and were assessed by examining the box-whisker plot produced
from SPSS (Field, 2013). Outliers are data points plotted above the top whisker or below
the bottom whisker (Laerd Statistics, 2012e). Based on my visual inspection of the
boxplot shown in Figure 12, I confirmed outliers were present in the data for PLWHA
who were enrolled in the RWHAP and enrolled in an ACAQHP.

Figure 12. Box plot showing the presence of outliers for health status data (as defined by
viral load suppression) for PLWHA enrolled in the RWHAP and for PLWHA enrolled in
an ACAQHP.
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Due to heterogeneity in the equality of variances, violations in the assumptions of
normality in the distribution of the dependent variable around the independent variables,
and the presence of significant outliers in the dataset, I used a Mann-Whitney U to
analyze the data instead of an independent samples t test (Laerd Statistics, 2018c). The
Mann-Whitney U test is a nonparametric test used to determine if statistically
significance differences exist between two groups when an independent samples t test
when data fails to meet the required assumptions (Laerd Statistics, 2018c). The MannWhitney U test has three assumptions that must be met prior to running the statistical test
which include a continuous or ordinal dependent variable, a categorical independent
variable with two groups, and an independence of observations (Laerd Statistics, 2018c).
As I met all three assumptions based on the design of my study, I used a Mann-Whitney
U test to determine if there were differences in health status (as defined by viral load
suppression) between PLWHA enrolled in the RWHAP and PLWHA enrolled in an
ACAQHP.
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Appendix H: Research Question 5 – Chi-Square Assumptions
In the fifth research question, I used a chi-square to address the difference ins
difficulty in paying out-of-pocket medical expenses (as defined by problems paying for
any out-of-pocket medical or health insurance costs) between PLWHA enrolled in the
RWHAP and PLWHA enrolled in an ACAQHP. There are three assumptions that must
be satisfied to run this test. I met the first two assumptions (variables must be categorical
and an independence of observations) based on the design of my study. The third
assumption of a chi-square test is that all cells in the SPSS cross-tabulation output table
must have expected counts that are greater than five (Field, 2013). As can be seen in
Table 17, I met this assumption as all cell counts for the expected count were greater than
five.
Table 17
Insurance * Financial Crosstabulation

Count
Expected Count

No Financial
Issues
4201
3558.3

Financial
Issues
635
1277.7

Total
4836
4836

RWHAP

Count
Expected Count

18366
19008.7

7468
6825.3

25834
25834

Total

Count
Expected Count

22567
22567

8103
8103

30670
30670

Coverage
ACA

As I met all three assumptions of a chi-square test, I used this test to examine the
difference in difficulty in paying out-of-pocket medical expenses (as defined by problems
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paying for any out-of-pocket medical or health insurance costs) between PLWHA
enrolled in the RWHAP and PLWHA enrolled in an ACAQHP.

